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Abstract 
Microbial cell factory, which converts biomass feedstock to value-added compounds such as 
fuels, chemicals, materials and pharmaceuticals, has been proposed as a sustainable and 
renewable alternative to the traditional petrochemical industry.  Saccharomyces cerevisiae is one 
of the most widely used microbial cell factories, to produce ethanol as the first generation of 
biofuel.  To enable this yeast as a producer for 1-butanol, which is a next-generation gasoline 
substitute, I discovered, characterized and engineered an endogenous 1-butanol pathway in S. 
cerevisiae.  Upon introduction of a single gene deletion adh1Δ, S. cerevisiae was able to 
accumulate more than 120 mg/L 1-butanol from glucose in the rich medium.  Precursor feeding, 
13C-isotope labeling and gene deletion experiments demonstrated that the endogenous 1-butanol 
production was dependent on catabolism of threonine in a manner similar to fusel alcohol 
production by the Ehrlich pathway.  Overexpression of the pathway enzymes and elimination of 
competing pathways achieved the highest reported 1-butanol titer in S. cerevisiae (243 mg/L). 
Though 1-butanol titer was improved through pathway-based engineering, such rational 
design often meets with great challenges in cellular reprogramming due to our limited 
knowledge of complex biological systems.  Directed evolution, on the other hand, has been 
proved as a better strategy by performing iterative cycles of mutagenesis and selection.  Current 
practice of directed evolution is mostly confined to individual proteins, due to the lack of 
efficient tools to introduce mutations globally and iteratively in a genome.  In the rest of this 
dissertation, I sought to develop a new method, RNA-interference assisted genome evolution 
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(RAGE), to apply directed evolution strategy in genome scale engineering of S. cerevisiae.  
A functional RNA interference (RNAi) pathway was reconstituted in S. cerevisiae by 
introducing the Dicer and Argonaute proteins from Saccharomyces castellii as previously 
reported.  We then performed the first RNAi screening in S. cerevisiae.  The RNAi plasmid 
library was constructed with random genomic fragments and a convergent promoter expression 
cassette, which drives the in vivo synthesis of double-stranded RNAs (dsRNAs) to mediate 
knockdown of homologous genes.  The library was confirmed with a complete coverage of the 
yeast genome, and employed to perform a suppressor analysis of a telomere-defect mutation 
yku70Δ.  Two known and three novel knockdown modifications were identified to alleviate the 
growth arrest of the Δyku70 strain at higher temperature, confirming the effectiveness of our 
RNAi library for genotyping.  After establishing RNAi screening in S. cerevisiae, we combined it 
with directed evolution to rapidly engineer yeast cells for improved acetic acid (HAc) tolerance.  
Three rounds of iterative RNAi screening resulted in accumulation of three gene knockdown 
modifications that acted synergistically to confer substantially improved HAc tolerance.  
Together, these results demonstrated the RAGE method as an efficient, genome-scale and 
generally applicable strategy for directed genome evolution in S. cerevisiae.  
I then expanded the application of RAGE to create a comprehensive genetic library 
(RAGE2.0).  By directional cloning of a full-length, normalized cDNA library, one-step 
construction of the genome-wide ORF-overexpression and anti-sense RNA libraries was 
achieved.  In the presence of the RNAi pathway, the RAGE2.0 library resulted in genome-wide 
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overexpression and knockdown modifications simultaneously.  A wide range of phenotypes, 
including protein secretion, substrate utilization, and fuel molecule production, were screened 
with the RAGE2.0 library in a high-throughput manner.  Both overexpression and knockdown 
targets were successfully identified to improve these phenotypes.   
I further developed the RAGE3.0 method for automated genome engineering in yeast.  Upon 
introduction of specific double-stranded breaks (DSBs) in the repetitive sequences by CRISPR 
nucleases, the genome-wide overexpression and knockdown cassettes in the RAGE2.0 library 
can be integrated into the genomic loci of repetitive sequences at high efficiency.  This process 
can be iteratively performed to accumulate multiple genetic modifications in a single cell of an 
evolving yeast population.  RAGE3.0 only involves simple liquid handling steps, hence it is 
readily automated with an integrated robotic platform.  We envision this automated genome 
engineering method can enable generation of vast genetic diversity from which new or improved 
properties may emerge, and therefore greatly accelerate basic and applied biological research in 
S. cerevisiae. 
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Chapter 1 Introduction 
 
1.1.  Microbial cell factory 
Microbial cell factory, which converts biomass resources to value-added compounds such as 
fuels, chemicals, materials and pharmaceuticals, has been proposed as a sustainable and 
renewable alternative to the traditional petrochemical industry1.  However, microorganisms are 
evolved to reproduce and survive in their native niche, and thus intensive reprogramming of the 
cellular machinery is needed to tailor the host cells for industrial applications2, 3.  Numerous 
attempts have been made to overcome technical hurdles in the development of economically 
feasible processes based on microbial cell factories.  For example, the cellulolytic capacity has 
been engineered into production hosts by secreting or surface-displaying 
cellulases/hemicellulases4, 5.  Engineered metabolic pathways have been introduced to enable the 
fermentation of non-glucose sugars derived from lignocellulosic feedstock6.  Novel biochemical 
transformations performed by heterologous pathways in either native or engineered forms can 
expand the scope of molecules that the microbes can synthesize.  Both non-native pathways and 
host metabolism have been modified to redirect the metabolic fluxes without compromising the 
general fitness, in order to maximize the fermentation productivity and yield6-10.  High levels of 
tolerance to the inhibitors in the lignocellulosic hydrolysate, the substrates and the final products 
as well as the harsh industrial environment (temperature, pH, osmotic pressure, etc.) are needed 
for robust production processes.   
Though impressive progress has been made to engineer these industrially desired traits, the 
task of strain improvement remains challenging. This is because both our knowledge of complex 
biological systems and the tools to manipulate the cellular machinery are rather limited.  
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Conventional strain engineering approaches relies on random mutagenesis, which is achieved 
through chemical mutagens/UV irradiation11, prolonged cultivation under selective pressure12, 
transposon insertions13-15 and genome shuffling16, 17.  These methods are often labor-intensive, 
time-consuming, dependent on serendipity, and extremely difficult to analyze and transfer the 
genetic basis of a selected trait.  Recently, the scale, efficiency and precision of genetic analysis 
and manipulation have been remarkably improved by several enabling technologies, including 
but not limited to microarray DNA synthesis, next-generation DNA sequencing (NGS), 
programmable DNA-binding proteins, in vivo biosensors, etc.  Nowadays, billions of genome 
variants can be created in a directed and/or combinatorial manner, and the mutant strains with the 
optimal performance can be rapidly isolated.  Collectively, these new technologies and their 
applications exemplify an emerging discipline called “genome scale engineering”18-21.     
 
1.2. Genome scale engineering 
The practice of genome scale engineering can be broadly classified into three categories: 
genome editing, transcriptome engineering and genome synthesis (Fig. 1.1).  Genome editing 
precisely or combinatorially modify the target genome at multiple loci.  Modifications locate 
either in the open-reading frames (ORFs) or in the cis-acting regulatory elements such as 
promoters and ribosome-binding sites (RBSs).  Transcriptome engineering essentially targets 
trans-acting regulatory elements, such as transcription factors (TFs) and non-coding RNAs 
(ncRNAs), by mutating endogenous regulators or introducing artificial ones.  Genome synthesis 
involves hierarchical assembly of short chemically synthesized DNA fragments into genomic 
constructs.  Although current synthetic genomes are constructed mainly based on their wild type 
templates, the ultimate goal is to write genome sequences de novo. 
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Figure 1.1. Overview of genome scale engineering tools in microbial systems.  Programmable 
nucleases and recombineering are the two most promising targeted genome editing technologies.  
Transcriptome engineering targets trans-acting regulatory elements including transcription factors and 
non-coding RNAs. 
 
1.2.1. Targeted genome editing 
Targeted genome editing can be performed with a series of tools including recombinases22, 23, 
group II intron retrotransposition24, programmable nucleases25, and recombineering26, 27.  The last 
two tools are considered most promising due to their high targeting efficiency and ease of 
retargeting (Fig. 1.1).   
Programmable nucleases mainly includes TALENs (Transcription Activator-Like Effector 
4 
 
Nucleases) and CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) nucleases, 
whose DNA-binding specificities can be easily predicted and altered25.  These nucleases are 
introduced to create double-stranded breaks (DSBs) at target DNA sequences, and DSBs greatly 
stimulate homologous recombination (HR) to facilitate gene modification near the DSBs20, 25, 28.   
Recombineering uses phage proteins (RecET, λ-Red) to efficiently recombine a donor DNA 
strand with a bacterial genome via HR26, 29.   In particular, recombination with ssDNA 
oligonucleotides can be mediated by the λ-Red-like protein in Escherichia coli, where oligos are 
incorporated to the lagging strand during genome replication at high efficiency30.  Combining 
recombineering with microarray-derived oligonucleotide pools, the Multiplex Automated 
Genome Engineering (MAGE) method can continuously introduce combinatorial modifications 
across the E. coli genome31.    
 
1.2.2. Transcriptome engineering 
Comparing with targeted genome editing, transcriptome engineering provides a 
complementary strategy for genome scale engineering.  Targeting at trans-acting regulatory 
elements, genetic modulation is achieved without modifying the target chromosome loci.  This 
feature not only eliminates the need for prior knowledge of host genomes, which is required by 
most genome editing methods that depend on HR, but also avoids the neighboring effects caused 
by physical modifications on a genome.  Transcription factors (TFs) and regulatory non-coding 
RNAs (ncRNAs) are the most common targets for transcriptome engineering (Fig. 1.1).   
Thanks to transcriptional regulatory networks, cells can rapidly coordinate the expression of 
thousands of genes when facing both internal and environmental stimuli32.  Such networks 
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exhibit pyramid-shaped hierarchical structures, with most transcription factors (TF) at the bottom 
levels, some midlevel TFs, and only a few master TFs on top33.   Whereas specific TFs at the 
bottom levels modulate dozens of genes in the same functional group, the master TFs have 
global influence over the gene expression profile33.  Such properties make TFs the ideal targets 
for transcriptome reprogramming by modulating many genes simultaneously34, 35.   
Two main strategies have been applied to engineer TFs: modulation of native transcriptional 
machinery and introduction of artificial TFs. As a demonstration of native TF engineering, 
Global Transcriptional Machinery Engineering (gTME) introduces mutations to the master TFs 
that mainly mediate DNA recognition, based on the assumption that variations in these TFs may 
exert substantial changes to the promoter preference of the RNA polymerase.  As proof of 
concept, the principal sigma factor in E. coli (σ70) was subjected to error-prone PCR.  From the 
resultant strain libraries, mutants with improved tolerance to sodium dodecyl sulfate (SDS) and 
ethanol were identified through serial subculturing36.  In Saccharomyces cerevisiae, the TATA-
binding protein Spt15p and a TATA-binding protein-associated factor Taf25p were mutated.  The 
best variant, which harbored three amino acid mutations in Spt15p, conferred a 70% 
improvement in the ethanol productivity37.  On the other hand, artificial transcription factor 
(ATF) libraries have also been created to generate transcriptional diversity.  A minimal ATF may 
only contain a DNA-binding domain, whose interaction with its target sequence most likely 
down-regulate the expression of a nearby gene by interfering with the transcriptional initiation or 
elongation38.  The DNA-binding domain can also be attached to effector (activator/repressor) 
domains or ligand-binding domains, which permits more sophisticated regulation.  Most ATF 
reported so far has employed zinc finger proteins (ZFPs) as the DNA-binding domains, and the 
library of ATFs is constructed through combinatorial assembly of individual zing fingers with 
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diverse DNA-binding specificities.   The first example of such effort was the introduction of over 
105 ZFPs attached with effector domains into S. cerevisiae39.  The library consisted of three- or 
four-finger ZFPs, which recognize 9bp or 12bp DNA sequences with limited randomness 
constrained by choice of individual fingers (40 and 25 individual fingers for three- and four-
finger proteins, respectively).  Several artificial TFs have been identified to confer a number of 
tolerance phenotypes towards heat, osmotic pressure and an antifungal drug ketoconazole39.  A 
similar strategy has been applied to E. coli to isolate tolerant strains towards heat shock38 and 
butanol40.   
In addition to TF networks, non-coding RNA molecules (ncRNAs) are also increasingly 
recognized as key regulators across the biological kingdoms41, 42.  To be suitable for genome-
wide application, synthetic ncRNAs should be preferably trans-acting, permitting simple 
introduction of a genome-wide library with minimal considerations on local genetic context.  
Also, the interaction between an ncRNA and its DNA or mRNA target should be mainly 
determined by Watson-Crick base pairing, so that the binding specificity and efficiency can be 
predictable and programmable.    
In bacteria, trans-acting small RNAs (sRNAs) and antisense RNAs (asRNAs) are two main 
regulatory ncRNAs41.  Na et al. recently developed a general framework to design synthetic 
sRNAs in E. coli for metabolic engineering43.  The synthetic sRNAs were composed of a 
scaffold sequence and a target-binding sequence.  The scaffold was derived from a naturally 
occurring sRNAs, MicC, and the scaffold can recruit the Hfq protein to facilitate sRNA-mRNA 
interaction and mRNA degradation.  The native target binding sequence of MicC can be replaced 
by the antisense sequence to the translation initiation region (TIR) of any given gene.  
Correlation was found between the repression capability and the binding energy of the antisense 
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sequence, which allowed for fine-tuning of knockdown efficiency.  Although the sRNA library 
constructed in that study only target the cadaverine production related genes43, it is possible to 
expand the strategy to a genome scale.   
On the other hand, asRNAs have been used for functional genomics study in a series of 
bacteria, such as Streptococcus mutans44 and Staphylococcus aureus45.  However, it has been 
long recognized that asRNAs are inefficient for gene repression in E. coli46.  Recently, it was 
found that asRNA molecules with paired-termini have enhanced stability and hence improved 
repression capacity47.  Enzymatic digested E. coli genomic DNA fragments has been cloned into 
a paired-termini expression vector to generate a genome-wide asRNA library, which was used to 
successfully isolate asRNAs that target essential genes and led to conditional growth inhibitory48.   
As for eukaryotes, the most common ncRNA machinery for gene expression regulation is 
RNA interference (RNAi), a cellular gene silencing mechanism whereby mRNAs are targeted for 
degradation by homologous double-stranded RNAs (dsRNAs)49, 50.  RNAi proves to be a 
powerful tool for genome-wide reduction-of-function screen in many higher eukaryotes51, 52, yet 
its applications in microbes are rare.  This is probably due to the lack of a native RNAi pathway 
in S. cerevisiae, which is the most-widely used microbial eukaryote.  Recently, heterologous 
RNAi machinery has been reconstituted in S. cerevisiae53, which opens up the possibility of 
genome-wide RNAi screen in this yeast.   
In addition to naturally-occurring ncRNAs, synthetic RNAs were also used to modulate gene 
expression in the CRISPR-mediated interference (CRISPRi) and CRISPR-mediated activation 
technologies.  By co-expressing of a Cas9 mutant with abolished endonuclease activity (dCas9) 
and a guide RNA targeting at the non-template DNA strand of a target gene, up to 1,000-fold 
reduction in gene expression was achieved in E. coli54.  In S. cerevisiae, the silencing efficiency 
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may be further improved by fusing the dCas9 protein to transcription repressors or chromatin 
silencers55.  For gene activation, transcriptional activators can be delivered by the dCas9-guide 
RNA complex to the upstream region of a promoter, resulting in up-regulation in E. coli56 and 
yeast55, 57.   
 
1.2.3. Genome synthesis 
Genome synthesis is one of the most impressive achievement of synthetic biology, ranging 
from viral genomes58, 59, bacterial genomes60-62 to yeast chromosomes63, 64.  Early efforts mainly 
focused on increasing the scale of the final DNA constructs, from the 7.5 kb cDNA copy of a 
poliovirus genome58 to a 1.08 Mb bacterial genome61.   In terms of DNA sequences, the synthetic 
genomes are almost exact copies of the native ones, except a few inserted “watermarks” such as 
the names of the team members60, 61.  A recent report took a step further to build a designer yeast 
chromosome that was substantially different from its wild-type template64.  Compared to the 
native chromosome III of S. cerevisiae, the designer chromosome synIII was ~ 14% smaller due 
to the deletion of some non-essential regions such as transfer RNAs, transposons, introns, etc.  
However, the design principles are still very simple, and it requires substantial technological 
development before we can write a fully synthetic genome.   
 
1.3.  High-throughput genotyping with genetic libraries 
One important application of genome scale engineering is to create genome-wide libraries, 
which are powerful tools to comprehensively investigate the impact of individual genetic 
modification on a given phenotype.  For overexpression libraries, either genomic fragments65 or 
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all the open reading frames (ORFs) under the control of a promoter66 can be cloned into an 
extrachromosomal vector.  After screen/enrichment, the inserts can be identified through 
microarray analysis67 or DNA sequencing.  Genome-wide knockout libraries can be generated by 
many ways.  Transposon mutagenesis has been optimized for unbiased integration of an 
antibiotic marker cassette into the entire genome, hence creating a random knockout library68, 69. 
Also, all the nonessential genes can be disrupted through homologous recombination, resulting in 
the construction of the yeast deletion collection70, 71 and the Keio knockout collection in E. coli72.  
In addition to knockout, reduction-of-function screen has also been applied for genome-wide 
analysis.  Examples include screening with asRNAs and RNAi that are discussed before.  
Knockdown libraries are especially important to study essential genes whose deletion mutations 
are lethal.  For example, insertion of an antibiotic marker into the terminator region to destabilize 
the mRNA enabled knockdown modification on the essential genes in S. cerevisiae73.  Notably, 
there are also technologies that can create comprehensive genetic libraries including both 
overexpression and knockdown modifications.  For the trackable multiplex recombineering 
(TRMR), two kinds of synthetic cassettes were designed for promoter replacement: the ‘up’ 
cassette containing a strong promoter, and the ‘down’ cassette containing an inert sequence to 
replace the native RBS.  Through recombineering, these synthetic cassettes were incorporated in 
front of every gene in E. coli, which led to either increased or decreased expression of a target 
gene74. 
To facilitate subsequent analysis with these genetic libraries, molecular barcodes have been 
used to monitor the abundance of every mutant strain in a mixed population.  Microarray 
analysis with complementary probes75, as well as the “Bar-Seq” method76, can be used to 
quantify the dynamics of barcodes and their linked mutants in various screen experiments, 
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enabling high-throughput mapping of relevant genes to a given phenotype.   Such high-
throughput capacity explains the wide application of molecular barcodes in analyzing 
overexpression66, knockout70 and TRMR libraries74. 
Adding more dimensions to such approaches, i.e. modification at two or even more loci, is 
necessary because of the non-linear interactions between single genetic variations.  For 
combinatorial overexpression libraries, coexpressing genomic libraries (CoGEL) constructed 
genomic libraries in a series of vectors (plasmid or fosmid) with compatible replication origins 
and different resistance markers, which enables coexistence of two or more genomic insets in 
one cell.  This approach successfully identified known and novel combinations of genetic 
changes that conferred improved acid tolerance in E. coli77.  On the other hand, construction of 
double-mutant library from single loss-of-function collections by mating or conjugation has been 
demonstrated in model organisms such as E. coli78, 79 and S. cerevisiae80, 81.  An impressive 
application was the depiction of a genome-scale digenic interaction network in S. cerevisiae, by 
examining 5.4 million gene-gene pairs in double-mutant library82.  However, current protocols to 
generate genome-wide double-mutant libraries are quite resource-intensive and time-consuming, 
as complicated replica-pinning procedures are needed to perform mating, recombination and 
selection.  Therefore, alternative approaches that simplify the introduction of a second mutation 
on a genome scale are desirable to speed up the discovery of synergistic modifications.  The 
introduction of an RNAi library to create genome-wide knockdown modifications requires only a 
single step of transformation of the host cells83, 84.  Such simplicity and effectiveness should 
enable the use of iterative RNAi screening to accumulate beneficial knockdown modifications.    
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1.4. RNA interference 
Since its discovery in Caenorhabditis elegans in 199849, RNA interference (RNAi) has 
literally “heralded a revolution” in biotechnology50.  RNAi is a cellular gene silencing 
mechanism, where messenger RNAs are targeted for degradation by homologous double-
stranded RNA (dsRNA).  The major functions of RNAi include post-transcriptional modulation 
of gene expression, assembly of silent chromatin structures, and defense against invasion by 
heterologous nucleic acids such as viruses50.   
Different organisms comprise different mechanisms for RNAi, but the basic process shared 
three common steps (Fig. 1.2)50.  First, small RNA duplexes (siRNAs) are generated from long 
dsRNA precursors by a ribonuclease III (RNase III) enzyme called Dicer.  Second, these small 
RNAs are loaded into Argonaute proteins to form a protein-RNA complex known as RNA-
induced silencing complex (RISC).  Third, RISC finds and cleaves the target mRNA molecule 
whose sequence is homologous to the small RNA loaded in the complex.  In this way, sequence-
specific gene silencing can be achieved by dsRNAs and the RNAi pathway.  The effectiveness 
and specificity of RNAi facilitate its wide use in functional genomics, therapeutics and metabolic 
engineering.  RNAi-based genetic screens have been demonstrated in both lower organisms and 
mammalian cells51, 52, which help to elucidate various important biological mechanisms 
underlying developmental biology, signal transduction pathways and human diseases.   
Successful RNAi screening experiments depend on a well-designed library of RNAi reagents 
and high-throughput read-out of target phenotypes51, 52.  A collection of RNAi reagents, synthetic 
or derived from genomic DNA/cDNA, has been constructed to suit different purposes of genetic 
screens.  RNAi reagents can be generated in vitro and then delivered into the cells transiently, or 
can be generated in vivo from vectors for long-term effects.  On the other hand, two screening 
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formats can be applied for phenotype characterization.  Either a systematic screen where each 
gene is silenced individually, or a pooled library coupled with high-throughput selection and 
screening can be used to target many genes at once.  While the systematic screen permits a 
comprehensive depiction of the genotype-phenotype relationship for a given trait, the selection 
strategy provides a higher throughput and less expensive method based on the selectable cell 
growth advantage or fluorescence-activated cell sorting (FACS).  Since its first demonstration in 
C. elegans in 2000, RNAi screening has accumulated a multitude of tools to expand the power of 
this genome engineering strategy.  
Recently, a functional RNAi pathway has been reconstituted in S. cerevisiae by introducing 
two RNAi proteins Ago1 and Dcr1 from another budding yeast Saccharomyces castellii53.  
However, RNAi screening has yet been reported in S. cerevisiae.  Though there are several 
genome-wide libraries available for S. cerevisiae, RNAi screening possesses some unique 
advantages over the classical loss-of-function screens.  First, for those essential genes whose 
deletion is lethal and thus not accessible in gene knockout libraries, RNAi screening provides a 
way to assay their functions by creating reduction-of-function mutants that are still viable.  
Second, RNAi screening enables the fine-tuning of gene expression by knockdown, which 
theoretically provides more information than comparing only two states: wild type and complete 
deletion.  Third, a modifier screening can provide invaluable insight about genetic interactions by 
performing a genome-wide screening in a mutant background, but it requires a time-consuming 
and labor-intensive process to cross a query strain with a complete gene deletion library.  On the 
contrary, a pooled RNAi library can be introduced through a single step of transformation in a 
query background, which will greatly save the time and labor to carry out the modifier screening.  
Based on these considerations, it is highly desirable to devise an RNAi screening platform in S. 
13 
 
cerevisiae. 
 
Figure 1.2. Scheme of RNA interference process.  Long ds long dsRNA precursors are digested by the 
Dicer protein to produce small interference RNA duplexes (siRNAs).  Then, siRNAs are loaded into 
Argonaute proteins to form RNA-induced silencing complex (RISC).  RISC finds and cleaves the target 
homologous mRNA molecule, and leads to gene silencing.   
 
1.5. Directed evolution 
There are two methods to engineer biological entities: rational design and directed evolution.  
Given our limited knowledge of the complex biological systems, directed evolution has been 
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proved as a better engineering strategy than rational design18.  By mimicking the natural 
evolution process—variation and selection—in the laboratory85, directed evolution has achieved 
enormous success in engineering industrially relevant properties5, 86, 87, without the need for the 
prior knowledge of target systems.  However, the success of directed evolution is mostly 
confined to the level of individual proteins.  The main obstacle to apply this strategy on a 
genome scale is the lack of efficient tools to create genome-wide diversity both globally and 
iteratively.   
 
Figure 1.3. Scheme of directed protein evolution5.  Iterative cycles of mutagenesis and 
selection/screening are performed to continuously improve the properties of the target protein, until the 
engineering objectives are achieved or no more improvement is observed. 
 
To design a feasible strategy for directed genome evolution, it is necessary to learn from the 
success of directed protein evolution.  To identify variants with altered or improved functions, 
four key steps are performed (Fig. 1.3)87: First, choosing a good starting parent; second, creating 
a library of variants; third, selecting variants with desired property and last, repeating the process 
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until no further improvement can be achieved or the engineering objective is reached.  While 
different selection/screen strategies are needed for a variety of applications, the creation of 
library generally falls into two categories85.  The first method is “asexual” evolution by 
sequential rounds of random mutagenesis, and the other method is “sexual” evolution by gene 
recombination.  Error-prone PCR is the standard method to introduce point mutations randomly 
into a protein sequence, and DNA shuffling is the most common strategy to create combinations 
of selected mutations.  These mature techniques provide convenient ways to sample the protein 
sequence space by continuously walking through the “fitness landscapes.”  Library construction 
techniques that can fulfill similar tasks on a genome scale are definitely needed to enable 
directed genome evolution. 
 
1.6. Project overview 
This dissertation focuses on the engineering of S. cerevisiae as an efficient microbial cell 
factory for chemical and fuel production.  Two different approaches were taken: the traditional 
metabolic engineering strategy to improve the endogenous 1-butanol production; and a new 
method I developed named RNAi-Assisted Genome Evolution (RAGE) for genome-scale 
engineering. 
Chapter 2 reports the discovery, characterization and engineering of an endogenous 1-butanol 
pathway in Saccharomyces cerevisiae.  Upon introduction of a single gene deletion adh1Δ, S. 
cerevisiae was able to accumulate more than 120 mg/L 1-butanol from glucose in rich medium.  
Precursor feeding, 13C-isotope labeling and gene deletion experiments demonstrated that the 
endogenous 1-butanol production was dependent on catabolism of threonine in a manner similar 
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to fusel alcohol production by the Ehrlich pathway.  Specifically, the leucine biosynthesis 
pathway was engaged in the conversion of key 2-keto acid intermediates.  Metabolic engineering 
efforts, including overexpression of the pathway enzymes and elimination of competing 
pathways, achieved the highest reported 1-butanol titer in S. cerevisiae (242.8 mg/L). 
In Chapter 3, I established RAGE as a generally applicable method for genome scale 
engineering in the yeast S. cerevisiae.  Through iterative cycles of creating a library of RNAi 
induced reduction-of-function mutants coupled with high throughput screening or selection, 
RAGE can continuously improve target trait(s) by accumulating multiplex beneficial genetic 
modifications in an evolving yeast genome.  To validate the RNAi library constructed with yeast 
genomic DNA and convergent-promoter expression cassette, I demonstrated RNAi screening in 
S. cerevisiae for the first time by identifying two known and three novel suppressors of a 
telomerase-deficient mutation yku70Δ.  I then showed the application of RAGE for improved 
acetic acid tolerance, a key trait for microbial production of chemicals and fuels.  Three rounds 
of iterative RNAi screening led to the identification of three gene knockdown targets that acted 
synergistically to confer an engineered yeast strain with substantially improved acetic acid 
tolerance.  
Chapter 4 describes the development of a comprehensive genetic library in yeast (RAGE2.0).  
I created a full-length cDNA library of S. cerevisiae, whose quality and coverage are improved 
through size fractionation and normalization.  Directional cloning of the resultant cDNA 
collection achieved one-step construction of the ORF-overexpression and anti-sense RNA 
libraries.  In the presence of the RNAi pathway, the RAGE2.0 library resulted in genome-wide 
overexpression and knockdown modifications simultaneously.  A wide range of phenotypes, 
including protein secretion, substrate utilization, and fuel molecule production, were screened 
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with the RAGE2.0 library in a high-throughput manner.  Both overexpression and knockdown 
targets were successfully identified to improve these phenotypes.   
In Chapter 5, the RAGE3.0 method was devised for automated yeast genome engineering.  
An inducible CRISPR system was constructed to introduce specific double-stranded breaks 
(DSBs) in the repetitive δ sequences of the yeast genomes.  The efficiency of integration of a 
GFP donor cassette into the δ elements was greatly improved; about 70% cells can be modified 
in a single round of transformation.  CRISPR-assisted δ-integration was used to introduce the 
genome-wide overexpression and knockdown cassettes in the RAGE2.0 library, and this process 
was iteratively performed to accumulate dozens of genetic modifications in a single cell of an 
evolving yeast population.  Mutant strains with multiplex genetic modifications were isolated 
with improved glycerol utilization.  RAGE3.0 only involves simple liquid handling steps, hence 
it is readily automated with an integrated robotic platform in the future.   
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Chapter 2 Endogenous 1-Butanol Production in Saccharomyces 
cerevisiae 
 
2.1. Introduction 
Microbial cell factory, which offers sustainable solutions to global warming and energy 
crisis, has emerged as a promising alternative to the traditional petrochemical industry1, 2.  
Among the most prominent examples of microbial cell factory is the yeast Saccharomyces 
cerevisiae, which is currently used to produce ethanol as an alternative fuel3.  However, due to 
their superior fuel characteristics compared to ethanol, advanced biofuels have attracted a 
growing interest4, 5.  In particular, 1-butanol is considered a substantially better gasoline 
substitute than ethanol6.  The energy density of 1-butanol (29.2 MJ/L) is comparable to that of 
gasoline (32.5 MJ/L), and much higher than that of ethanol (21.2 MJ/L)7.  While ethanol can 
only be blended with gasoline to a final volume percentage of 85%, 1-butanol can be used in 
pure form or blended in gasoline at any ratio7.  Furthermore, 1-butanol is more hydrophobic and 
less corrosive than ethanol, and therefore can be transported through the existing pipeline 
infrastructure7. 
Traditionally, biological synthesis of 1-butanol is performed by Clostridium species through 
the acetone-butanol-ethanol (ABE) fermentation process8.  However, inherent challenges of 
Clostridium manipulation and fermentation, such as a lack of genetic tools, unavoidable 
byproducts and intolerance to 1-butanol and oxygen, have hindered further improvement of the 
ABE fermentation.  Therefore, production of 1-butanol in industrially friendly organisms, such 
as Escherichia coli and S. cerevisiae, has been the focus of recent efforts5.  Two metabolic routes 
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have been explored to produce 1-butanol.  The first route is the heterologous expression of the 
Clostridium 1-butanol pathway9, 10, which is essentially the same as the reversed β-oxidation 
pathway for butanol production11.  This CoA-dependent pathway enables an impressive 
production titer (30 g/L) in E. coli12, but its performance in S. cerevisiae is far less promising 
(2.5 mg/L13 and 16.3 mg/L14).  The second route takes advantage of the amino-acid metabolic 
pathways 15, where 1-butanol is produced via keto-acid intermediates in E. coli.  The drawback 
of this strategy is the unavoidable co-production of 1-propanol, the synthesis of which shares a 
common intermediate (2-ketobutyrate) with the 1-butanol pathway16.   
Although the current production level of 1-butanol in S. cerevisiae is far behind Clostridium 
and E. coli14, there are advantages to utilize S. cerevisiae as a 1-butanol producer.  S. cerevisiae is 
very robust toward inhibitors and low pH condition, and there is no phage contamination issues 
with yeast compared to bacterial hosts3.  S. cerevisiae has also been shown as one of the most 
tolerant organisms toward 1-butanol17, 18.  Additionally, with the widest application in 
biorefinery, S. cerevisiae can serve as a “drop-in” cell factory with compatibility to current 
industrial infrastructure19.  Low concentrations of 1-butanol have been found in fusel oil isolated 
from yeast wine fermentation20, and the origin of 1-butanol is believed to be from plant-derived 
2-keto acid precursors21 or bacterial contamination22.  Early studies showed 1-butanol 
accumulation in mutated isoleucine- and valine-requiring S. cerevisiae strains22, implying a 
native 1-butanol pathway may exist in S. cerevisiae strains with certain genetic background.  
However, it is not clear whether endogenous 1-butanol production is a universal capacity of S. 
cerevisiae. 
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Figure 2.1. Proposed endogenous 1-butanol pathway in S. cerevisiae.  Co-enzymes and co-factors are 
omitted for simplicity.  Pathways that are not directly involved in 1-butanol production are shown in grey, 
and the metabolites in these pathways are written in short forms.  The information of biochemical 
pathways and enzyme locations is from literature23, 24.  The localization of Thr1p and Thr4p are in 
question, but our results suggest they are mitochondrial enzymes (see 2.3 section and Table 2.3 for 
details).  KIV: α-ketoisovalerate; KMV: α-keto-β-methylvalerate; LEU: leucine; VAL: valine; ILE: 
isoleucine; KDCs: 2-keto-acid decarboxylases; ADHs: alcohol dehydrogenases.   
 
In this chapter, we report characterization and engineering of an endogenous 1-butanol 
pathway in S. cerevisiae.  Adh1p was found as a switch for the endogenous 1-butanol production, 
and an amino-acid dependent pathway was proposed which is similar to the metabolic route 
engineered in E. coli (Fig. 2.1)16.  The involvement of the proposed pathway in 1-butanol 
production was characterized by precursor feeding, 13C-isotope tracer experiments and genetic 
manipulations.  A substantial 1-butanol production level (242.8 mg/L) was achieved in our 
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metabolically engineered yeast strains, which is the highest 1-butanol titer reported in S. 
cerevisiae from glucose14. 
 
2.2. Results 
2.2.1. ADH1 as a switch for 1-butanol production 
We noted that the wild-type S. cerevisiae strain can consume 1-butanol in YPAD medium 
(Fig. 2.2A), which contains ~200 mg/L 1-butanol after filtration and ~70 mg/L 1-butanol after 
autoclave sterilization.  We speculate that alcohol dehydrogenases (ADHs) are responsible for 1-
butanol oxidation.  To test our hypothesis, the ADH1 gene, which encoded the most abundant 
ADH in S. cerevisiae25, was deleted.  Adh1p catalyzes the reversible redox reaction between 
acetaldehyde and ethanol in vitro, and the normal function of Adh1p is to reduce acetaldehyde to 
ethanol employing NADH as a cofactor25.  In the adh1Δ strain, reduced ethanol production (Fig. 
2.2B and Fig. 2.3) and acetaldehyde accumulation (Fig. 2.11B) were observed.  The adh1Δ 
mutant strain grew poorly compared to the wild type strain (Fig. 2.3), probably resulting from 
acetaldehyde toxicity and disrupted cofactor balance of NAD+/NADH26.  Unexpectedly, the 
adh1Δ strain also accumulated 1-butanol under both micro-anaerobic (Fig. 2.2A) and aerobic 
(Fig. 2.3) conditions in the YPAD medium.   
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Figure 2.2. Switching on 1-butanol production by adh1 knockout.  Time courses of 1-butanol (A) and 
ethanol (B) production in filtered YPAD media under micro-anaerobic condition are shown for the wild 
type strain (filled square and solid line), the adh1Δ strain (open circle and dashed line) and the adh1Δ 
strain with adh1 overexpressed on pRS425 (open triangle and dotted line).  The filtered YPAD medium 
contains ~200 mg/L 1-butanol at the beginning of fermentation, which is defined as 0 mg/L in the figure.  
The negative values indicate 1-butanol consumption.  Error bars indicate standard deviation of three 
biological replicates. 
 
Without glucose or the adh1Δ strain, no 1-butanol production was observed in the rich 
medium alone (Fig. 2.4).  The production of 1-butanol at much lower concentrations by the 
adh1Δ strain was also observed in synthetic dropout medium and citric/phosphate buffer 
supplemented with only glucose (Fig. 2.5).  The adh1Δ strain with Adh1p over-expression 
restored 1-butanol consumption at a reduced rate than the wild-type strain (Fig. 2.2A), implying 
that there were other ADHs involved in 1-butanol oxidization.  Another reason why the adh1Δ 
deletion can activate 1-butanol production is that when ethanol production is reduced, metabolic 
flux through the 1-butanol pathway is increased. 
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Figure 2.3. Comparison of aerobic fermentation profiles between the wild type strain (solid line) 
and the adh1Δ mutant (dashed line) strain.  Fermentation was performed in autoclaved YPAD media 
(pH=5) under aerobic conditions with a starting OD as 0.1.  The experiment has been repeated three 
times, and one typical set of data is reported. 
 
0 1 2 3 4
-200
-150
-100
-50
0
50
100
150
N
e
t 
b
u
ta
n
o
l 
p
ro
d
u
c
ti
o
n
 (
m
g
/L
)
Time (d)
 2% Glc + no cell
 No Glc + cell
 2% Glc + cell
 
Figure 2.4.  No 1-butanol accumulation in the rich medium without glucose or the adh1Δ strain.  
Fermentation was performed in filtered YPA media (pH=5) under micro-anaerobic condition.  The filtered 
YPAD medium contains ~200 mg/L 1-butanol at the beginning of fermentation, which is defined as 0 
mg/L in the figure.  Error bars indicate standard deviation of three biological replicates. 
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Figure 2.5. Production of 1-butanol by the adh1Δ strain from 2% glucose.  Three media, citric 
acid/phosphate buffer (A and B), SC synthetic dropout medium (C and D) and filtered YPAD rich 
medium (E and F) were tested with different pH values under micro-anaerobic condition.  The filtered 
YPAD medium contains ~200 mg/L 1-butanol at the beginning of fermentation, which is defined as 0 
mg/L in the figure.  Time courses of ethanol and 1-butanol production are reported in (A, C, E) and (B, D, 
F), respectively.  Error bars indicate standard deviation of three biological replicates. 
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2.2.2. Precursor feeding studies in the proposed 1-butanol pathway 
Based on similarity to the Ehrlich pathway which produces other fusel alcohols27, we propose 
an endogenous 1-butanol pathway as follows (Fig. 2.1).  First, 2-ketobutyrate (2-KB) is 
generated from L-threonine through a transamination reaction catalyzed by Ilv1p/Cha1p.  Then 
2-KB is converted to 2-ketovalerate (2-KV) via a keto-acid chain elongation process that is 
carried out by the leucine biosynthesis pathway enzymes Leu4p/Leu9p, Leu2p and Leu1p16, 24.  
Butyl aldehyde is produced from the decarboxylation of 2-KV by 2-keto acid decarboxylases 
(KDCs), and is further reduced to 1-butanol by ADHs21.   
 
Fig. 2.6. Effects of precursor feeding on alcohol production by the adh1Δ strain.  Fermentation was 
performed in citric acid/phosphate buffer with 2% glucose (pH=5) under micro-anaerobic condition with 
added L-threonine (A) or 2-keto acids (B).  Glc: D-glucose; Thr: L-threonine; KB: 2-ketobutyrate; KV: 2-
ketovalerate; EtOH: ethanol; PrOH: 1-propanol; BuOH: 1-butanol.  Symbol—2% Glc (closed square), 
2% Glc+2% Thr in (A) (open circle), 2% Glc+0.1% KB in (B) (open circle), 2% Glc+0.2% KB (open 
triangle), 2% Glc+0.1% KV (open inverse triangle) and 2% Glc+0.2% KV (open diamond).  Error bars 
indicate standard deviation of three biological replicates. 
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We fed the precursors in the proposed pathway and quantified 1-butanol production.  In 
citric acid/phosphate buffer (pH=5) supplemented with 2% glucose, addition of L-threonine 
stimulated 1-butanol production in a dose-dependent manner (Fig. 2.6A and Fig. 2.7).   
 
Figure 2.7.  Dose-dependent stimulation of 1-butanol production by L-threonine addition.  Time 
courses of ethanol and 1-butanol production are shown in (A) and (B), respectively.  Fermentation was 
performed in citric acid/phosphate buffer with 2% glucose (pH=5) under micro-anaerobic condition.  The 
experiment has been repeated three times, and one representative set of data is reported.   
 
To further elucidate the pathway, 13C-labeled glucose (D-Glucose-13C6) and threonine (L-
Threonine-1,2-13C2) were used, and mass spectrometry (MS) fragmentation patterns of the 1-
butanol product were analyzed (Fig. 2.8 and Fig. 2.9A).  To our surprise, the carbon atoms from 
exogenous threonine were not incorporated into 1-butanol, and 1-butanol was solely synthesized 
from glucose (Fig. 2.9 and Table 2.1).  Such findings implied that the increased accumulation of 
1-butanol was not due to direct transformation of exogenous threonine.  Given that threonine 
deaminase (Ilv1p/Cha1p) and α-isopropylmalate synthase (Leu4p), which catalyze conversion of 
L-threonine to 2-ethylmalate, are localized in the mitochondria (Fig. 2.1)24, we reason that 
exogenous threonine cannot be transported from the cytosol into the mitochondria to enter the 
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proposed 1-butanol pathway.   
 
Figure 2.8. Production of 1-butanol from 13C-labeled substrates.  (A) Biochemical transformation 
from L-threonine to 1-butanol.  (B) Generation of fragment ions of 1-butanol in positive electron impact 
(EI) mode.   
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Figure 2.9.  Mass spectrum fragmentation patterns of 1-butanol with 13C-labeled substrates.  Axis 
units: x-axis: m/z; y-axis: arbitrary units.  Fermentation was performed in citric acid/phosphate buffer 
(pH=5) under micro-anaerobic condition, supplemented with 2% glucose and/or 2% amino acids.  For 1-
butanol produced in medium containing D-Glc-12C6 with or without 
13C-labeled amino acids, there were 
no obvious differences in MS patterns, indicating 1-butanol-12C4 was produced and no 
13C atom was 
incorporated into 1-butanol.  For 1-butanol produced in medium containing 13C-labeled glucose and 12C-
amino acids, the MS patterns indicated that 1-butanol-13C4
 was produced (see the m/z=56 ion) and no 12C 
atom was incorporated into 1-butanol.  The analysis of labeling patterns is summarized in Table 2.1.   
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Table 2.1. Predicted and measured 1-butanol MS fragmentation patterns from 13C-labeled 
substrates.  Fermentation was performed in citric acid/phosphate buffer (pH=5) under micro-anaerobic 
condition.  Measured 1-butanol 13C-labeling patterns match the predicted patterns based on the 
assumption that 1-butanol is produced from endogenous threonine rather than exogenous threonine.  See 
Fig. 2.9 for detailed analysis. 
 D-Glc-12C6 
D-Glc-12C6 
L-Thr-1,2-13C2 
D-Glc-13C6 
L-Thr-12C4 
Labeled Carbon#* in acetyl-CoA None None 5, 6 
Carbon source of threonine Glc Added Glc Added Glc Added 
Labeled Carbon# in threonine None None None 1,2 1-4 None 
Labeled Carbon# in 1-butanol (predicted) None None None 2 2-5 5 
Labeled Carbon# in 1-butanol (measured) None None** 2-5 
* Carbon # is referred as in Fig. 2.8A and Fig. 2.8B 
** Absence of 13C-labeled 1-butanol was also confirmed by 13C NMR (data not shown) 
 
To rationalize how exogenous threonine stimulated 1-butanol production, we hypothesize 
that it can satisfy cytosolic requirement of threonine for protein expression and glycine synthesis.  
Thus threonine transport from mitochondria to cytosol is reduced and more threonine is available 
in the mitochondria for transformation into 1-butanol through the proposed pathway.  To test this 
hypothesis, we also supplemented L-glycine to the medium, suspecting that this would also 
reduce the requirement for threonine efflux from the mitochondria (Fig. 2.1)28.  We found that L-
glycine supplementation indeed resulted in improved 1-butanol production, but to a lesser extent 
compared to threonine (Fig. 2.6A and Fig. 2.10).  A 13C-labeling study with L-Glycine-2-13C also 
indicated that exogenous glycine was not directly incorporated into 1-butanol, and all the carbon 
atoms of 1-butanol were from glucose (Fig. 2.9). 
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Figure 2.10. Production of 1-butanol with 2% L-glycine addition in knockout strains. Fermentation 
was performed in citric acid/phosphate buffer with 2% glucose (pH=5) under micro-anaerobic conditions.  
Error bars indicate standard deviation of three biological replicates. 
 
Addition of 2-KB had no observable effect on 1-butanol production, but resulted in 
significant 1-propanol production (Fig. 2.6B and Fig. 2.11A).  These results indicate that 
supplemented 2-KB cannot enter the keto-acid chain elongation process catalyzed by the leucine 
biosynthesis enzymes.  There might be two reasons: 1) 2-KB cannot be transported from the 
cytosol into the mitochondria, where it is converted to 2-ethylmalate by α-isopropylmalate 
synthase (Fig. 2.1); 2) KDCs have much higher affinity for 2-KB than α-isopropylmalate 
synthase, and therefore decarboxylation of 2-KB by KDCs prevents incorporation of 2-KB into 
the 1-butanol pathway.  In addition, the very low level of 1-propanol production from glucose 
with or without added threonine was observed (Fig. 2.6A).  This phenomenon indicates that the 
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concentration of cytosolic 2-KB is low, probably due to the lack of cytosolic transamination 
activity toward threonine for 2-KB synthesis (Fig. 2.1). 
 
Figure 2.11. Effects of precursor feeding on alcohol production without pH adjustment.  (A) Time 
courses of ethanol, 1-propanol and 1-butanol production in the presence of 0.1% added threonine or 2-
keto acids in citric acid/phosphate buffer (pH was not adjusted) under micro-anaerobic condition.  
Symbol type—2% Glc (black square), 2% Glc+0.1% Thr (red circle), 2% Glc+0.1% KB (blue triangle), 
and 2% Glc+0.1% KV (purple inverse triangle).  Error bars indicate standard deviation of two biological 
replicates.  (B) Alcohol and aldehyde production with different concentrations of 2-KV addition in citric 
acid/phosphate buffer (pH was not adjusted) under micro-anaerobic condition.  The experiment has been 
repeated three times, and one representative set of data is reported. 
 
Contrary to threonine and 2-KB, our results indicate that 2-KV can be directly converted to 
1-butanol by S. cerevisiae.  At pH = 5, a condition under which most 2-KV (pKa=3.38) is in the 
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dissociated form that cannot freely diffuse across the plasma membrane, only moderate 1-butanol 
production was observed (0.08 g 1-butanol/g 2-KV, Fig. 2.6B).  Without pH adjustment, addition 
of 2-KV greatly lowered the pH value of the medium, and 2-KV should mainly exist in the un-
dissociated form.  In this case, substantial conversion of 2-KV to 1-butanol and butyl aldehyde 
was observed (Fig. 2.11B, yield of 1-butanol plus butyl aldehyde from 2-KV: 0.36 g/g (0.1% 
KV), 0.44 g/g (0.2% KV), and 0.64 g/g (theoretical yield)).   
 
2.2.3. Characterization of the 1-butanol pathway by gene deletion 
We investigated how deletion of individual genes from the proposed 1-butanol pathway (Fig. 
2.1) could affect 1-butanol production in the adh1Δ background.  Due to the greatly reduced 
fitness of the adh1Δ strain, we were unable to obtain the following double-mutant strains: 
adh1Δ/thr1Δ, adh1Δ/thr4Δ, and adh1Δ/cha1Δ.  For the constructed double mutants, ilv1Δ or 
leu1Δ led to substantial reduction of 1-butanol production from glucose in citric acid/phosphate 
buffer (pH=5), and leu4Δ nearly abolished 1-butanol accumulation (Fig. 2.12A).  Deletion of the 
LEU9 gene, which encodes an isoenzyme of Leu4p24, had no obvious effect on 1-butanol 
production (Fig. 2.12A), suggesting that Leu9p plays a minor role in the aldol addition of acetyl-
CoA to 2-KB.  We then explored how these mutants behaved with supplemented threonine.  
Production of 1-butanol was reduced for all double-deletion mutant strains compared to the 
adh1Δ single-deletion strain in citric acid/phosphate buffer with 2% glucose and 2% L-threonine 
(pH=5), and reduction was observed to a greater extent relative to the condition with no added 
threonine (Fig. 2.12B).  The gene-knockout mutations of ilv1Δ, leu4Δ and leu1Δ also led to 
reduced 1-butanol production with 2% supplemented L-glycine relative to the adh1Δ single-
deletion strain (Fig. 2.10).  Together, these results indicate that 1-butanol production from 
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glucose is dependent on the proposed pathway, and the stimulated 1-butanol accumulation by 
exogenous L-threonine and L-glycine is also related to the proposed pathway.   
 
Figure 2.12. Comparison of 1-butanol production in various gene knockout strains.  A second gene 
deletion was introduced in the adh1Δ strain.  Fermentation was performed in citric acid/phosphate buffer 
with 2% glucose (pH=5) under micro-anaerobic condition, with (A) or without (B) 2% L-threonine 
supplemented.  Symbol—ilv1Δ adh1Δ (closed square), leu4Δ adh1Δ (open circle), leu9Δ adh1Δ (open 
triangle), leu1Δ adh1Δ (open inverse triangle) and adh1Δ (open diamond).  Glc: D-glucose; Thr: L-
threonine.  Error bars indicate standard deviation of three biological replicates. 
 
2.2.4. Gene overexpression to improve 1-butanol production 
To re-direct metabolic flux toward the endogenous 1-butanol pathway, the genes in the 
proposed pathway were over-expressed individually or in combination (Fig. 2.13).  Resting cells 
were cultured under micro-aerobic condition in the filtered YPAD medium.  Accumulation of 1-
butanol decreased after reaching a maximum, probably due to activation of Adh2p which is 
known for its ability to oxidize alcohols25.  Thus, comparison of the 1-butanol production was 
performed with the titer data from day one and day two, when the butanol production peak had 
not yet been reached (Fig. 2.13 and Table 2.2).  Unless indicated otherwise, pRS425, which 
harbors a LEU2 expression cassette, was the backbone plasmid for most of the constructs (Table 
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2.2).  Background α-isopropylmalate dehydrogenase activity has been reported in laboratory S. 
cerevisiae strains that lack a functional LEU2 gene29, and additional copies of the LEU2 gene on 
the pRS425 plasmid resulted in only slightly increased 1-butanol production after day two (Fig. 
2.13A). 
To increase threonine biosynthesis, five genes encoding for enzymes that are responsible for 
converting aspartic acid to threonine (i.e., hom3, hom2, hom6, thr1 and thr4) were over-
expressed simultaneously on a multi-copy plasmid pRS426-THR30.  The strains harboring 
pRS426-THR accumulated 280.8±77.2% more 1-butanol than the adh1Δ strain on the first day, 
but the 1-butanol concentration did not increase after the first day (Table 2.2).  To increase 2-KB 
availability, additional copies of the ILV1 and CHA1 genes were introduced on the pRS425 
plasmid.  On day two, 42.9±21.4% and 73.1±9.2% improvement in 1-butanol production was 
detected with over-expression of Ilv1p and Cha1p, respectively (Fig. 2.13A).  Enhanced 
conversion from 2-KB to 2-KV was achieved by over-expression of the LEU4 and LEU1 genes 
on pRS425, and the strain with the resultant plasmid pRS425-LEU reached a 51.2±20.8% higher 
1-butanol titer than the adh1Δ strain on day two (Fig. 2.13A).   
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Figure 2.13. 1-Butanol production by metabolically engineered strains.  Recombinant strains were 
constructed in the adh1Δ strain (denoted as C).  p425 is an empty plasmid harboring a LEU2 expression 
cassette.  For over-expression, backbone vectors are omitted for simplicity and can be found in Table 2.2.  
For double-mutant strains, only the second knockout in addition to adh1Δ is shown as D(gene name).  
Fermentation was performed in filtered YPAD media (pH=5) under micro-anaerobic condition.  The 
filtered YPAD medium contains ~200 mg/L 1-butanol at the beginning of fermentation, which is defined 
as 0 mg/L in the figure.  The net butanol production on Day 2 was reported.  All metabolic engineering 
efforts are summarized in (A) except for over-expression of ADHs in (B).  Error bars indicate standard 
deviation of three biological replicates. 
 
Regarding KDCs, it has been previously reported that decarboxylation of linear-chain 2-keto 
acids, pyruvate, 2-KB and 2-KV, is catalyzed exclusively by Pdc1p, Pdc5p, and Pdc6p, and not 
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by Aro10p or Thi3p21.  Given the preference of these enzymes toward pyruvate over 2-KV21, we 
did not test over-expression of these KDCs, which we speculated would lead to increased 
production of ethanol rather than 1-butanol.  Two other KDCs, KivD from Lactococcus lactis15 
and an S. cerevisiae Aro10pI355Y mutant31, were tested on the basis of their reported activity and 
preference toward 2-KV.  Whereas KivD had no significant effect on 1-butanol production, the 
strain over-expressing the Aro10pI355Y mutant accumulated 52.1±8.5% more 1-butanol than the 
adh1Δ strain on day two (Fig. 2.13A). 
For the last step, ADHs catalyze reduction of butyl aldehyde to 1-butanol.  Six ADHs from 
S. cerevisiae (Adh1p-Adh6p) together with BdhB from Clostridium acetobutylicum were over-
expressed in the adh1Δ background (Fig. 2.13B).  The mitochondrial signal peptide of Adh4p 
was removed to create a cytosolic mutant, which increased 1-butanol production by 
216.5±55.3% on the first day in the adh1Δ background (Table 2.2).  The Adh6p over-expression 
strain showed a similar 1-butanol production profile as the adh1Δ strain (Fig. 2.13B).  Strains 
over-expressing other ADHs all exhibited no accumulation or even consumption of 1-butanol 
(Fig. 2.13B and Table 2.2). 
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Table 2.2. Comparison in 1-butanol production of recombinant yeast strains.  Fermentation was 
performed in filtered YPAD medium (pH=5) under micro-anaerobic condition.  The filtered YPAD 
medium contains ~200 mg/L 1-butanol at the beginning of fermentation, which is defined as 0 mg/L in 
the table.  The negative values reported indicate 1-butanol consumption. 
1-Butanol concentration 
(mg/L) 
Day 1 Day 2 Day 4 
Percentage difference 
in titer (Day 1) 
Percentage difference 
in titer (Day 2) 
adh1Δ (C) 41.2±1.0 117.4±27.2 124.5±3.0 0.0±2.4% 0.0±23.2% 
pRS425 98.6±20.2 124.4±34.0 142.0±19.7 139.3±49.0% 6.0±29.0% 
pRS426-THR 156.9±31.8 142.1±31.0 174.1±43.7 280.8±77.2% 21.1±26.4% 
pRS426-THR-R2 121.7±33.8 44.6±35.4 47.1±37.7 195.4±82.0% -62.0±30.1% 
pRS425-ilv1 117.6±14.1 167.7±25.2 185.0±18.5 185.4±34.2% 42.9±21.4% 
pRS425-cha1 n.m.* 203.2±10.8 142.6±17.3 n.a.** 73.1±9.2% 
pRS425-LEU n.m. 177.4±24.4 195.4±25.2 n.a. 51.2±20.8% 
pRS425-kivD n.m. 143.6±58.6 120.1±39.6 n.a. 22.3±49.9% 
pRS425-aro10m n.m. 178.5±10.0 97.9±44.1 n.a. 52.1±8.5% 
pRS425-adh1 n.m. 28.4±24.0 -13.2±16.9 n.a. -75.8±20.4% 
pRS425-adh2 -52.0±33.7 -78.8±20.6 -112.8±34.0 -226.2±81.8% -167.1±17.6% 
pRS425-adh3 25.4±17.9 7.5±6.5 -23.0±3.3 -38.3±43.4% -93.6±5.5% 
pRS425-adh4m 130.4±22.8 10.4±45.0 -13.4±14.5 216.5±55.3% -91.1±38.3 
pRS425-adh5 -35.6±14.8 -63.8±28.0 -64.9±14.4 -186.4±35.9% -154.3±23.8% 
pRS423-adh6 35.9±21.2 102.1±7.4 90.7±12.6 -12.9±51.5% -13.0±6.3% 
pRS423-bdhB 48.7±6.6 27.7±4.3 9.8±0.5 18.2±16.0% -76.4±3.7% 
ilv2Δ n.m. 242.8±21.0 199.9±22.3 n.a. 106.8±17.9% 
ilv3Δ 98.3±0.7 184.1±8.6 147.0±19.6 138.6±1.7% 56.9±7.3% 
ilv6Δ 83.9±1.2 155.9±17.0 143.9±3.7 103.6±2.9% 32.8±14.5% 
n.m.: not measured  
n.a.: not available 
   Errors indicate standard deviation of three biological replicates 
 
2.2.5. Elimination of competing pathways 
Competing reactions were eliminated to avoid loss of precursors in the proposed 1-butanol 
pathway (Fig. 2.1).  The benefit of eliminating the acetolactate synthase activity (ilv6Δ/ilv2Δ) is 
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threefold: (1) it prevents the conversion of 2-KB to L-isoleucine, and thus increases the 
availability of 2-KB for 1-butanol synthesis; (2) it raises the concentrations of two key 
intermediates (aspartic acid and acetyl-CoA) by conserving their common precursor, pyruvate, 
which is otherwise used for L-leucine and L-valine biosynthesis; (3) it reduces flux through the 
leucine biosynthesis pathway, which could then take a more active participation in 2-KV 
synthesis.  On day two, a 1-butanol titer of 242.8±21.0 mg/L was observed for the ilv2Δ/adh1Δ 
double mutant, which was 106.8±17.9% higher than the adh1Δ strain (Fig. 2.13A).  The ilv6Δ 
mutation had a less obvious impact on 1-butanol accumulation (32.8±14.5% improvement, Fig. 
2.13A and Table 2.2).  Knockout of ilv3 was also performed to decrease the isoleucine, leucine 
and valine biosynthesis, which led to a 1-butanol titer that was 56.9±7.3% more than the single 
mutant adh1Δ strain (Fig. 2.13A and Table 2.2). 
 
2.3. Conclusions and Future Prospects 
Previous efforts toward reconstituting the Clostridium 1-butanol pathway in S. cerevisiae met 
with many challenges, including difficulty in functional expression of bacterial proteins, limited 
availability of cytosolic acetyl-CoA, and sequestration of the CoA supply to synthesize acyl-CoA 
intermediates13, 14.  On the contrary, employment of an endogenous amino-acid pathway for 1-
butanol synthesis not only avoids issues related to introduction of a heterologous pathway, but 
also takes advantage of accumulated knowledge for amino-acid hyper-production.  Though a 
similar pathway has been constructed and engineered in E. coli15, 16, performance of this 
threonine-dependent pathway should be better in S. cerevisiae by avoiding 1-propanol co-
production16.  The absence of 1-propanol as a byproduct is enabled by separation of 2-KB from 
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cytosolic KDCs by the mitochondrial membrane (Fig. 2.1).  In addition, computational metabolic 
simulations suggested that S. cerevisiae possesses greater potential in higher alcohol 
overproduction than E. coli, upon introduction of extra flexibility in the yeast central metabolism 
by incorporating metabolic shortcuts from E. coli (such as pyridine nucleotide transhydrogenase, 
the anaplerotic pathways, the Entner-Doudoroff pathway, and acetyl-CoA synthesis by pyruvate 
formate-lyase)32.  Together with the advantages of yeast host over bacterial hosts for alcohol 
fermentation, we believe that the engineering of the proposed pathway for 1-butanol production 
in S. cerevisiae is promising.   
We observed that exogenous L-threonine cannot enter mitochondria to be directly 
incorporated into 1-butanol synthesis.  This observation suggests that some enzymes catalyzing 
the threonine biosynthesis reactions are located in the mitochondria (Fig. 2.1).  Especially for the 
Thr1p and Thr4p enzymes that catalyze the last two steps of threonine synthesis, no direct 
biochemical evidence is available to determine their subcellular localization (Table 2.3).  The 
green fluorescence protein (GFP) has been fused to the carboxyl terminal of Thr1p to assign its 
localization by imaging, but only ambiguous result was obtained33.  Though the GFP-fused 
Thr4p protein was localized to cytoplasm and nucleus33, computational analysis of the Thr4p 
primary sequence suggested an 82% probability that Thr4p would be transported into 
mitochondria34 (Table 2.3).  To make it more complicated, the C-terminal fusion of GFP has 
been found to cause mis-localization of a target protein33.  Together, no clear localization 
assignment of Thr1p and Thr4p can be made from literature, and our results imply that they are 
mitochondrial proteins.  Further biochemical investigation by subcellular fractionation will be 
valuable to determine the Thr1p and Thr4p localization. 
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Table 2.3.  Enzyme localization of the aspartic acid and threonine biosynthesis pathway in S. 
cerevisiae 
Enzyme Predication 134 Predication 233 Other references 
Aat1p 0.98* Mitochondria Mitochondria35 
Aat2p 0.05 Cytoplasm Cytoplasm/Peroxisome36 
Hom3p 0.20 Cytoplasm  
Hom2p 0.18 Cytoplasm/Nucleus Plasma membrane37 
Hom6p 0.14 Cytoplasm/Nucleus  
Thr1p 0.06 Ambiguous Unknown (www.yeastgenome.org) 
Thr4p 0.82 Cytoplasm /Nucleus  
*The value indicates the probability of export to mitochondria, calculated from the MitoProt algorithm34. 
 
We found that exogenous L-glycine boosted 1-butanol accumulation but cannot be converted 
directly into 1-butanol (Fig. 2.9), and also noted that the stimulation of 1-butanol production by 
L-glycine was dependent on the proposed pathway (Fig. 2.10).  These findings provides an 
alternative explanation to the observations in a recent report that suggested a metabolic route for 
1-butanol production with L-glycine and butyl-CoA as substrates in S. cerevisiae29.  Based on 
that route, 13C atom of L-Glycine-2-13C would be incorporated in 1-butanol, but it was not 
observed in this study (Fig. 2.9).  Also, involvement of butyl-CoA in 1-butanol production is 
questionable, as butyl-CoA concentration is rather low in wild type S. cerevisiae13.  Therefore, 
we argue that the stimulation of 1-butanol production by L-glycine may be due to the reduced 
conversion of L-threonine to L-glycine in the presence of exogenous L-glycine, resulting in 
increased transformation of L-threonine to 1-butanol through our proposed pathway.   
The reduced 1-butanol accumulation by gene knockout mutant strains suggested the 
involvement of the proposed pathway.  However, 1-butanol production was not 100% abolished.  
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There are two possibilities.  First, the isoenzymes catalyzing the same reaction (Ilv1p/Cha1p or 
Leu4p/Leu9p) may account for the residual 1-butanol production.  Second, there might also be 
other endogenous routes for 1-butanol production.  Over-expression of the enzymes in the 
proposed pathway led to increased 1-butanol titer to various degrees.  Moderate improvement by 
over-expression of the wild-type threonine biosynthesis pathway is consistent with the previous 
observation that threonine biosynthesis is tightly regulated30.  It is interesting to further 
investigate whether feedback-inhibition mutant enzymes30 can enable deregulation and over-
production of L-threonine and 1-butanol.  Enhanced threonine transamination activity by 
Ilv1p/Cha1p over-expression led to substantial improvement in 1-butanol titer, indicating this is a 
key step to direct the metabolic flux toward the proposed pathway.  The fact that Cha1p over-
expression led to higher 1-butanol accumulation than that of Ilv1p was consistent with the results 
of the gene knockout experiment, where ilv1Δ resulted in only 23.0±9.0% reduction of 1-butanol 
production (Fig. 2.12A).  Cha1p might also play a role in the stimulated 1-butanol production by 
exogenous L-threonine, as Cha1p is transcriptional induced by L-threonine38, 39.  Over-expression 
of the leucine biosynthesis pathway resulted in only limited improvement in 1-butanol 
production, which might be due to the fact that conversion of 2-KB to 2-KV is not a natural 
biochemical transformation catalyzed by the leucine biosynthesis pathway15.  The leucine 
pathway naturally takes 2-ketoisovalerate (KIV) as its substrate (Fig. 2.1), which possesses one 
more methyl group than 2-KB.  It is therefore highly possible that the catalytic reactions with 2-
KB as the starting precursor is not as efficient as the leucine synthesis.  No specific wild-type 
KDCs or ADHs enzymes were found to catalyze transformation of 2-KV to butyl aldehyde and 
to 1-butanol.  Engineered or heterologous KDCs and ADHs with preferences toward 2-KV and 
butyl aldehyde, respectively, are therefore highly desirable to selectively pull out the 2-keto acid 
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intermediate to form 1-butanol.  Elimination of the valine, leucine and isoleucine biosynthesis 
pathway by ilv2Δ resulted in the highest 1-butanol production in this study, which is consistent 
with the observation in E. coli16.  As ethanol was still the main fermentation product by the 
adh1Δ strain, metabolic engineering effort to eliminate ethanol production should greatly 
improve 1-butanol productivity.  Possible strategies include disruption of all ADH genes40 or 
creation of a KDC-negative S. cerevisiae strain41.  Particularly, gene deletion of the ADH2 gene 
is highly desirable as it oxidizes 1-butanol once being activated (Fig. 2.3 and Table 2.2). 
In addition to 1-butanol, other short-chain alcohols have also been proposed as advanced 
fuel alternatives4, 42.  These alcohols are naturally found as trace products in yeast fermentation 
and known as “fusel alcohols”27.  The Erlich pathway is responsible for the biosynthesis of these 
alcohols, from 2-keto acids as the degradation intermediates of branched-chain amino acids27.  
Recently, introduction of a broad specificity KDC and the yeast ADH2 has activated the Erlich 
pathway in E. coli and enabled the accumulation of isobutanol, 1-propanol, 1-butanol, 2-methyl-
1-butanol, 3-methyl-1-butanol and 2-phenylethanol15.  Among the fusel alcohols, the branched-
chain isomer of 1-butanol, isobutanol, has been the focus of recent studies in both E. coli and 
yeast4, 42.  In E. coli, the enhanced conversion of pyruvate to 2-ketoisovalerate (KIV), together 
with the decreased competition of pyruvate, resulted in a titer of 22 g/L isobutanol15.  In S. 
cerevisiae, the engineering has been complicated by the organelle compartmentation, where the 
synthesis of KIV from L-valine and the conversion of KIV to isobutanol are performed in the 
mitochondria and the cytosol, respectively4, 27.  Therefore, by now the most successful strategy to 
overproduce isobutanol in yeast (0.63 g/L) involves cytosolic over-expression of Ilv2p, Ilv5p, 
Ilv3p mutants without mitochondria targeting signals, as well as inactivation of the endogenous 
mitochondrial pathway by deleting the first enzyme Ilv2p43.  In addition, highly specific KDC 
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and ADH enzymes have also been screened to further improve isobutanol production43, 44.  These 
strategies may offer useful perspective on the engineering of the endogenous 1-butanol pathway 
in the present study, given its similarities with the isobutanol pathway.  Recent research on the 
isobutanol biosynthesis engineering in S. cerevisiae is summarized in an excellent review4.   
In summary, we reported the endogenous 1-butanol production in S. cerevisiae from a 
renewable substrate, glucose, upon deletion of the ADH1 gene.  We proposed and characterized 
an endogenous 1-butanol pathway in S. cerevisiae, and showed potential for over-production of 
1-butanol by metabolic engineering.  Combination of beneficial manipulations and systematic 
strain engineering are in progress to further improve the titer and productivity of 1-butanol 
fermentation.  Given the accumulated knowledge about amino-acid biosynthesis and regulation, 
it is believed that high productivity of 1-butanol production can be achieved through this 
threonine-dependent pathway by further strain engineering. 
 
2.4. Materials and methods 
2.4.1. Media and cultivation conditions 
Citric acid/phosphate buffer was used to prepare culture media with controlled pH 
(http://www.sigmaaldrich.com/life-science/core-bioreagents/biological-buffers/).  S. cerevisiae 
strains were cultivated in either synthetic dropout medium (0.17% Difco yeast nitrogen base 
without amino acids and ammonium sulfate, 0.5% ammonium sulfate and 0.083% amino acid 
drop out mix, 0.01% adenine hemisulfate and 2% glucose) or YPAD medium (1% yeast extract, 
2% peptone, 0.01% adenine hemisulfate and 2% glucose).  For 1-butanol production in precursor 
feeding and gene knockout experiments, only 2% glucose and indicated precursors were added 
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into citric acid/phosphate buffer.  Media pH was adjusted to 5 after addition of precursors by 12 
M HCl or 10 M NaOH.  To select and maintain strains carrying the KanMX marker, G418 (200 
mg/L) was supplemented in YPAD medium.  S. cerevisiae strains were cultured at 30 °C with 
250 rpm agitation in baffled shake-flasks for aerobic growth.  For micro-anaerobic fermentation, 
4 mL cultures were grown at 30 °C and 250 rpm in Bellco 18150 mm anaerobic glass tubes 
sealed with rubber stoppers and aluminum crimps (Chemglass, Vineland, NJ).  Vacuum was 
applied through a syringe needle for 20 minutes, and sterile nitrogen was then added to create 
micro-aerobic conditions.  E. coli strains were cultured at 37 °C and 250 rpm in Luria broth (LB) 
medium (Fisher Scientific, Pittsburgh, PA) with the supplement of 100 μg/mL ampicillin.  All 
chemicals were purchased from Sigma-Aldrich or Fisher Scientific.   
 
2.4.2. DNA manipulation 
Plasmid cloning was performed by In-fusion HD cloning Kit (Clontech Laboratories, Mountain 
View, CA) following the manufacturer’s instructions or by the DNA assembler method45.  The 
complete list of plasmids in this study is summarized in Table 2.4.  For DNA manipulations, 
yeast plasmids were isolated using a Zymoprep II yeast plasmid isolation kit (Zymo Research, 
Irvine, CA) and transferred into E. coli for amplification.  QIAprep Spin Plasmid Mini-prep Kits 
(Qiagen, Valencia, CA) were employed to prepare plasmid DNA from E. coli.  Yeast genomic 
DNA was isolated by Wizard Genomic DNA Purification Kit (Promega, Madison, WI).  All 
enzymes used for recombinant DNA cloning were from New England Biolabs (Ipswich, MA) 
unless otherwise noted.  The products of PCR, digestion and ligation reactions were purified by 
QIAquick PCR Purification and Gel Extraction Kits (Qiagen, Valencia, CA).   
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2.4.3. Strain constructions 
The complete list of strains in this study was summarized in Table 2.5.  S. cerevisiae strain 
YSG50 ura3Δ (MATα ura3Δ ade2-1 his3-11,15 leu2-3,112 can1-100 trp1-1) was designated as 
the wild type (WT) strain46.  Zymo 5α Z-competent E. coli (Zymo Research, Irvine, CA) was 
used for yeast plasmid amplification.  To perform gene deletions, the open reading frames (ORF) 
of target genes were disrupted by inserting the LoxP-ura3-LoxP or LoxP-KanMX-LoxP cassettes 
which were PCR-amplified from plasmid pUG72 or pUG6, respectively47.  Between consecutive 
gene deletions, the selection marker was recycled through the Cre-LoxP recombination 
mechanism by pSH47 or pSH6347.  Pathway integration into the delta sites in the yeast genome 
was achieved by a home-made integration plasmid.  Following PmeI digestion, the recombinant 
plasmid would release a linear DNA fragment in which the pathway to integrate and the KanMX 
marker were flanked by delta sequences.   
 
2.4.4. Metabolite detection 
Alcohol and aldehyde compounds were quantified by an Agilent 7890 gas chromatograph 
equipped with an Agilent 5975 mass selective detector (Agilent Inc., Palo Alto, CA) at the Roy J. 
Carver Metabolomics Center (University of Illinois, Urbana, IL).  Filtered culture supernatant 
was stored at -80 ºC prior to analysis to minimize evaporation.  Samples (1 L) were injected in 
split mode (10:1), and analyzed on a 15 m Zebron ZB-FFAP column with 0.25 mm I.D. and 0.25 
m film thickness (Phenomenex, Torrance, CA).  Injection port and interface temperature was 
set at 250 ºC, and the ion source set to 230 ºC.  The helium carrier gas was set at a constant flow 
rate of 1.6 mL/min.  The oven temperature program was set as the following: a) 2 min isothermal 
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heating at 60 ºC, b) increase at a rate of 10 ºC min-1 to 80 ºC for 0 min, c) and then 40 ºC min-1 to 
200 ºC for the final 4 min.  The mass spectrometer was operated in positive electron impact 
mode (EI) at 69.9 eV ionization energy with an m/z 25-300 scan range.  All chromatogram 
spectra were analyzed with the HP Chemstation program (Agilent, Palo Alto, CA, USA).   
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Table 2.4. List of plasmids in this study. 
Name Description 
pRS425 2μ ori, LEU2 marker 
pRS423 2μ ori, HIS3 marker 
pRS426 2μ ori, URA3 marker 
pRS426-THR 
PTEF1-hom3-TPGK1-PTPI1-hom2-TGPD1-PENO2-hom6-TTEF1-PPDC1-thr1-THXT7-PFBA1-
thr4-TTEF2 
pRS425-ilv1 PTEF1-ilv1-TPGK1 
pRS425-cha1 PTEF1-cha1-TPGK1 
pRS425-LEU PTEF1-leu4-TPGK1-PTPI1-leu1-TGPD1 
pRS425-kivD PTEF1-kivD-TPGK1 
pRS425-aro10m PTEF1-aro10m-TPGK1 (aro10m encodes Aro10p
I355Y) 
pRS425-adh1 PTEF1-adh1-TPGK1 
pRS425-adh2 PTEF1-adh2-TPGK1 
pRS425-adh3 PTEF1-adh3-TPGK1 
pRS425-adh4m PTEF1-adh4m-TPGK1 (adh4m as a mutant of adh4 with first 129 nt truncated) 
pRS425-adh5 PTEF1-adh5-TPGK1 
pRS423-adh6 PTEF1-adh6-TPGK1 
pRS423-bdhB PTEF1-BdhB-TPGK1 
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Table 2.5. List of strains in this study. 
Name Description 
YSG50 ura3Δ MATα ura3Δ ade2-1 his3-11,15 leu2-3,112 can1-100 trp1-146. 
adh1Δ YSG50 ura3Δ adh1Δ (with URA3 marker recycled) 
adh1Δ ilv1Δ YSG50 ura3Δ adh1Δ ilv1Δ::ura3 
adh1Δ leu4Δ YSG50 ura3Δ adh1Δ leu4Δ::ura3 
adh1Δ leu9Δ YSG50 ura3Δ adh1Δ leu9Δ::ura3 
adh1Δ leu1Δ YSG50 ura3Δ adh1Δ leu1Δ::ura3 
adh1Δ ilv2Δ YSG50 ura3Δ adh1Δ ilv2Δ::ura3 
adh1Δ ilv6Δ YSG50 ura3Δ adh1Δ ilv6Δ::ura3 
adh1Δ ilv3Δ YSG50 ura3Δ adh1Δ ilv3Δ::ura3 
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Chapter 3 RAGE1.0: Complex Phenotype Engineering 
 
3.1. Introduction 
Complex phenotypes, such as inhibiter tolerance, involves synergistic actions of many genes
1
. 
Such complex phenotypes are often poorly understood and extremely difficult to engineer
2, 3
.  
Adaptive engineering has been the method-of-choice to isolate evolved strains with improved 
inhibitor tolerance, through serial transfers with increasing inhibitor stresses in the medium
4
.  
Though effective, adaptive engineering is very time-consuming because the appearance of 
mutations is infrequent and most of these mutations are detrimental or neutral
4
.   Therefore, new 
methods are needed to efficiently generate multiplex genetic diversity on a genome scale, as the 
engineering of complex traits often requires simultaneous modulation of many genes
2, 3, 5, 6
.   
The current ability to engineer a genome in multiplex is mostly limited to bacterial hosts
3
.  A 
microbial genome can now be synthesized de novo which should in principle enable the ultimate 
genome-scale engineering, but this strategy is limited to small bacterial genomes and is also too 
expensive and tedious for most genome engineering applications
7
. In Escherichia coli, 
recombination-based genetic engineering (recombineering) enables generation of combinatorial 
genomic diversity
5
 or genome-wide identification of gene targets for a certain trait
8
.  However, 
lack of efficient tools for large-scale DNA oligonucleotide-mediated allelic replacement hinders 
the application of recombineering in eukaryotes.   
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Figure 3.1. RNAi-assisted genome evolution enables rapid cellular reprogramming through 
iterative rounds of RNAi library creation and high throughput screening or selection.  (A) 
Traditional strain libraries approach.  Individual gene-knockout is performed to construct a mutant library.  
Synthetic Genetic Array (SGA) creates an array of double-mutant strains through multiple steps of 
manipulation.  (B) Creation of a pooled RNAi library only requires a simple step of transformation.  (C) 
The ease of RNAi library construction enables repeated rounds of screening in an evolving genetic 
background (RAGE), which accumulates the beneficial modifications identified from the previous rounds 
of screening by integration. 
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S. cerevisiae is not only a prominent model eukaryotic organism but also a widely used 
platform organism for industrial production of chemicals and fuels
9, 10
.  For this well-studied 
eukaryote S. cerevisiae, non-essential genes have been individually deleted to construct strain 
libraries for functional screening
11, 12
 (Fig. 3.1A).  Synthetic Genetic Array (SGA) has been 
developed to assay genetic interactions, whereby a query strain with a modified genetic 
background is crossed with a gene-deletion library to create an ordered array of haploid double-
mutant strains
13
 (Fig. 3.1A).  Although strain libraries have provided invaluable knowledge 
about numerous important biological processes
14
, the tedious procedure to introduce genome-
wide perturbations on a wild-type or mutated genome severely limits our ability to reprogram 
eukaryotic cells (Fig. 3.1A).  In addition, gene-knockout libraries are only available for certain 
laboratory strains of the S. cerevisiae species
15
, whereas different strains exhibit dramatic 
differences in phenotypes
16
. Therefore, effective tools to iteratively introduce genome-wide 
modifications in customized genetic backgrounds are highly desirable for successful genome 
engineering practice in yeast.  
Here we report RAGE for engineering complex traits in yeast by directed genome evolution 
with iterative RNAi screening.  Directed evolution mimics Darwinian evolution in a test tube and 
involves iterative rounds of genetic diversification and high throughput screening or selection, 
and has achieved enormous success in tailoring biological systems ranging from single proteins 
to whole cells
17, 18
.  However, no satisfying tools exist to apply directed evolution strategy on a 
genome scale in S. cerevisiae, as the current method to introduce genome-wide mutations in an 
evolving yeast genome is prohibitively tedious (Fig. 3.1A).  On the other hand, the introduction 
of a pooled RNAi library to create genome-wide reduction-of-function modifications requires 
only a single step of transformation of the host cells
19, 20
 (Fig. 3.1B).  Such simplicity and 
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effectiveness should enable the use of directed evolution strategy by repeating the cycles of 
RNAi screening to accumulate beneficial knockdown modifications (Fig. 3.1C).  RNAi is a 
cellular gene silencing mechanism broadly distributed in eukaryotic organisms, whereby 
messenger RNAs (mRNAs) are targeted for degradation by homologous double-stranded RNAs 
(dsRNAs)
21, 22
.  RNAi screening enables genome-wide reduction-of-function perturbations 
without allelic modifications, and is widely used in eukaryotic functional genomics
20, 23
.  All 
known S. cerevisiae strains lack a native RNAi pathway
24
.  Recently, a heterologous RNAi 
pathway from Saccharomyces castelli was functionally reconstituted in S. cerevisiae to achieve 
effective gene silencing
24
.  Three human proteins, Ago2, Dicer and TRBP, were also found to be 
sufficient to enable gene knockdown in S. cerevisiae by RNAi
25
.  In addition, the RNAi 
machinery was implemented as a metabolic engineering tool to improve itaconic acid production 
in this yeast
26
.  So far, however, no RNAi screening has been reported in this model eukaryotic 
organism.  We first demonstrated RNAi screening in S. cerevisiae for suppressor analysis of a 
telomerase-deficient mutation yku70Δ, and then applied iterative RNAi screening for improved 
acetic acid (HAc) tolerance. 
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3.2. Results 
3.2.1. Functional reconstitution of the RNAi pathway 
We first sought to establish RNAi screening in S. cerevisiae.  A Saccharomyces castellii 
RNAi pathway was functionally introduced into S. cerevisiae recently
24
.  We reconstituted this S. 
castellii RNAi pathway into our target yeast strain CEN.PK2-1c and named the resulting strain 
as the CAD strain (Fig. 3.2).  
 
Figure 3.2. The integration copy number of the RNAi pathway in the CAD strain determined by 
quantitative real-time PCR (qPCR).  Three colonies were assayed.   The genomic DNA of the CAD 
strain was used as template, and the primers qTEF1p For/Rev, qAgo1 For/Rev and qDcr1 For/Rev were 
used to quantify the copy numbers of PTEF1, ago1 and dcr1.  The alg9 gene was used as the internal 
control whose copy number was set to be one.  Error bars represent the two concentrations of genomic 
DNA (differed by 10 fold) added as template in the qPCR reactions.  The integration copy number of the 
RNAi pathway was determined to be one (for PTEF1, there is an endogenous copy in the genome, so the 
total copy number will be two). 
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We observed repression of the expression of a reporter protein, green fluorescent protein 
(GFP), to various degrees by the gfp-silencing constructs based on either the anti-sense design or 
the convergent-promoter design (Fig. 3.3). The TEF1p-GFPrc construct transcribes the full-
length anti-sense RNA of the GFP gene, while the TTrc-GFP constructs transcribe dsRNAs 
derived from different regions of the GFP gene (Fig. 3.3A).  The reduction of GFP fluorescence 
was dependent on both the RNAi pathway and the RNA expression (Fig 3.3), indicating that the 
imported RNAi pathway was functional.  For the convergent-promoter constructs, both the 
position and the length of the inserts affected the repression efficiency.  In particular, the 223-
631 bp region corresponds to the digestion product of the GFP gene by Sau3AI, and the 
derivative dsRNA led to a 40% reduction of GFP fluorescence signal.  DNA fragments derived 
from 1-180 bp, 1-360 bp, 1-540 bp and 1-717 bp of the GFP gene were also cloned into the 
convergent promoter cassette, and it was found that the repression efficiency decreased with 
longer insets (Fig. 3.3B).   
The convergent-promoter design was subsequently used to construct a genome-wide RNAi 
library.  Convergent promoters can drive the in vivo synthesis of two complementary RNA 
molecules to form a dsRNA molecule.  The dsRNA can trigger the RNaseIII-like enzyme Dicer 
to cleave long dsRNAs into small interferencing RNAs (siRNAs) of 21-25 bp.  These siRNAs 
are then loaded into a multi-subunit RNA-induced silencing complex (RISC), which will target 
and degrade the cellular mRNA with homologous sequences.  In particular, two strong 
constitutive promoters, PTEF1 and PTPI1, were used as the convergent pair, between which a 
BamHI site was engineered to facilitate the insertion of genomic DNA fragments generated by 
Sau3AI digestion.  The convergent promoter cassette was assembled into a single-copy plasmid 
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pRS416 to construct the plasmid pRS416-GPDtrc-TEF1p-BamHI-TPI1prc- PGK1t (aka pRS416-
TTrc).  
 
Figure 3.3. Repression of GFP fluorescence by RNAi constructs.  The overexpression cassette of GFP 
was integrated into the leu2 locus of the CAD or CEN.PK2-1c strain.  (A) Scheme for RNAi expression 
design. (B) Silencing of GFP expression.  The average on the mean GFP fluorescence of three biological 
replicates are reported.  The error bars indicate standard deviations. The 100% reference of GFP signal 
was defined as the strain containing the integrated GFP expression cassette and the control plasmid 
pRS416.  The RNAi cassettes locate either on a single-copy plasmid pRS416 (white bar) or in the ura3 
locus of the yeast genome (grey bar). (C) FACS histograms showing GFP fluorescence of the yeast 
strains harboring different RNAi constructs.  Dashed lines indicate the plasmid pRS416 is used to express 
the RNAi cassettes, whereas solid lines indicate the RNAi cassettes are integrated in the ura3 locus.  The 
No GFP strain is the CEN.PK2-1c strain with the pRS416-TTrc plasmid.  The Control strain is the 
CEN.PK2-1c strain with an integrated GFP-overexpressing cassette and the pRS416-TTrc plasmid.  The 
No Path strain is the CEN.PK2-1c strain with an integrated GFP-overexpressing cassette and the pRS416-
TEF1p-GFPrc plasmid.  The No GFPrc strain is the CAD strain with an integrated GFP-overexpressing 
cassette and the empty pRS416 plasmid.  
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By adapting the convergent-promoter design (Fig. 3.3A), we created a pooled long-dsRNA 
library from the yeast genomic DNA fragments which were generated by enzymatic digestion
27
.  
We randomly sequenced 50 plasmids from the library, and the statistical analysis of the DNA 
sequencing results was summarized in Fig. 3.4.  The insets of the majority of plasmids consisted 
of only one genomic fragment, while for some contained more than one DNA fragments (Fig. 
3.4B), probably resulting from the ligation of genomic DNA fragments with compatible ends.  
To prevent the self-ligation between the genomic DNA fragments, a fill-in reaction of the 
overhangs could be performed by Klenow fragment.  Together, 83 fragments were present in the 
50 sequenced plasmids.  The sizes of the fragments ranged from 41 bp to 1109 bp, with an 
average size of 177 bp (Fig. 3.4A).  
Table 3.1. Estimation of library coverage 
Library Size Redundancy Probability of coverage* 
50,000** 0.71 50.76% 
100,000** 1.42 75.75% 
422,400
#
 5.98 99.75% 
500,000** 7.08 99.92% 
* The coverage was calculated based on the assumption of the Poisson distribution.  The equation was 
28
, where E<C> is the probability of any single nucleotide in the genome 
covered by at least one clone in the library, L is the average length of the fragment which is equal to 177 
bp, N is the library size, and G is the genome size of S. cerevisiae which is 12.5 Mbp.   
** Simulated calculation by assuming the library size equals to 50, 000, 100, 000 and 500, 000 
#
 The actual library size obtained for the pooled RNAi library on a plasmid 
 
This 177 bp average fragment size was employed to estimate the coverage of the yeast 
genome by the genomic DNA derived RNAi library (Table 3.1).  The possibility of covering the 
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complete yeast genome was estimated at more than 99.8% (Table 3.1).  The sources of these 
fragments were randomly distributed on the yeast genome, including 17 out of 18 yeast 
chromosomes, the mitochondrial DNA and the 2μ plasmid (Fig. 3.4C). Taken together, it was 
suggested that a satisfying coverage of the yeast genome was achieved. 
 
Figure 3.4. The DNA sequencing results of 50 randomly picked plasmids from the RNAi library.  
(A) The size distribution of the genomic DNA fragments.  (B) The number of fragments per plasmid.  (C) 
The locations of the genomic DNA mapped to the yeast genome.  Each column represents one 
chromosome, the height of which is proportional to the sizes of the chromosomes.  Each bar indicates the 
location of one fragment.  The fragments derived from the mitochondrial genome and 2μ plasmid were 
omitted for clarity. 
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3.2.2. Suppressor analysis of the yku70Δ mutation by RNAi screening 
To verify the RNAi library, we performed a genome-wide RNAi screening to identify 
suppressors of the yku70Δ mutation (Fig. 3.5A).  Yku70 is a telomere-associated protein29, 30.  At 
an elevated temperature such as 37 °C, the null mutation of the yku70 gene will lead to single 
stranded DNA accumulation at the telomere, which triggers DNA damage response and then 
cell-cycle arrest
29
.  The temperature-dependent growth phenotype caused by the yku70Δ 
mutation provides a valuable model to study genetic interactions involved in DNA-repair and 
cell-cycle pathways
29-31
.  We transformed our RNAi library plasmids into the CAD strain with 
the yku70 gene deleted.  The transformants were selected on solid synthetic medium at 37 °C.  
Colonies that grew larger than the control strain were picked up and tested for their growth 
capacity under challenging temperatures in liquid media.  Plasmids isolated from the top growers 
were re-transformed into fresh yeast cells, and those still conferring improved growth at 37 °C 
were sequenced to identify the origins of the RNAi cassettes (Fig. 3.5B).  The inserts within the 
selected RNAi cassettes were found to be the fragments from one essential gene ret1, and four 
non-essential genes say1, ssa1, cst6 and mlp2 (Table S2).  The mlp2 and ssa1 genes were 
previously identified as suppressors of the yku70Δ mutation31, 32, which confirmed the 
effectiveness of our RNAi library for genome-wide screening. 
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Figure 3.5. RNAi screening in S. cerevisiae to identify yku70Δ suppressors.  (A) Scheme for 
suppressor screening of yku70Δ.  (B) Comparison of growth capacity in synthetic dropout medium at 
37 °C.  The initial OD600 was 0.2, and the cell density after growing for 12 hrs was normalized to the 
CAD strain containing the control plasmid.  (C) Estimation of knockdown efficiency where the 
expression levels of target proteins were quantified by the GFP tag
33
.  The 100% reference of GFP signal 
was defined as the strains with the control plasmid for each target gene respectively.  Reduction of GFP 
fluorescence was reported as 1-(RNAi strain fluorescence / Control strain fluorescence).  All the RNAi 
constructs were transcribed from a single-copy plasmid pRS416.  Si: selected RNAi constructs; Di: 
designed RNAi constructs; k/o: knockout; C: control plasmid pRS416-TTrc; N/A: knockout is lethal.  
Error bars indicate standard deviation of three biological replicates. 
 
To eliminate the “off-target” effects, we designed a second RNAi construct targeting a 
different region of the same transcript for each gene (Table 3.2).  The “off-target” effect often 
resulted from the partial homology to other transcripts
34
, and it was unlikely that two 
independent RNAi cassettes would have the common “off-target” suppression effects.  All the 
designed RNAi constructs rescued the temperature sensitivity of yku70Δ at 37 °C (Fig. 3.5B).  
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We further estimated the knockdown efficiency by fusing the target endogenous proteins with a 
carboxyl-terminal GFP tag for quantification
33
.  All the selected and designed RNAi cassettes 
showed reduction of GFP fluorescence (Fig. 3.5C).  The suppression effects of the selected non-
essential genes were also validated by examining the gene knockout mutants (Fig. 3.5B).  These 
results confirmed that the selected genes were suppressors of the yku70Δ mutation.   
Table 3.2. Summary of the selected and designed RNAi cassettes for HAc tolerance 
Name Number of fragments per inserts Size (bp) Mapped to the target gene 
ret1_Si 1 75 ret1 2803-2877/3450* 
say1_Si 1 123 say1 91-213/1275 
ssa1_Si 1 67 ssa1 213-279/1929 
cst6_Si 2** 46 cst6 1629-1584/1764 
  70 ydr109c 100-169/2148 
mlp2_Si 2 120 mlp2 2937-2818/5040 
  51 V 552895-552945/1091291*** 
ret1_Di 1 180 ret1 662-841/3450 
say1_Di 1 180 say1 801-980/1275 
ssa1_Di 1 180 ssa1 488-667/1929 
cst6_Di 1 180 cst6 311-490/1764 
mlp2_Di 1 180 mlp2 101-280/5040 
* For the genes, A-B/X indicated that the RNAi insert corresponds to the A-B bp region of the gene’s 
ORF, whose length is X bp.   
** For some of the selected RNAi plasmids, the inserts containing more than one inserts.  In this case, a 
designed RNAi construct as well as the knockout mutant were created to confirm which RNAi cassette(s) 
within the inserts was (were) the positive hit(s). 
*** If the fragment is not from an ORF, the location is denoted as a reference to the chromosome. 
 
While the newly-isolated modifiers will provide novel molecular insights on telomere 
biology (Table 3.3), the identification of an essential gene as a suppressor of the yku70Δ 
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mutation highlighted the advantage of RNAi screening over gene-knockout libraries by including 
the genes whose null mutations are lethal.   
Table 3.3. Gene functions of confirmed suppressor of yku70Δ*. 
Gene Description (www.yeastgenome.com) 
ret1 
Second-largest subunit of RNA polymerase III, which is responsible for the transcription 
of tRNA and 5S RNA genes, and other low molecular weight RNAs 
say1 
Sterol deacetylase; component of the sterol acetylation/deacetylation cycle along with 
Atf2p; integral membrane protein with active site in the ER lumen; green fluorescent 
protein (GFP)-fusion protein localizes to the endoplasmic reticulum 
ssa1 
ATPase involved in protein folding and NLS-directed nuclear transport; member of 
HSP70 family; forms chaperone complex with Ydj1p; localized to nucleus, cytoplasm, 
and cell wall; 98% identical with paralog Ssa2p, but subtle differences between the two 
proteins provide functional specificity with respect to propagation of yeast [URE3] prions 
and vacuolar-mediated degradations of gluconeogenesis enzymes; general targeting factor 
of Hsp104p to prion fibrils 
cst6 
Basic leucine zipper (bZIP) transcription factor, in ATF/CREB family; mediates 
transcriptional activation of NCE103 (encoding carbonic anhydrase) in response to low 
CO2 levels such as in the ambient air; proposed to be a regulator of oleate responsive 
genes; involved in utilization of non-optimal carbon sources and chromosome stability; 
CST6 has a paralog, ACA1, that arose from the whole genome duplication 
mlp2 
Guanine nucleotide exchange factor (GEF) for ADP ribosylation factors involved in 
proliferation of the Golgi, intra-Golgi transport and ER-to-Golgi transport; found in the 
cytoplasm and on Golgi-associated coated vesicles 
* It is noteworthy that the ssa1 and mlp2 genes were known suppressors of yku70Δ mutation.  The 
deletion of cst6 was reported to rescue the temperature sensitivity of the cdc13-1 mutant strain35, where 
the cdc13 gene encodes another telomere-capping protein29. The Say1 protein physically interacts with 
Sap3036, which was also identified as a suppressor of yku70Δ31, suggesting say1 and sap30 were involved 
in the same regulatory mechanism in response to yku70Δ defect. 
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3.2.3. RNAi-assisted genome evolution for improved HAc tolerance 
After establishing RNAi screening in S. cerevisiae, we combined it with directed evolution to 
rapidly engineer yeast cells for improved HAc tolerance (Fig. 3.1C).  Although bioethanol 
fermentation by S. cerevisiae from sugarcane sucrose and corn starch has been widely applied 
for biofuel production
9, 10
, the use of lignocellulosic biomass as substrate by this yeast is highly 
desirable for a more sustainable biofuel process
37
.  Acetic acid (HAc) is an unavoidable inhibitor 
either from the pretreatment step of lignocelluloses or as the by-product during alcoholic 
fermentation
38, 39
, and tolerance to HAc is highly desirable for commercial production of 
chemicals and fuels by S. cerevisiae
39
.   
 
Figure 3.6. Reduced HAc tolerance of mutant strains nap1Δ and fps1Δ in CEN.PK2-1c background.  
The strains were cultured aerobically in SC-U medium containing 0.5% (v/v) HAc.  The initial OD600 was 
0.2, and the cell density after growing for 12 hrs was normalized to the CAD strain containing the control 
plasmid.  Error bars indicate standard deviation of three biological replicates.  The introduction of nap1Δ 
or fps1Δ was known to improve HAc tolerance in the BY4741 strain40, 41, but failed to elicit the same 
phenotype in the CEN.PK2-1c strain.  
 
Previous screening efforts to increase HAc tolerance in S. cerevisiae are limited to 
BY4741/4742 strains based on which most gene-knockout libraries are created
39, 42
.  Our results 
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showed that the mutations that were reported to improve HAc tolerance in BY-strains failed to 
elicit growth advantage in our CEN.PK2-1c strain under HAc stress (Fig. 3.6). 
We first confirmed that introduction of this heterologous RNAi pathway had little impact on 
cellular growth and HAc tolerance of S. cerevisiae (Fig. 3.7A), which is consistent with a 
previous report
43
. 
 
Figure 3.7.  Improving HAc tolerance by RNAi screening in S. cerevisiae.  (A) No obvious difference 
in growth capacity was found upon introduction of the S. castellii RNAi pathway.  The strains were 
grown aerobically in synthetic dropout medium (pH=4.5) with or without 0.5% (v/v) HAc.  The initial 
OD600 was 0.2, and the cell density after growing for 12 hr was normalized to the wild-type strain 
containing the control plasmid.  The same culture condition was employed in (B) and (D).  (B) The 
knockout mutations of the selected gene targets in the first round of RAGE led to reduced growth rates in 
synthetic dropout medium without HAc stress compared to the CAD strain containing the control plasmid.  
(C) Scheme for RNAi expression cassettes of the ptc6 gene.  The ptc6 gene fragments with varying 
lengths were cloned in the anti-sense direction under the control of PTEF1 promoter.  TTrc-ptc6-Si was the 
selected RNAi cassette with the convergent-promoter design.  (D) The different knockdown levels 
enabled by various RNAi cassettes of the ptc6 gene led to varying HAc tolerance in the recombinant yeast 
strains.  Error bars indicate standard deviation of three biological replicates.  The knockdown efficiency 
was estimated by the GFP-tagging experiment following the same procedure as in Fig. 3.8B.    
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Figure 3.8. Knockdown targets identified by RNAi screening for improved HAc tolerance. (A) 
Comparison of growth capacity in the presence of 0.5% (v/v) HAc in synthetic dropout medium (pH = 
4.5).  The initial OD600 was 0.2, and the cell density after growing for 12 hrs was normalized to the CAD 
strain containing the control plasmid.  (B) Estimation of knockdown efficiency where the expression 
levels of target proteins were quantified by the GFP tag
33
.  The 100% reference of GFP signal was defined 
as the strains with the control plasmid for each target gene respectively.  Reduction of GFP fluorescence 
was reported as 1-(RNAi strain fluorescence/ Control strain fluorescence).  All the RNAi constructs were 
transcribed from a single-copy plasmid pRS416 in (A) and (B).  (C) HAc tolerance of strains with 
combinations of RNAi cassettes from the first round of RAGE.  The same growth condition was 
employed as in (A).  The names of the strains are denoted by two letters.  The first letter indicates the 
integrated cassette in the his3 locus, while the second letter indicates the RNAi cassette on the plasmid.  R: 
rnt1_Si, Y: ymr1_Si, P: ptc6_Si, K: ypk3_Si, N: no integration C: the control plasmid pRS416-TTrc. 
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Table 3.4. Summary of the selected and designed RNAi cassettes for HAc tolerance 
Name Number of fragments per inserts 
Size 
(bp) 
Mapped to the target gene 
Based on CAD 
A12 (rnt1_Si) 1 152 rnt1 991-840/1416* 
D11 (ymr1_Si) 1 119 ymr1 265-147/2067 
F6 (ptc6_Si) 1 79 ptc6 649-571/1329 
H6 (ypk3_Si) 1 1017 ypk3 -79-937/1578 
rnt1_Di 1 180 rnt1 457-636/1416 
ymr1_Di 1 180 ymr1 1631-1810/2067 
ptc6_Di 1 180 ptc6 721-900/1329 
ypk3_Di 1 180 ypk3 471-650/1578 
Based on CAD_ymr1i 
D11_#9 1 142 sec7 3677-3536/6030 
Based on CAD_ptc6i 
F6_#19 1 198 ypr084w 365-168/1371 
F6_#23 1 103 afg3 2286-2236/2286 
Based on CAD_ptc6i_ypr084wi 
F6_#19_#18 1 61 rgd1 1342-1282/2001 
F6_#19_#27 1 72 
XIII 586652-586580/ 924431**, 
including part of the tRNA
Val(AAC)
 
* For the genes, A-B/X indicated that the RNAi insert corresponds to the A-B bp region of the gene’s 
ORF, whose length is X bp.   
** If the fragment is not from an ORF, the location is denoted as a reference to the chromosome. 
Following a similar procedure of the suppressor screening for yku70Δ (Fig. 3.6A), four RNAi 
cassettes that conferred yeast cells with increased growth under 0.5% (v/v) HAc stress were 
identified and confirmed in the first round of RAGE (Fig. 3.8A and Fig. 3.8B, and Table 3.4).  
We then integrated the four selected RNAi cassettes into the yeast genome separately, and the 
resultant strains all exhibited better fitness than the wild-type strain under HAc stress (Fig. 3.8C).  
These strains were then employed as new parent strains for the second round of RNAi screening 
(Fig. 3.9A).  With a mini-library containing the four selected plasmids from the first round, we 
found that the combination of the beneficial RNAi modifications did not necessarily lead to 
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incremental improvements (Fig. 3.8C), highlighting the necessity to perform genome-wide 
screening to identify targets for further engineering.   
 
Fig. 3.9. Yeast strains engineered by RAGE showing improved HAc tolerance.  (A) Scheme of 
iterative RNAi screening to accumulate beneficial knockdown modifications in a yeast genome.    (B) 
Growth capacity of the yeast strains identified from three rounds of RAGE with different levels of HAc in 
synthetic dropout medium (pH = 4.5).  The initial OD600 was 0.01, and the cell density was measured after 
growing for 24 hrs (0%, 0.5% and 0.7% (v/v)) or 48 hrs (0.9% and 1.0%).  No cell growth was observed 
for the 1.0% (v/v) HAc group after 72 hrs.  Fold improvements were compared to the CAD strain 
containing the control plasmid.  (C) Contribution of individual knockdown modification from the R3 
strain to the enhanced HAc tolerance.  Plasmids harboring the selected RNAi cassettes for ptc6, ypr084w 
and tRNA
Val(AAC)
 were transformed into the CAD strain to achieve individual gene silencing.  The same 
growth condition was employed as in (C) except that only two HAc concentrations (0.5% and 0.7%) were 
tested.  C: the CAD strain harboring the control plasmid pRS416-TTrc; R1-R3: the best strains selected 
from the first, second and third round of RAGE, respectively, with all the selected RNAi cassettes 
integrated (see Table 3.8 for details).  The R1-R3 strains were all transformed with the control plasmid 
pRS416-TTrc to enable growth in the SC-U medium.  Error bars indicate standard deviation of three 
biological replicates.  
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The genome-wide RNAi library was transformed into the new parent strains (Fig. 3.9A).  A 
higher HAc concentration (0.6% (v/v)) than the first round (0.5% (v/v)) was used to isolate 
mutant strains with better HAc tolerance.  In the background of the strain integrated with the 
RNAi cassette for ptc6 (named as the first round strain R1), the RNAi cassette for ypr084w 
resulted in the highest fitness in the second round of screening (Fig. 3.9A).  Thus the 
recombinant strain integrated with both the ptc6 RNAi and ypr084w RNAi cassettes (named as 
the second round strain R2) was created and used as the parent strain for the third round of RNAi 
screening with 0.7% (v/v) HAc as selection pressure.  The best mutant strain was found to 
contain an RNAi cassette with a genomic DNA fragment from tRNA
Val(AAC)
 as the insert (named 
as the third round strain R3, Fig. 3.9A).   
 
3.2.4. Superior HAc tolerance of engineered strains by RAGE 
The mutant strains with the highest fitness in each round of RAGE were compared in parallel 
with the control strain for the growth capacity in the presence of different concentrations of HAc.  
A general trend of R3 > R2 > R1 > control was observed under almost all the conditions, 
indicating the step-wise improvement of HAc tolerance (Fig. 3.9B).  The tolerance phenotype of 
the R3 strain was significantly increased, which accumulated greater than 20-fold more biomass 
under 0.9% (v/v) HAc relative to the control strain.  The 100% inhibitory HAc concentration for 
growth was elevated from 0.8% to 1.0% (v/v). 
Next, we evaluated the contribution of each RNAi cassette to the HAc tolerance of the R3 
strain.  The yeast strains carrying only one of the selected RNAi cassettes for ptc6, ypr084w and 
tRNA
Val(AAC)
 were constructed and compared with the R3 strain for the growth capacity with 
elevated HAc levels (0.5% and 0.7% (v/v)).  The results showed that each cassette led to 
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increased biomass accumulation to some extent relative to the control, but the superior tolerance 
of the R3 strain cannot be readily explained by simply adding up these individual effects (Fig. 
3.9C).  The mechanism of the observed synergy cannot be deduced directly from the known 
functions of the targeted genes (Table 3.5).  Such non-linear interactions between the RNAi 
cassettes highlighted the necessity of iterative rounds of screening to accumulate the beneficial 
knockdown perturbations. 
Table 3.5. Gene functions of the knockdown targets identified by RAGE. 
Gene Description (www.yeastgenome.com) 
rnt1 Nuclear dsRNA-specific ribonuclease (RNase III); involved in rDNA transcription, rRNA 
processing and U2 snRNA 3' end formation by cleavage of a stem-loop structure at the 3' 
end of U2 snRNA; involved in polyadenylation-independent transcription termination; 
involved in the cell wall stress response, regulating the degradation of cell wall integrity and 
morphogenesis checkpoint genes 
ymr1 Phosphatidylinositol 3-phosphate (PI3P) phosphatase; involved in various protein sorting 
pathways, including CVT targeting and endosome to vacuole transport; has similarity to the 
conserved myotubularin dual specificity phosphatase family 
ptc6 Mitochondrial type 2C protein phosphatase (PP2C) with similarity to mammalian PP1Ks; 
involved in mitophagy; null mutant is sensitive to rapamycin and has decreased 
phosphorylation of the Pda1 subunit of pyruvate dehydrogenase 
ypk3 An AGC kinase phosphorylated by cAMP-dependent protein kinase (PKA) in a TORC1-
dependent manner 
sec7 Guanine nucleotide exchange factor (GEF) for ADP ribosylation factors involved in 
proliferation of the Golgi, intra-Golgi transport and ER-to-Golgi transport; found in the 
cytoplasm and on Golgi-associated coated vesicles 
ypr084w Putative protein of unknown function 
afg3 Component, with Yta12p, of the mitochondrial inner membrane m-AAA protease; mediates 
degradation of misfolded or unassembled proteins and is also required for correct assembly 
of mitochondrial enzyme complexes; involved in cytoplasmic mRNA translation and aging 
rgd1 GTPase-activating protein (RhoGAP) for Rho3p and Rho4p, possibly involved in control of 
actin cytoskeleton organization 
tRNA
Val(AAC)
 tV(AAC)M3, Valine tRNA (tRNA-Val), predicted by tRNAscan-SE analysis 
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The fermentation performance of the R3 strain and the control strain were evaluated under an 
oxygen-limited condition.  Three levels of HAc stress were applied as 0%, 0.7% and 1.0% (v/v) 
in the synthetic minimal medium.  The performance of the R3 strain was superior to the control 
under all the conditions in terms of glucose utilization, biomass accumulation and ethanol 
productivity (Fig. 3.10).  Specifically, in the presence of 0.7% HAc, the R3 strain exhibited a 
63.1±3.2% increase in ethanol productivity relative to the control strain in the period of 0-24 hr.  
Though the final ethanol titers were similar for the two strains, the R3 strain accumulated 
15.3±3.5% more biomass than the control.  Without the HAc stress, the R3 strain showed the 
same ethanol production profile as the control strain.  Notably, after the glucose was depleted, 
the R3 strain exhibited a much faster assimilation rate of acetate than the control (Fig. 3.10).  
The enhanced capacity to utilize acetate might provide some clues why the R3 strain had a 
higher level of HAc tolerance.  These results confirmed that RAGE successfully improved the 
HAc tolerance and fermentation performance of S. cerevisiae. 
 
3.3. Conclusions and Future Prospects 
RNAi proves to be an enabling technology with broad applications for functional analysis, 
therapeutics and metabolic engineering in mammalian cells, insect cells and plants
44, 45
.  
Although RNAi is not a novel technique, RAGE further expands the power of RNAi by the 
identification and fine-tuning of multiplex gene targets and engineer yeast cells on a genome 
scale.  The potential of employing RNAi screening for directed genome evolution offers great 
advantages over conventional gene-knockout strategies, such as providing a simple tool to 
modify a eukaryotic genome globally and iteratively, enabling fine-tuning of gene expression, 
including essential genes in functional screening, and identifying beneficial traits which requires 
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synergistic genetic modifications.  By targeting mRNAs to introduce reduction-of-function 
mutations, RAGE might be especially useful in industrial organisms for which gene deletion is 
extremely challenging due to polyploidy
46
.   
 
Figure 3.10. Fermentation profiles of the engineered and wild-type yeast strains.  Cells were cultured 
in biological replicates in the SC-U medium containing 20 g/L glucose and 0% (A and B), 0.7% (C and D) 
and 1% (E and F) HAc (v/v).  The initial OD600 was adjusted to 1.  Oxygen-limited condition was 
employed with un-baffled shake flasks and 100 rpm agitation.  Biomass accumulation was monitored by 
optical density (A, C and E).  The concentrations of glucose, acetate and ethanol were measured by 
HPLC (B, D and F).  Error bars indicate standard deviation of three biological replicates. 
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When interpreting the results of RNAi screening, cautions need to be taken against “off-target” 
effect, which is mainly resulted from cross-silencing of other transcripts with partial homology
34
.  
The “off-target” effect is well-documented for different eukaryotic systems in literature20, 34, 47, 48.  
The most effective way to ensure that the observed phenotypes are “on-target” is to show that 
these phenotypes can be generated by independent RNAi molecules which target the same gene 
but contain completely distinct sequences
19, 20, 23
, as performed in this study by analyzing the 
phenotypes caused by a second designed dsRNA molecule for each gene target (Fig. 3.5B and 
Fig. 3.8A).  While it is very critical to minimize “off-target” effect when applying RNAi as 
therapeutics
49
, it is probably less important to achieve high specificity of RNAi in microbial 
strain engineering. 
In this work, we constructed the RNAi library by inserting the genomic DNA fragments 
generated by Sau3AI into a pair of convergent promoters for dsRNA synthesis.  Whereas this is 
an established method
27
, it is possible to further improve the coverage and effectiveness of the 
RNAi library.  First, though a library size that is big enough can ensure the complete coverage of 
the yeast genome, the biased fragmentation pattern determined by the recognition site of Sau3AI 
may preclude the identification of some genes in the screening.  For these genes, the dsRNA 
molecules transcribed from the Sau3AI fragments may not generate observable phenotypes due 
to weak knockdown levels.  To solve this issue, a collection of random fragmentation strategies 
with less inherent bias through enzymatic, chemical and mechanical means can be employed, 
which are originally developed to create the shotgun libraries for genome sequencing
50
.  Second, 
the knockdown efficiency enabled by the long dsRNA molecules is moderate, which may limit 
the sensitivity of RNAi screening.  For example, the knockout mutations of some identified 
yku70Δ suppressors led to more substantial growth advantage than the knockdown mutations 
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(Fig. 3.3B).  Whereas the incompleteness of knockdown mutations is a well-recognized issue of 
RNAi screening, it is possible to improve the gene-silencing efficiency by optimizing the format 
of RNAi reagents.  For example, in this study we observed that the full-length anti-sense RNA 
resulted in more profound knockdown effects than the dsRNA molecules transcribed by the 
convergent promoters (Fig. 3.3B).  Therefore, one way to improve the sensitivity of RNAi 
screening is to use the full-length anti-sense RNAi library, which can be created by cloning of 
the full-length cDNA library in a reversed direction after a promoter sequence (Chapter 4).  It is 
noted that in a recent report, hairpin RNAi molecules were implemented for RNAi down-
regulation in S. cerevisiae
26
.  Different parameters, such as the hairpin length and expression 
context, were manipulated for optimized gene silencing effectiveness.  It is thus possible to use 
hairpin RNAi design for the library construction in RAGE.  For S. cerevisiae strains with 
sequenced genomes, it is also possible to design synthetic genome-wide RNAi library by 
computational algorithms to optimize the potency and specificity
51
.   
In its current form, a pooled library on an episomal plasmid coupled with an efficient 
selection strategy is implemented in RAGE.  However, a separate integration step is needed at 
the beginning of each round to create a new parent strain.  It should be noted that the plasmid-
borne and integrated versions of the same RNAi cassette may lead to different phenotypes.  For 
example, the integrated RNAi cassette for ptc6 (Fig. 3.8C, group PC) resulted in a slightly 
higher HAc tolerance than the plasmid-borne version (Fig. 3.8A, group ptc6_Si).   In addition, 
the gfp-knockdown constructs that were integrated generally led to a stronger silencing effect 
than their plasmid-borne counterparts (Fig. 3.3B).  The strains harboring the integrated RNAi 
cassettes also exhibited less population heterogeneity in GFP fluorescence profile, compared to 
the strains with the RNAi cassettes on the plasmid (Fig. 3.3C).  Together, these observations 
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indicate that the different expression contexts, from a plasmid or a genomic location, may affect 
the kinetics of dsRNA transcription and therefore lead to different knockdown levels.   This 
dependency of gene silencing effectiveness on RNAi expression format was also consistent with 
a previous report
26
.  Therefore, it is critical to confirm that the improved trait is still retained 
upon the integration of a selected RNAi cassette.  It is also possible to avoid the changes in 
expression contexts by direct integration of the RNAi library into the host genome for library 
creation, which should further speed up and automate the entire process of RAGE (Chapter 5).  
While the transformation efficiency of an episomal plasmid can easily achieve a complete 
coverage of the entire genome, the integration efficiency needs to be greatly improved to create a 
comprehensive library, possibly through the introduction of double-stranded breaks (DSBs) on a 
genome
52
.  Recent development in creating site-specific DSBs by engineered nucleases (zinc-
finger nucleases or ZFNs
53
, transcription-activator like effector nucleases or TALENs
54, 55
, and 
clustered regularly interspaced short palindromic repeats (CRISPR) or CRISPR-associated 
nucleases
56, 57
) may facilitate the automation of RAGE by direct integration (Chapter 5).  
For the engineered strains obtained by RAGE, further investigation of the mechanisms 
underlying the superior HAc tolerance will provide invaluable knowledge about the target traits.  
Based on the known functions of the selected knockdown gene targets (Table 3.5), it is 
noteworthy that ypk3 and ptc6 are involved in the Target of rapamycin (TOR) pathway, which is 
responsible for the signalling of acetic acid-induced apoptosis58.  The gene rnt1 can mediate 
selective mRNA degradation and thus regulate the cell wall stress response59, which is 
experienced by HAc-challenged yeast cells39.  The gene ypk3 might also play a role in the cell 
wall integrity as a homolog of ypk160, and the deletion of ypk1 can improve acid tolerance of the 
yeast cells61.  Though the function of ypr084w is unknown, ypr084w exhibits negative 
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interactions with the slm4 and spf1 genes62, which are the determinants of HAc resistance63.  
Reprogramming of tRNA modifications was reported to regulate the stress response of yeast 
cells64, 65, and it will be interesting to further investigate how our selected RNAi construct for 
tRNAVal(AAC) plays a role in such process. 
It is noted that the knockout mutations of the selected genes failed to improve HAc tolerance 
as the knockdown mutations did (Fig. 3.8A).  The phenomenon that the performance of a 
knockdown mutant strain was better than both the wild-type and knockout strains has been 
observed previously in S. cerevisiae
66
.  For some essential genes whose knockout mutations are 
lethal, the reduction-of-function mutants exhibit growth advantages compared to the wild-type 
strain
66
.   We speculate that the underlying reason may be that the knockout mutations of such 
genes may have dual roles, which result in not only improved tolerance to a certain chemical but 
also impaired general fitness.  Indeed, the knockout strains of the selected gene targets in the first 
round of RAGE grew at reduced rates compared to the CAD strain without HAc stress (Fig. 
3.7B), indicating the complete disruption of the normal functions of these genes may affect the 
general fitness of the yeast cells.  Therefore an optimal knockdown level may exist to balance the 
trade-off between general fitness and inhibitor tolerance.  The optimal knockdown level may be 
determined by fine-tuning the knockdown level of a selected target, which is possible by 
switching among different RNAi reagent forms (anti-sense RNAs or dsRNAs) and varying the 
lengths and positions of the RNAi cassettes.  These strategies successfully enabled different 
levels of suppression of both the gfp gene (Fig. 3.3) and the ptc6 gene (Fig. 3.7C and Fig. 3.7D).   
Here we show the de novo creation of an artificial RNAi regulatory mechanism tailored for 
the host and target trait(s) in an organism that lacks a native RNAi machinery.  RAGE employs a 
genomic DNA/cDNA-derived library
27
 and thus does not require genome sequence information 
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or a pre-constructed gene-knockout library.  Such strategy should be widely applicable in any 
host of interest with basic genetic tools and a functional RNAi pathway (native or engineered).  
Although RNAi is only conserved in eukaryote, a recent method based on synthetic small 
regulatory RNAs (sRNAs) was developed to modulate the expression of up to 122 chromosomal 
genes in E. coli
67
.  Thus it is also possible to extend the application of RAGE in bacteria by 
accumulating beneficial sRNAs in the E. coli genome to continuously improve a target trait.  
Given the versatile tools and broad applications available for both RNA interference and directed 
evolution, we envision RAGE will become a powerful genome-scale engineering tool for studies 
in biology, medicine and biotechnology.   
 
3.4. Methods and Materials 
3.4.1. Strains, media, and cultivation conditions 
S. cerevisiae strain CEN.PK2-1c (MATa ura3-52 trp1-289 leu2-3,112 his3Δ1 MAL2-8C 
SUC2) was purchased from EUROSCARF (Frankfurt, Germany).  Zymo 5α Z-competent E. coli 
(Zymo Research, Irvine, CA) and NEB 5α Electrocompetent E. coli (New England Biolabs, 
Ipswich, MA) were used for plasmid amplification and library construction, respectively.  S. 
castellii strain was obtained from the ARS culture collection (NRRL number Y-12630) (Peoria, 
IL).  S. cerevisiae strains were cultivated in either synthetic dropout medium (0.17% Difco yeast 
nitrogen base without amino acids and ammonium sulfate, 0.5% ammonium sulfate and 0.083% 
amino acid drop out mix, 0.01% adenine hemisulfate and 2% glucose) or YPAD medium (1% 
yeast extract, 2% peptone, 0.01% adenine hemisulfate and 2% glucose).  10% (v/v) filtered 
acetic acid (HAc) solution stock was added into the above medium to make stressed medium.  
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Before mixing, both the medium and HAc stock were adjusted to pH = 4.5.  S. cerevisiae strains 
were cultured at 30 °C and with 250 rpm agitation in baffled shake-flasks for aerobic growth, 
and at 30 °C and 100 rpm in un-baffled shake-flasks for fermentation.  E. coli strains were 
cultured at 37 °C and 250 rpm in Luria broth (LB) medium (Fisher Scientific, Pittsburgh, PA) 
with the supplement of 100 μg/mL ampicillin.  S. castellii strain was cultured in YPAD medium 
at 30 °C and 250 rpm.  All chemicals were purchased through Sigma-Aldrich or Fisher Scientific. 
 
3.4.2. DNA manipulation 
Plasmid cloning was mostly done by In-fusion HD cloning Kit (Clontech Laboratories, 
Mountain View, CA) following the manufacturer’s instructions or by the DNA assembler 
method 
68
.  The complete list of the plasmids, primers and strains in this study is summarized in 
Tables 3.6-3.8.  For DNA manipulations, yeast plasmids were isolated using a Zymoprep II 
yeast plasmid isolation kit (Zymo Research, Irvine, CA) and transferred into E. coli for 
amplification.  QIAprep Spin Plasmid Mini-prep Kits (Qiagen, Valencia, CA) were employed to 
prepare plasmid DNA from E. coli.  Yeast genomic DNA was isolated by Wizard Genomic DNA 
Purification Kit (Promega, Madison, WI).  All enzymes used for recombinant DNA cloning were 
from New England Biolabs unless otherwise noted.  The products of PCR, digestion and ligation 
reactions were purified by QIAquick PCR Purification and Gel Extraction Kits (Qiagen, 
Valencia, CA).   
 
91 
 
3.4.3. Reconstitution of the RNAi machinery in S. cerevisiae 
The genomic DNA of S. castellii strain was isolated and used as template to clone the ago1 
and dcr1 genes.  An expression cassette in which the ago1 and dcr1 genes were driven by 
constitutive promoters PTEF1 and PTPI1, respectively, was assembled into a delta-integration 
vector by the DNA assembler method.  The integration copy number of the RNAi pathway was 
analyzed by quantitative PCR (qPCR) with LightCycler
®
 480 SYBR Green I Master (Roche, 
Indianapolis, IN) following the manufacturer’s instructions.  To test whether the RNAi 
machinery is functional, a reporter system based on green fluorescent protein (GFP) was devised.  
The GFP fluorescence of the engineered strains was analyzed by LSR II Flow Cytometer (BD, 
Franklin Lakes, NJ).   
 
3.4.4. Construction of a genome-wide RNAi library 
Two strong constitutive promoters, PTEF1 and PTPI1, were cloned in opposite directions to 
drive the in vivo synthesis of a dsRNA molecule
27
.  A BamHI restriction site is engineered 
between the two promoters to facilitate the insertion of genomic DNA fragments generated by 
complete Sau3AI digestion.  The expression cassette was placed on a single-copy plasmid 
pRS416.  The ligation products of the genomic DNA fragments and the linearized vector were 
transformed into E. coli cells by electroporation to create a pooled plasmid library.  Specifically, 
the genomic DNA of yeast strain CEN.PK2-1c was isolated.  In a 50 μL reaction, a titration of 
0.4-4 U Sau3AI enzyme was added to digest 50 μg genomic DNA for 15 min at 37 °C.  After 
heat inactivation at 65 °C for 20 min, the digestion mixtures were column purified, and 0.5 μL of 
the purified DNA was loaded along with the intact genomic DNA on a 0.7% agarose gel.  After 
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staining with ethidium bromide and visualizing under UV light, the digestion reaction with 4 U 
Sau3AI was considered complete and used for the following experiments.   
The ligation was performed by T4 ligase with 300 ng genomic DNA fragments and 100 ng 
pRS416-TTrc plasmid linearized by BamHI.  The single-copy plasmid pRS416 was chosen as 
the vector to ensure that each yeast cell only carried one RNAi cassette in the library.  The 
ligation product was n-butanol precipitated and resuspended in 10 μL ddH2O, which was 
transformed with 100 μL NEB 5-alpha Electrocompetent E. coli by electroporation.  The E. coli 
cells were immediately transferred into 1 mL SOC medium.  After recovered for 1 hr, all the 
cells were used to inoculate 25 mL LB medium plus 100 μg/mL ampicillin (Amp) and allowed to 
grow until saturation.  One hundredth of the cells was plated on an LB+Amp plate to estimate the 
transformation efficiency.  A library size of 4.22×10
5
 was obtained, while the control reaction 
with only the digested plasmid gave only 1.4×10
3
 transformants.  The plasmid library was 
isolated from the overnight E. coli culture.  
 
3.4.5. Construction of a yeast knockdown library and screening 
In the CAD strain, the standard LiAc/ssDNA/PEG protocol
69
 was used to transform 20 μg 
RNAi library plasmids or the control plasmid.  Twenty micro-gram of the library DNA was able 
to achieve a library size more than 5×10
5
 to ensure a complete coverage of the yeast genome.  
Following the transformation, the yeast cells were recovered in 1 mL YPAD medium for 4 hr, 
and then washed with ddH2O.  For yku70Δ suppressor screening, the transformants were spread 
onto 15 mm diameter petri-dish plates of solid SC-U medium.  The amount of cells was adjusted 
so that each plate would form about 10
4
 colonies at a permissive temperature 30 °C and about 
10
3
 colonies when challenged with 37 °C.  The library plates and the control plates were 
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incubated at 37 °C for 3~4 days.  Ninety-three colonies whose sizes were bigger than the largest 
colonies on the control plates were picked from the library plates.  The growth performances of 
the selected colonies and the control strain were compared in SC-U medium at 37 °C.  The initial 
OD600 for all the strains were adjusted to 0.2, and the growth was monitored at 4, 8, 12 and 24 
hrs time intervals.  The RNAi plasmids from the top strains whose growth behaviors were 
considerably better than the control strain were isolated and amplified by E. coli.  The selected 
plasmids were then individually re-transformed, of which four were able to retain the enhanced 
HAc tolerance in a fresh background with three biological replicates.  The confirmed plasmids 
were sent for DNA sequencing analysis.  The BLAST search was used to identify the sources of 
the inserts in the selected RNAi plasmids.  For each new-identified gene target, a designed RNAi 
mutant and a knockout mutant were constructed for further analysis.  A similar procedure was 
employed for HAc tolerance screening, except that 0.5% (v/v) HAc was supplemented into the 
growth medium and the cells was cultured at 30 °C. 
 
3.4.6 Analysis of the newly discovered RNAi targets 
To gain a deeper understanding of the selected RNAi targets, both the designed RNAi and 
the deletion mutants were created and tested for HAc tolerance.  The designed RNAi plasmids 
were constructed by cloning a different region from each target transcript other than the selected 
plasmids into the pRS416-TTrc plasmid (Tables 3.2 and 3.4).  The selected plasmids were 
named as pRS416-TTrc-gene name-Si, while the designed plasmids were named as pRS416-
TTrc-gene name-Di.  To perform gene deletion, the open reading frames (ORFs) of target genes 
were disrupted by inserting the LoxP-ura3-LoxP cassette, which was PCR-amplified from 
plasmid pUG72.  The primers were designed in such a way that the ura3 cassette was flanked by 
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40 bp sequences that were homologous to the upstream and downstream regions of the target 
ORFs.  The same procedure was used to knockout the nap1 and fps1 genes that were known to 
improve HAc tolerance in BY4741 strain.  The strains containing selected RNAi, designed RNAi, 
deletion and the control plasmid pRS416-TTrc were compared in parallel for the aerobic growth 
capacity in the presence of HAc stress.  Three biological replicates of each strain were inoculated 
in 3 mL SC-U to grow until saturation.  Then 50 μL culture was used to inoculate 3 mL fresh 
SC-U to synchronize the growth phase.  After 20 hrs, the stationary-phase cells were transferred 
into 4 mL SC-U medium with 0.5% (v/v) HAc.  The amount of inoculation was adjusted so that 
the starting OD600 was 0.2.  The cell density was monitored at 4, 8, 12, 24 and 36 hr.  The 
normalized OD600 values with the control strain as the reference were used to evaluate the HAc 
tolerance.  The same procedure was used to assay the HAc tolerance unless specified otherwise. 
 
3.4.7. Second and third rounds of RAGE 
A similar screening procedure was employed in the subsequent rounds as in the first one.  
For the second round, the four selected RNAi cassettes in the first round were subcloned into the 
multiple cloning site of pRS403 plasmid and integrated into the his3 locus of the CAD strain to 
construct the new parent strains.  Then the RNAi plasmid library was transformed into the new 
parent strains to perform the second round of RAGE.  The stress level of 0.6% (v/v) HAc was 
applied for the screening on the solid medium and the growth quantification in the liquid 
medium.  For the third round of screening, the RNAi cassette for ypr084w was subcloned into 
pRS404 and integrated into the trp1 locus of CAD_ptc6i to create the new parent strain.  The 
stress level of 0.7% was applied.  The details about all the selected and designed RNAi cassettes 
can be found in Table 3.4. 
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3.4.8. Characterization of engineered strains for HAc tolerance 
The engineered R1, R2 and R3 strains, together with the control strain, were tested for the 
biomass accumulation in the synthetic dropout medium SC-U containing 0, 0.5, 0.7, 0.9 and 1.0% 
(v/v) HAc.  Three biological replicates of each strain were inoculated in 3 mL SC-U to grow 
until saturation.  Then 50 μL culture was used to inoculate 3 mL fresh SC-U to synchronize the 
growth phase.  After 20 hrs, the stationary-phase cells were transferred into three culture tubes 
containing 3 mL SC-U medium and varying concentrations of HAc.  The initial OD600 was 
adjusted to 0.01 and 1 mL cell culture was taken periodically at 24, 48 and 72 hrs to measure the 
cell density.  The same procedure was used to compare the R3 strain and the strains containing 
only one of the three RNAi cassettes from the R3 strain. 
The fermentation performance of the R3 strain and the control strain was compared.  Three 
biological replicates of each strain were inoculated in 3 mL SC-U medium in 15 mL round-
bottom Falcon tubes to grow until saturation.  Then 1 mL culture was transferred into 20 mL SC-
U medium in 125 mL baffled shake-flasks.  The preparation of the seed culture was performed 
aerobically (30 °C and 250 rpm).  After 20 hrs, the stationary-phase cells were transferred into 50 
mL SC-U medium in un-baffled 250 mL shake-flasks.  The fermentation was carried out under 
an oxygen-limited condition (30 °C and 100 rpm).  Three levels of HAc stress were applied as 
0%, 0.7% and 1.0% (v/v) in the synthetic dropout medium SC-U.  1 mL samples were taken at 0, 
4, 8, 12, 24 and 48 hrs for the measurement of cell density and HPLC analysis.  An HPX-87H 
column (BioRad, Hercules, CA) coupled with a refractive index detector (Shimadzu Scientific 
Instruments, Columbia, MD) was used to separate and analyze the concentrations of glucose, 
ethanol, and acetate in the broth following the manufacturer’s instructions. 
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3.4.9. Estimation of the gene knockdown efficiency 
By knocking-in the GFP gene as a carboxy-terminal fusion reporter, it is possible to quantify 
the expression levels of the target proteins.  All the primers and the process to create a perfect in-
frame GFP fusion protein were reported elsewhere
33
.  We measured the knockdown efficiency 
for the four target genes found in the first round of RAGE.  The cells were cultured aerobically 
in SC-His/Ura and subjected to the flow cytometry analysis in their log-phase.   
To determine the knockdown efficiency of the other two RNAi cassettes (ypr084w and 
tRNA
Val(AAC)
), a semi-quantification assay was employed to measure the level of target RNA 
molecules
24
.  The reason why we did not use the GFP-fusion construct is that the his3 selection 
marker used to insert GFP cassette was already used to integrate the RNAi cassettes.  The total 
RNAs from the R3 strain and the control strain were isolated using the RNeasy mini kit 
(QIAGEN, Valencia, CA).  The cDNA synthesis was performed by the Transcriptor First Strand 
cDNA Synthesis Kit (Roche, Indianapolis, IN).  In each reverse-transcription reaction for a 
certain gene, 5 μg of the RNA was used as template, and the gene-specific primers for the target 
gene and the internal control gene act1 were added in the same reaction.  For the control samples, 
only the reverse-transcriptase was omitted.  The primers for the cDNA synthesis were named as 
gene-name-cDNA Rev (Table 3.7).  For the PCR reactions, 1 μL of the RT-reaction was added 
to a 100 μL reaction.  The primers were named as gene-name-RT-PCR For/Rev.  The PCR 
reaction was dispensed as 20 μL aliquots and run for the indicated numbers of cycles (16, 20 and 
24 for act1, 20, 24 and 28 for ptc6 and ypr084w).  Then 4 μL 6X loading dye was mixed with the 
PCR reaction, and 6 μL of the mixture was loaded onto 1.5% agarose gel for ethidium bromide 
staining and UV visualization (Fig. 3.11).  No RT-PCR products were obtained after 32 cycles 
for the control samples or for the tRNA
Val(AAC) 
samples.   
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Figure 3.11. Semi-quantification of mRNA levels.  RT-PCR products with increasing cycles of 
amplification were loaded onto 1.5% agarose gel and stained by ethidium bromide.  Cycle number:  X=20 
for the act1 gene, and X=24 for the ptc6 and ypr084w genes.  No RT-PCR product was detected in 
control samples or for tRNA
Val(AAC)
 after 32 cycles.  
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Table 3.6 List of plasmids used in this chapter 
Plasmid Primers for PCR Notes 
pRS425-TEF1p-PmeI-PGK1t 
pRS-TEF1p-40bp For/TEF1p-PmeI-PGK1t 
Rev 
Helper plasmid to clone genes into the TEF1p-PGK1t 
cassette; constructed by DNA assembler TEF1p-PmeI-PGK1t For/PGK1t-pRS-40bp 
Rev 
pRS425-PGK1t-TPI1p-PmeI-GPDt 
pRS-PGK1t For/PGK1t-TPI1p Rev 
Helper plasmid to clone genes into the TPI1p-GPDt 
cassette; constructed by DNA assembler 
PGK1t-TPI1p For/TPI1p-PmeI-GPDt Rev 
TPI1p-PmeI-GPDt For/GPDt-pRS Rev 
pRS416-GPDtrc-TEF1p-BamHI-
TPI1prc-PGK1t (aka pRS416-
TTrc) 
pRS-GPDtrc For/GPDtrc Rev 
Helper plasmid with convergent promoters to produce 
dsRNA 
GPDtrc-TEF1p For/TEF1p-BamHI-TPI1prc 
Rev BamHI-TPI1prc For/TPI1prc-PGK1t Rev 
TPI1prc-PGK1t For/PGK1t-pRS-40bp Rev 
pRS425-TEF1p-GFP-PGK1t TEF1p-GFP-1 For/GFP-PGK1t Rev Construction of expression cassette for GFP 
pRS425-TEF1p-GFPrc-PGK1t TEF1p-GFPrc For/GFPrc-PGK1t Rev Construction of anti-sense expression cassette for GFP 
pRS405-TEF1p-GFP-PGK1t pRS-TEF1p For/PGK1t-pRS Rev Integration of GFP expression cassette into leu2 site 
pRS416-TEF1p-GFPrc-PGK1t pRS-TEF1p For/PGK1t-pRS Rev Anti-sense expression cassette for GFP on a single 
copy plasmid pRS416-TTrc-GFP-223-631 TEF1p-GFP-223 For/GFP-631-TPI1prc Rev 
To express dsRNA derived from 223-631bp, 1-180bp, 
1-360bp, 1-540bp and 1-717bp of GFP by convergent 
promoters 
pRS416-TTrc-GFP-1-180 TEF1p-GFP-001 For/GFP-180-TPI1prc Rev 
pRS416-TTrc-GFP-1-360 TEF1p-GFP-001 For/GFP-360-TPI1prc Rev 
pRS416-TTrc-GFP-1-540 TEF1p-GFP-001 For/GFP-540-TPI1prc Rev 
pRS416-TTrc-GFP-1-717 TEF1p-GFP-001 For/GFP-717-TPI1prc Rev 
pRS425-TEF1p-AGO1-PGK1t 
TEF1p-AGO-1 For/AGO-1 Rev Helper plasmid to clone ago1 into TEF1p-PGK1t 
cassette AGO-2 For/AGO-2-PGK1t Rev 
pRS425-PGK1t-TPI1p-DCR1-
GPD1t 
TPI1p-DCR1 For/DCR1-GPD1t Rev Helper plasmid to clone dcr1into TPI1p-GPDt cassette 
pRS-delta-KanMX-LoxP-TEF1p-
AGO1-PGK1t-TPI1p-DCR1-
GPD1t 
pRS For/PGK1t Rev Integration of S. castellii RNAi pathway into delta-site, 
constructed by DNA assembler PGK1t For/pRS Rev 
pRS403-RNAi-cassette 
pRS-TEF1p F/PGK1t-pRS Rev 
Integration of selected RNAi cassettes into the his3 
locus pRS404-RNAi-cassette Integration of selected RNAi cassettes into the trp1 
locus pRS405-RNAi-cassette Integration of selected RNAi cassettes into the leu2 
locus pRS406-RNAi-cassette Integration of GFP RNAi cassettes into the ura3 locus 
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Table 3.7. List of primers used in this chapter 
Primer name Primer sequence (5’3’) 
pRS-TEF1p-40bp For TAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACAGCAACAGGCGCGTTGGAC 
TEF1p-PmeI-PGK1t Rev AATTGATCTATCGATTTCAATTCAATTCAATGTTTAAACTTTGTAATTAAAACTTAG 
TEF1p-PmeI-PGK1t For CTAAGTTTTAATTACAAAGTTTAAACATTGAATTGAATTGAAATCGATAGATCAATT 
PGK1t-pRS Rev GATTACGCCAAGCGCGCAATTAACCCTCACTAAAGGGAACCAGGAAGAATACACTATAC 
pRS-PGK1t-40bp For GTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACATTGAATTGAATTGAAATCG 
PGK1t-TPI1p Rev TAATCTTCCACCAACCTGATGGGTTCCTAGATATACAGGAAGAATACACTATAC 
PGK1t-TPI1p For GTATAGTGTATTCTTCCTGTATATCTAGGAACCCATCAGGTTGGTGGAAGATTA 
TPI1p-PmeI-GPDt Rev ATTTAAATGCAAGATTTAAAGTAAATTCACGTTTAAACTTTTAGTTTATGTATGTG 
TPI1p-PmeI-GPDt For CACATACATAAACTAAAAGTTTAAACGTGAATTTACTTTAAATCTTGCATTTAAAT 
GPDt-pRS Rev GATTACGCCAAGCGCGCAATTAACCCTCACTAAAGGGAACGGAATCTGTGTATATTACTG 
pRS-GPDtrc For CGTAATACGACTCACGGAATCTGTGTATATTAC 
GPDtrc Rev GTGAATTTACTTTAAATC 
GPDtrc-TEF1p For TTAAAGTAAATTCACAGCAACAGGCGCGTTGGAC 
TEF1p-BamHI-TPI1prc Rev ATACATAAACTAAAAGGATCCTTTGTAATTAAAACTTAGATTAG 
BamHI-TPI1prc For TTTTAGTTTATGTATGTG 
TPI1prc-PGK1t Rev TCAATTCAATTCAATTATATCTAGGAACCCATC 
TPI1prc-PGK1t For GATGGGTTCCTAGATATAATTGAATTGAATTGA 
pRS-TEF1p For GGCGAATTGGGTACCAGCAACAGGCGCGTTGGAC 
PGK1t-pRS Rev AAAGCTGGAGCTCCACAGGAAGAATACACTATAC 
TEF1p-GFP-1 For ATAGCAATCTAATCTAAGTTTTAATTACAAAATGAGTAAAGGAGAAGAAC 
GFP-PGK1t Rev AATTGATCTATCGATTTCAATTCAATTCAATCTATTTGTATAGTTCATCC 
TEF1p-rcGFP For ATAGCAATCTAATCTAAGTTTTAATTACAAACTATTTGTATAGTTCATCC 
rcGFP-PGK1t Rev AATTGATCTATCGATTTCAATTCAATTCAATATGAGTAAAGGAGAAGAAC 
TEF1p-GFP-226 For AGTTTTAATTACAAAGATCATATGAAACGGCATGAC 
GFP-631-TPIprc Rev ATACATAAACTAAAAGATCTTTCGAAAGGGCAGATTG 
TEF1p-GFP-001 For AGTTTTAATTACAAAATGAGTAAAGGAGAAGAAC 
GFP-180-TPIrc Rev ATACATAAACTAAAAAAGTGTTGGCCATGGAAC 
GFP-360-TPIrc Rev ATACATAAACTAAAAAACAAGGGTATCACCTTC 
GFP-540-TPIrc Rev ATACATAAACTAAAAGTCTGCTAGTTGAACGCTTCC 
GFP-717-TPIrc Rev ATACATAAACTAAAACTATTTGTATAGTTCATCC 
TEF1p-AGO-1 For ATAGCAATCTAATCTAAGTTTTAATTACAAAATGTCATCCAATTCGGAGG 
AGO-1 Rev CCTTTTCACCTGGTTTTGG 
AGO-2 For CCAAAACCAGGTGAAAAGG 
AGO-2-PGK1t Rev AATTGATCTATCGATTTCAATTCAATTCAATTCATATGTAGTACATGATG 
TPI1p-DCR1 For AACTACAAAAAACACATACATAAACTAAAAATGAATAGAGAAAAAAGCGCCGATC 
DCR1-GPD1t Rev ATTTAAATGCAAGATTTAAAGTAAATTCACTCACAGATTGTTGCAATGCCTC 
pRS For CGAGGTGCCGTAAAGCAC 
PGK1t Rev CAGGAAGAATACACTATAC 
PGK1t For ATTGAATTGAATTGAAATCG 
pRS Rev GCTCACATGTTCTTTCC 
qAgo For TGCCGTTCCACAGAGTAATTC 
qAgo Rev TCACCATTGAAGGAGATACGATC 
qDrc For AAAATGCACCTATCCCTATCCC 
qDcr Rev TGGGACTGAGACTGAGACTG 
S TEF1p For TTTTACTTCTTGCTCATTAG 
S TPI1p For TTTTTGTTTGTATTCTTTTC 
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Table 3.7. List of primers used in this chapter (continued) 
Primer name Primer sequence (5’3’) 
ypr084w-cDNA Rev GAGAGTTGTAAATTGAACTTG 
ypr084w-RT-PCR For CGAGGTTCATTATCCAAC 
ypr084w-RT-PCR Rev CTGTGTTCATCACATCATC 
ptc6-cDNA Rev ATTCATTAGTTTGGTTTCTC 
ptc6-RT-PCR For CTGCAACTCGAAACAAGAAC 
ptc6-RT-PCR Rev TAGAGGTGATGAGGTCAAC 
val-tRNA-cDNA Rev TTTCGCCCAGGATCGAAC 
val-tRNA-RT-PCR For GGTTTCGTGGTCTAG 
val-tRNA-RT-PCR Rev GAACTGGGGACGTTC 
GFP-cDNA Rev TGTGGTCTCTCTTTTCGTTGG 
GFP-RT-PCR For TTTCACTGGAGTTGTCCCAAT 
GFP-RT-PCR Rev GAAAGGGCAGATTGTGTGG 
act1-cDNA Rev TCAAAGAAGCCAAGATAGAACCA 
act1-RT-PCR For ACGTTGGTGATGAAGCTCAA 
act1-RT-PCR Rev ATACCTGGGAACATGGTGGT 
TEF1p-rnt1-Di For AGTTTTAATTACAAAGTTAAAAGGGAAAAGCGAGA  
rnt1-Di-TPIprc Rev AAGATTTAGCGATTAGGGCCTTTTAGTTTATGTAT 
TEF1p-ymr1-Di For AGTTTTAATTACAAAACGAAAGATTTTTAAGAAGA  
ymr1-Di-TPIprc Rev AAATTTCATACAGAGAAAAATTTTAGTTTATGTAT 
TEF1p-ptc6-Di For AGTTTTAATTACAAAATTGTCACGCAGGTGGGCGA  
ptc6-Di-TPIprc Rev TTTTGAATAATTTCGCCAACTTTTAGTTTATGTAT 
TEF1p-ypk3-Di For AGTTTTAATTACAAAGCAATTACGGAAAGCAGAAA  
ypk3-Di-TPIprc Rev CATCCAAACATTGTCAAGTTTTTTAGTTTATGTAT 
 
  
101 
 
Table 3.8. List of strains used in this chapter 
Strain Genotype Reference 
CEN.PK2-1c MATa ura3-52 trp1-289 leu2-3,112 his3Δ1 MAL2-8C SUC2 EUROSCARF 
CAD MATa δ::PTEF1-ago1-PTPI1-dcr1 This study 
CAD_GFP MATa δ::PTEF1-ago1-PTPI1-dcr1 leu2:: PTEF1-GFP This study 
CEN_GFP MATa leu2:: PTEF1-GFP This study 
CAD_yku70Δ MATa δ::PTEF1-ago1-PTPI1-dcr1 yku70Δ::ura3 This study 
CAD_rnt1i MATa δ::PTEF1-ago1-PTPI1-dcr1 his3::TTrc-rnt1-Si This study 
CAD_ymr1i MATa δ::PTEF1-ago1-PTPI1-dcr1 his3::TTrc-ymr1-Si This study 
CAD_ptc6i MATa δ::PTEF1-ago1-PTPI1-dcr1 his3::TTrc-ptc6-Si This study 
CAD_ypk3i MATa δ::PTEF1-ago1-PTPI1-dcr1 his3::TTrc-ypk3-Si This study 
CAD_ymr1Δ MATa δ::PTEF1-ago1-PTPI1-dcr1 ymr1Δ::ura3 This study 
CAD_ptc6Δ MATa δ::PTEF1-ago1-PTPI1-dcr1 1ptc6Δ::ura3 This study 
CAD_ypk3Δ MATa δ::PTEF1-ago1-PTPI1-dcr1 ypk3Δ::ura3 This study 
CAD_ptc6i_ypr084wi 
MATa δ::PTEF1-ago1-PTPI1-dcr1 his3::TTrc-ptc6-Si 
trp1::TTrc-ypr084w 
This study 
CAD_ptc6i_ypr084wi_t
RNAi 
MATa δ::PTEF1-ago1-PTPI1-dcr1 his3::TTrc-ptc6-Si 
trp1::TTrc-ypr084w leu2:: TTrc- tRNAVal(AAC) 
This study 
R1 (in Fig. 3.9) CAD_ptc6i strain with pRS416-TTrc This study 
R2 (in Fig. 3.9) CAD_ptc6i_ypr084wi strain with pRS416-TTrc This study 
R3 (in Fig. 3.9) CAD_ptc6i_ypr084wi_tRNAi strain with pRS416-TTrc This study 
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Chapter 4 RAGE 2.0: Constructing a Comprehensive Yeast Library  
 
 
4.1. Introduction 
4.1.1. Comprehensive genome-wide library 
Genome-wide strain libraries are powerful tools to comprehensively investigate the impact of 
individual genetic modification on a given phenotype.  Traditionally, it needs to create 
overexpression, knockout, and knockdown libraries separately, as the techniques for constructing 
these three types of libraries are fundamentally different.  Overexpression libraries are often 
created on an episomal vector, on which either genomic fragments
1
 or all the open reading 
frames (ORFs) under the control of a promoter
2
 can be cloned.  Genome-wide knockout libraries 
requires genome editing to disrupt the ORFs, through either transposon mutagenesis optimized 
for unbiased integration of an antibiotic marker cassette into the entire genome
3, 4
, or 
homologous recombination to replace the ORFs of non-essential genes with selection markers
5-7
.  
Knockdown screen can be achieved by both plasmid libraries and genome editing.  Plasmid-born 
regulatory non-coding RNAs (ncRNA) libraries can be introduced for genome-wide gene 
silencing, as exemplified by anti-sense RNA screen in bacteria
8-10
 and RNAi screen in 
eukaryotes
11-13
.  For genome editing, insertion of an antibiotic marker into the terminator region 
destabilizes the target mRNAs, and this method was used to make knockdown modifications of 
the essential genes in S. cerevisiae
14
.  Lacking of methods to create comprehensive genetic 
library complicates the genotyping effort, as the screen process, which is often resource-intensive 
and time-consuming, needs to be repeated for different libraries. 
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Recently, the trackable multiplex recombineering (TRMR) method has been developed to 
create comprehensive E. coli genetic libraries including both overexpression and knockdown 
modifications
15
.  Two kinds of synthetic cassettes were designed for promoter replacement: the 
‘up’ cassette containing a strong promoter, and the ‘down’ cassette containing an inert sequence 
to replace the native RBS.  Through recombineering, these synthetic cassettes were incorporated 
in front of every gene in E. coli, which led to either increased or decreased expression of a target 
gene
15
.  Nevertheless, it is very difficult to apply TRMR in S. cerevisiae, which lacks efficient 
mechanism for oligonucleotide-mediated allele replacement.  On the other hand, as plasmid 
transformation in S. cerevisiae is simple and efficient, we speculate that combination of plasmid-
borne overexpression and knockdown libraries should be a more feasible route to create a 
comprehensive genetic library.   
 
4.1.2. Construction of a normalized, full-length cDNA library 
To construct an overexpression library, full-length cDNA clones containing complete ORFs 
are required.  However, the majority of cDNA clones obtained by traditional methods are not 
full-length, mainly due to premature termination of reverse transcription during the first strand 
cDNA synthesis
16.  This problem of 5’ truncated cDNA synthesis is especially severe for long 
mRNAs that contain abundant secondary structures
17.  The Switching Mechanism At 5’ end of 
RNA Template (SMART) method was recently developed to enrich for full-length cDNAs, 
taking advantage of some unique features of the Moloney murine leukemia virus reverse 
transcriptase (MMLV RTase)
18
.  During the first-strand cDNA synthesis, the MMLV RTase acts 
as a terminal transferase to add a few additional C residues at the 3’ end of the cDNA only when 
it reaches the end of the mRNA template.  Such reaction will not happen with incomplete reverse 
111 
 
transcripts.  Then an RNA primer ending in three Gs base pairs with the added Cs and serves as 
an extended template. The MMLV RTase switches templates and continues the cDNA synthesis 
to incorporate the sequences in the RNA primer with a universal priming site (the SMART 
anchor).  Therefore, only full-length cDNAs containing the SMART anchor at their 5’ ends are 
amplified during subsequent PCR amplification
18
.  The PCR amplification step also incorporate 
unique adaptor sequences at the end of the cDNA molecules to facilitate directional cloning. 
Some improvements have been introduced to the SMART technology since its inception.  
First, size fractionation was performed after the PCR amplification step to remove smaller cDNA 
fragments that are preferentially amplified by PCR reaction
17
.  Second, a normalization step has 
been incorporated
19
, which is necessary due to the substantial variation in the transcript 
abundance
20
 (For the total mRNA mass, 10–20 abundant transcripts comprise about 20%, several 
hundred medium transcripts comprise 40–60%, and several thousand rare transcripts account for 
20–40%).  Among many cDNA normalization protocol19, selective degradation of abundant 
cDNAs during re-naturation process is considered the most straightforward and effective.  As 
second-order reaction kinetics governs the re-association of denatured DNAs, the double-
stranded DNAs (dsDNAs) portion mainly consists of the abundant cDNA individuals, and the 
remaining single-stranded DNAs (ssDNAs) is therefore relatively equalized
21
.  To this end, a 
duplex-specific nuclease (DSN) from the Kamchatka crab is very useful, because of its strong 
preference for cleaving dsDNA over ssDNA, irrespective of sequence lengths
22
.  This DSN is 
stable at high temperature (maximal activity observed at 60-65 °C), thus avoiding non-specific 
degradation of ss cDNAs due to secondary structure formation
21
.  Together, the size-
fractionation and normalization steps remarkable improve the quality and representativeness of 
the full-length cDNA libraries
19
.    
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In this chapter, we developed the RAGE2.0 method, where directional cloning of a full-
length, normalized cDNA library enabled simultaneous construction of the ORF-overexpression 
and anti-sense RNA libraries.  In the presence of an RNAi pathway, we achieved both genome-
wide overexpression and knockdown modifications in S. cerevisiae in one step.  A series of 
phenotypes, including protein surface display, substrate utilization, and fuel molecule production, 
were screened with the RAGE2.0 library in a high-throughput manner.  Both gene 
overexpression and knockdown targets were successfully identified for these phenotypes. 
 
4.2. Results 
4.2.1. Directional cloning of a full-length, normalized cDNA library of S. cerevisiae 
As both overexpression and reduction-of-function screens are important for genotype-
phenotype mapping, it is desirable to develop a method to incorporate both types of genetic 
modifications simultaneously to accelerate the screen process.    Inspired by the observation that 
full-length anti-sense mRNAs can efficiently knockdown a target gene through RNAi in 
Chapter 3, we devised a method for one-step construction of a comprehensive genome-wide 
library through directional cloning of full-length cDNAs.  When a full-length cDNA molecule is 
inserted in the sense direction under the control of a constitutive promoter, the resultant construct 
will lead to gene overexpression of the contained ORF. When inserted in the reversed direction, 
on the other hand, the resultant construct will transcribe the anti-sense mRNA of the target gene, 
and elicit gene silencing in the presence of RNAi machinery.  The directional cloning can be 
achieved by adding two different adaptor sequences to the ends of a cDNA molecule, and thus 
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the insertion direction can be controlled by arranging the homologous adaptor sequences in a 
desired order on destination plasmids.   
We first synthesized a full-length cDNA library using a commercial kit based on the SMART 
technology.  Two 15 bp adaptor sequences, 5’-CGGGGTACGATGAGA-3’ and 5’-
TTGATACCACTGCTT-3’, were incorporated at the 5’ and 3’ ends of the cDNA molecules, 
respectively (Fig. 4.1 and Table 4.6).  The size-fractionation step is included in this kit.  After 
treatment with another commercial kit for normalization, the cDNA library is ready to be cloned 
into the destination plasmid.  For directional cloning, we developed a constitutive expression 
cassette consisting of a PTEF1 promoter and a TPGK1 terminator.  Two versions of this cassette was 
constructed (Fig. 4.1).  While both contain the ccdB suicide gene to minimize empty vectors in 
the library
23
, the adaptor sequences flanking the ccdB gene in these two versions are arranged in 
opposite directions.  Two PmeI sites are incorporated to release the ccdB gene and to expose the 
adaptor sequences upon restriction digestion.  The exposed adaptors are designed for 
homologous recombination with their counterparts on the cDNA molecules through Gibson 
assembly reaction, resulting in cDNA insertion in either sense or anti-sense direction into the 
expression cassette.  Either the pRS416 or pRS426 plasmid was used as vectors for the 
expression cassette.  To simplify subsequent analysis, the sense and anti-sense plasmid libraries 
were constructed separately with the Gibson assembly reaction.  The reaction mix was then 
transformed into a ccdB sensitive E. coli strain by electroporation, and the transformants were 
recovered on solid medium to minimize uneven amplification of smaller plasmids.  The 
experiments were carefully executed to ensure the number of independent clones in the library to 
exceed 10
6
, representing more than 100-fold redundancy of the 6000 yeast genes.   
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Figure 4.1 Expression cassettes for directional cloning in the RAGE2.0 library.  The PTEF1 promoter 
and TPGK1 terminator are used to signal the start and end of transcription.  Two 15 bp adaptor sequences 
are incorporated to facilitate directional insertion of cDNAs flanked with the same pair of adaptors.  The 
toxic ccdB gene is replaced with the cDNA molecules during the RAG2.0 library construction, and the E. 
coli cells harboring the uncut plasmids with the intact ccdB gene cannot survive, hence reducing the 
presence of empty plasmids in the library. 
Ten colonies were randomly picked from each E. coli library (overexpression and 
knockdown), and the isolated plasmids were analyzed by DNA sequencing.  The results 
indicated that all the cDNAs were inserted in the expected directions, and most insets (19/20) 
were full-length cDNAs.  The only partial cDNA had the characteristic poly-A tail in an mRNA 
molecule, indicating a premature transcriptional intermediate.    
Table 4.1 Inset information from twenty random plasmids in the RAGE2.0 library 
Overexpression library Anti-sense library 
Gene name ORF length (bp) Gene name ORF length (bp) 
CBK1 2271 RPS4A 786 
OLE1 1533* TOS6 309 
RPS8B 604 INH1 258 
HSC82 2118 KAR2 2049 
SCD6 1050 GPM1 744 
ATP17 306 SPI1 447 
UFD1 1086 SSA4 1929 
HSP26 645 RIB4 510 
LSP1 1026 GIM3 390 
HTB1 396 PIL1 1020 
* A fragment (1-264bp) of the OLE1 ORF was cloned 
 
TEF1p-ccdB-PGK1t-F
1303 bp
ccdB gene15bp For 15bp RevTE F1p P GK1t
Pme I (439) Pme I (885)
TEF1p-ccdB-PGK1t-R
1303 bp
ccdB gene15bp Rev 15bp ForTE F1p P GK1t
Pme I (439) Pme I (885)
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4.2.2. High-throughput screening with the RAGE2.0 library 
4.2.2.1 Surface display of a cellulase 
Consolidated bioprocessing (CBP) is proposed to substantially lower the cost of cellulosic 
ethanol production, by combining enzyme production, cellulose hydrolysis and sugar 
fermentation in a single step
24
.  To realize CBP, constructing recombinant S. cerevisiae strains 
with cellulolytic capacity is one promising strategy
24, 25
.  Specifically, cellulase-displaying yeast 
cells has drawn intensive attention
26-28
.  Compared with secreting free cellulases, anchoring the 
cellulases on yeast cell surface is considered more efficient by improving local enzyme 
concentrations and enabling enzyme-enzyme synergy
26-28
.   However, the performance of current 
cellulolytic S. cerevisiae strains is far from optimal, and the low cellulase display level is 
considered the main obstacle
29
.    
There are essentially two ways to increase protein display level, including protein 
engineering and host engineering.  Although successful in many surface display applications, 
such as the insulin precursor
30
 and single-chain T-cell receptor (scTCR)
31
, protein engineering 
can be problematic to improve cellulase secretion, as deleterious mutations affecting catalytic 
activity may occur.  Instead, engineering the host cells by rational
32, 33
 or random
34
 approaches 
are presumably preferred.  As an example of the random approach, combining cDNA 
overexpression libraries with yeast surface display successfully identified several display-
enhancing genes conferring up to 8-fold improvement in scTCR secretion
34
.  Notably, whereas 
rational methods have demonstrated the importance of gene deletion in promoting protein 
secretion
35, 36
, reduction/loss-of-function screens have not been reported yet for this purpose.  
This is probably due to the difficulty to create genome-wide knockout/knockdown libraries de 
novo in a recombinant protein-displaying strain.  Therefore, a comprehensive screen is needed to 
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include knockdown modifications for the identification of yeast mutants with enhanced surface 
display capacity.   
 
Figure 4.2 Flow cytometry analysis of EGII-displaying yeast cells.  Both the plasmid-borne (blue line) 
and integrated (red line) EGII expression cassettes led to display of EGII on the yeast cell surface 
indicated by His3 epitope detection.  The CAD strain transformed with an empty pRS425 plasmid was 
used as a negative control (gray shade). 
 
As proof of concept, we performed a high-throughput genetic screen in a cellulase-displaying 
yeast strain with the RAGE2.0 library.   The expression cassette of Trichoderma reesei 
endoglucanase II (EGII, EC 3.2.1.4) was derived from a previous work in our lab with some 
modifications
27
.   The prepro secretion signal peptide, the His epitope tag, and the EGII ORF 
were kept intact of the original cassette PGAL10-(prepro signal peptide)-His-EGII-docS-TADH1.  
The dockerin module docS was replaced with the a-agglutinin mating adhesion receptor to allow 
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direct anchoring of EGII on the cell surface.  The promoter and terminator were changed to PTEF1 
and TPGK1, respectively, to permit constitutive expression.  The EGII cassette was first introduced 
into the CAD strain on the multi-copy plasmid pRS425.  Stained with a monoclonal anti-His 
antibody and analyzed by flow cytometry, the EGII enzyme was confirmed to be successfully 
displayed on the yeast cell surface (Fig. 4.2).  The EGII expression cassette was then integrated 
into the leu2 site in the CAD strain to create the CAD-EGII strain.   
 
Figure 4.3 Yeast mutant strains identified from the RAGE2.0 library with increased EGII display 
levels.  All the data were normalized relative to the CAD strain containing an empty pRS416 plasmid as 
the negative control.  Error bars indicate standards deviation of biological triplicates.   
 
The RAGE2.0 library constructed on the pRS416 plasmid was transformed into the CAD-
EGII strain to obtain >10
6
 independent clones.  After immunostaining, the cells were subjected to 
two rounds of Fluorescence-Activated Cell Sorting (FACS), and the top 1% brightest cells were 
collected in each round.  The plasmids from 93 mutant strains with the highest fluorescence were 
isolated and retransformed into the original CAD-EGII strain.  After retransformation, flow 
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cytometry results showed that there were 29 plasmids conferring increased fluorescence 
compared with the control strain.  The insets of the 29 plasmids were identified by DNA 
sequencing and BLAST search as 13 independent clones, containing 7 overexpression and 6 
knockdown cassettes (Table 4.2 and Fig. 4.3).  The fact that some cDNA cassettes appeared 
more than once in the selected collection indicated effective enrichment by FACS (Table 4.2).  
The improved displaying of EGII were also confirmed by enhanced hydrolysis of carboxymethyl 
cellulose (CMC) observed with the mutant strains (Fig. 4.3).  Together, these results 
demonstrated that the RAGE2.0 library was effective in identifying genetic modifications to 
improve surface display of a recombinant protein.   
Table 4.2 Selected genetic targets that improved the surface display level of EGII 
Overexpression target Knockdown target 
Gene name Frequency Gene name Frequency 
GET3 3/15 SED1 1/14 
SDH3 5/15 YCH1 4/14 
PEX5 1/15 SOL3 3/14 
ENT3 4/15 RNR2 3/14 
PTI1 1/15 SMT3 2/14 
IDH2 1/15 MRPL15 1/14 
TAR1 1/15   
 
4.2.2.2 Glycerol utilization 
Because of the tremendous growth in biodiesel utilization worldwide, glycerol, a by-product 
in biodiesel production, is potentially a cheap feedstock for microbial fermentation.  Efforts on 
transformation of glycerol into value-added products include the use of E. coli and S. cerevisiae 
to produce ethanol
37, 38
, triacylglycerol (TAG)
39
 and fatty acid ethyl esters (FAEEs)
40
.  Although 
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S. cerevisiae is able to grow on glycerol as a sole carbon source, the consumption rate and 
growth rate are quite slow compared to that of glucose
38-40
.  Thus, it is needed to improve 
glycerol utilization in yeast for any efficient fermentation with glycerol as the substrate.   
We constructed a RAGE2.0 library in the CAD strain containing >10
6
 independent clones.  
Serial transfer was performed along with the control strain in synthetic SC-U medium with 3% 
glycerol (v/v) as the sole carbon source.  When the OD600 value reached 1, yeast culture was 
inoculated into fresh medium using a 1% or 0.1% inoculum (Table 4.3).  The 0.1% inoculum 
was used in the last two rounds of subculturing as a more stringent enrichment procedure to 
minimize false positive
41
.  While both the RAGE2.0 library strain and the control strain exhibited 
accelerated growth during enrichment, the growth rate of the RAGE2.0 library is much faster 
than the control strain (Table 4.3). 
Table 4.3 Serial transfer to enrich yeast strains with improved glycerol utilization 
 
RAGE2.0 library Control 
Inoculum  
(%) 
Time  to reach 
OD=1(day) 
Inoculum  
(%) 
Time  to reach 
OD=1(day) 
Round 1 1 2.5 1 3.5 
Round 2 1 2 1 3 
Round 3 1 2 1 2.5 
Round 4 0.1 2.5 1 2.5 
Round 5 0.1 1.5   
 
The enriched library was streaked onto a solid SC-U glycerol plate.  The plasmids from 20 
randomly picked colonies were isolated, and the inserts of these plasmids were analyzed by 
DNA sequencing and BLAST search.  There were 4 independent knockdown cassettes identified 
with some cassettes appearing more than once (Table 4.4).  After retransformation, all 4 
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cassettes were confirmed to confer improved glycerol utilization compared to the control strain 
(Fig. 4.4). 
 
Figure 4.4 Yeast mutant strains identified from the RAGE2.0 library with improved glycerol 
utilization.  Cells were cultured in synthetic dropout medium SC-U with 3% (v/v) glycerol as the sole 
carbon source. The initial OD600 was 0.1, and the cell density was monitored at the indicated time 
intervals.  The CAD strain containing an empty pRS426 plasmid was used as the control strain.  Error 
bars indicate standard deviations of biological triplicates.   
 
Table 4.4 Selected genetic targets that improved glycerol utilization 
Knockdown target 
Gene name Frequency 
SDH3 2/20 
CIT1 6/20 
AFG1 1/15 
MDH1 1/15 
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4.2.2.3. Isobutanol production 
Although ethanol is the most widely used biofuel, advanced biofuels have attracted a 
growing interest due to their superior fuel properties
42, 43
.  In particular, butanol (mainly 1-
butanol and isobutanol) is considered a substantially better gasoline substitute than ethanol
44
, as 
it is more hydrophobic and less corrosive, of higher energy density
45
, and can be blended in 
gasoline at any ratio
45
.  Specifically, isobutanol can be produced by the Ehrlich pathway in S. 
cerevisiae as a degradation product derived from valine
46
.  Intensive engineering of the yeast 
metabolism has been performed to improve the isobutanol production through rational design
43
, 
yet little efforts have been taken for genome-wide screen for non-intuitive genetic targets.   
As isobutanol is derived from valine biosynthesis, construction of valine-overproducing 
strains seems a feasible route to boost isobutanol production.  Resistance towards a toxic analog 
of an amino acid has been linked to the overproduction of the target amino acid.  In particular, 
valine-overproducing Corynebacteria and E. coli strains has been evolved when isolating 
norvaline (NVA) tolerant mutants.  The underlying hypothesis is that the toxicity results from 
incorporation of the analog during protein synthesis, and a cell must overproduce the natural 
amino acid to outcompete the analog to survive.  Although different resistance mechanisms may 
also arise, such as improved analog efflux, this method has been successfully applied in E. coli to 
isolate mutant strains with improved accumulation of leucine and valine, as well as their 
derivative fusel alcohols, 3-methyl-1-butanol and isobutanol.   
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Table 4.5 Serial transfer to enrich yeast strains with improved NVA resistance. 
 
NVA concentration  
(g/L) 
Time to reach OD600=2.5 (day) 
RAGE2.0 library Control 
Round 1 4 1.5 2.5 
Round 2 4 1 1.5 
Round 3 4 1 1.5 
Round 4 5 1 1.5 
Round 5 5 1 1.5 
Round 6 6 1 1.5 
Round 7 6 1 1 
 
Here we screened for isobutanol-overproducing S. cerevisiae strains from the RAGE2.0 
library by selecting NVA-resistant mutants.  The same library constructed for glycerol utilization 
in the CAD strain was used for serial transfer in synthetic dropout medium containing increasing 
concentrations of NVA from 4 g/L to 6 g/L in seven rounds (Table 4.5).  For each round, 1% 
inoculum from the previous round was used to inoculate fresh medium when OD600 exceeded 2.5.  
The growth rates of the RAGE2.0 library and the control strain both increased over time, 
indicating adaptation of S. cerevisiae cells to the NVA toxicity (Table 4.5).  Nonetheless, the 
RAGE2.0 library strains grew remarkably faster than the control strain (Table 4.5).  After 
subculturing, the enriched library was streaked on SC-U plates containing 6g/L NVA.  Twenty 
colonies were randomly picked and tested for isobutanol production.  Only two mutant strains 
exhibited improved isobutanol production, and the plasmids isolated contained the same anti-
sense fragment (2140-2931 bp) of the BUL1 gene (the ORF length is 2931 bp).  After 
retransformation, this plasmid still conferred a higher isobutanol titer (53.0±1.2 mg/L) compared 
to the control strain (23.8±2.4 mg/L) (Fig. 4.5).   
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Figure 4.5 Yeast mutant strains identified from the RAGE2.0 library with improved isobutanol 
production.  Cells were cultured under oxygen limited condition in synthetic dropout medium SC-U with 
2% glucose. The initial OD600 was 1, and the cell density, ethanol production and isobutanol production 
were monitored at the indicated time intervals.  The CAD strain containing an empty pRS426 plasmid 
was used as the control strain.  Error bars indicate standard deviations of biological triplicates.   
 
 
4.3. Conclusions and Future Prospects 
In this chapter, we devised a strategy to construct a comprehensive library of S. cerevisiae.  
Whereas the cloning of the genome-wide cDNA library under the control of a promoter is a 
standard method to construct an overexpression library, we made two key modifications, 
including insertion of the cDNA molecules in a reversed direction and introduction of an RNAi 
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pathway to successfully adapt the same procedure to construct a knockdown library.  Therefore, 
all the high-throughput strategies used previously to screen the overexpression libraries can be 
readily applied to the RAGE2.0 library, which can generate more comprehensive knowledge 
about the genotype-phenotype relationship by including the reduction-of-function mutations.  In 
its current form, the RAGE2.0 library derives from the cDNA library, and thus does not require 
genome sequence or annotation to create.  This feature makes RAGE2.0 a simple and 
inexpensive solution for genetic screen, especially for less well-studied industrial strains and 
natural isolates, compared with the traditional genome-wide libraries that are created with the 
help of many specific DNA primers.  But it also suggests that some inherent drawbacks of the 
cDNA library may limit the use of RAGE2.0.  For example, even though the size fractionation 
and normalization steps can help to enrich those rare and/or long transcripts, some genes may be 
inevitably missing from the library.  In the future, microarray analysis and/or next-generation 
sequencing (NGS) may be performed to investigate the coverage of the RAGE2.0 library, so that 
missing cassettes can be manually added through the traditional cloning method.   
Coupled with high-throughput screening, the RAGE2.0 library successfully identified genetic 
modifications to improve a series of phenotypes that are important for microbial fermentation.  
Although retransformation have showed that the desirable traits were due to the selected 
cassettes rather than adaptive mutations in the genome, further investigation is needed to confirm 
that these cassettes mediate the improvement through expected modifications, rather than “off-
target” effects.  For knockdown targets, in particular, real time RT-PCR will help to estimate the 
gene repression efficiency by the selected anti-sense constructs, and gene deletion should also be 
performed to inspect how the target phenotypes are affected.  It is also interesting to examine 
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whether combinatorial optimization among the selected modifications can result in further 
improvement. 
For glycerol utilization and isobutanol production, only knockdown targets were identified.  
While there is a possibility that these are indeed the genetic modifications conferring the most 
remarkable improvements, it is more likely that the absence of the overexpression targets are due 
to the inherent limitation of the growth-based enrichment method.  Whereas a knockdown 
cassette triggers gene repression via transcription of the anti-sense mRNA, an overexpression 
cassette can only impact the phenotype by its encoded protein, whose expression may exert more 
burdens on the cell than that of an anti-sense mRNA.  Therefore, the growth advantage of an 
overexpression cassette may be compromised by its extra burden of protein expression.  During 
prolonged serial transfer process, those knockdown mutants may outcompete the overexpression 
mutants, and hence take over the whole population.  This could be one possible reason why no 
overexpression modifications were isolated to improve glycerol utilization and isobutanol 
production.  Such problems may be solved via the use of a colony size-based selection strategy. 
The mechanisms on how some selected cassettes affect the targeted phenotypes can be 
speculated from their known functions.  For example, a mutant strain with an improved EGII 
display level harbored a knockdown cassette of the SED1 gene.  The SED1 gene encodes a 
stress-induced structural cell wall protein Sed1p, which is anchored on the cell surface through a 
glycosylphosphatidylinositol (GPI) domain
47
.  It has been shown that the use of the SED1 
promoter and the Sed1p anchoring domain enabled highly efficient display of heterologous 
proteins on the cell surface of S. cerevisiae
29
, suggesting that the expression level of the Sed1p 
protein is quite high.  Hence, it is possible that decreased expression of the Sed1p protein can 
improve the capacity of the cell surface to accommodate other cell wall proteins, including the 
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EGII-agglutinin fusion.  In addition, three knockdown cassettes conferring improved glycerol 
utilization all targeted tricarboxylic acid (TCA)-related genes, SDH3, CIT1 and MDH1, and the 
reduced TCA activity has been linked to fast glycerol metabolism in E. coli
48
.  Moreover, 
knockdown of the BUL1 gene may lead to improved isobutanol production through mistargeting 
of the general amino acid permease Gap1p, whereas reduced expression of the Gap1p was found 
to increase isobutanol titer
49
.  Further mechanistic studies will be helpful to validate these 
speculations, as well as to understand other genetic modifications that lack intuitive functional 
explanations. 
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4.4. Materials and Methods 
4.4.1. Strains, media, and cultivation conditions 
S. cerevisiae strain CEN.PK2-1c (MATa ura3-52 trp1-289 leu2-3,112 his3Δ1 MAL2-8C 
SUC2) was purchased from EUROSCARF (Frankfurt, Germany).  Zymo 5α Z-competent E. coli 
(Zymo Research, Irvine, CA) and NEB 10β Electrocompetent E. coli (New England Biolabs, 
Ipswich, MA) were used for plasmid amplification and library construction, respectively.  S. 
cerevisiae strains were cultivated in either synthetic dropout medium (0.17% Difco yeast 
nitrogen base without amino acids and ammonium sulfate, 0.5% ammonium sulfate and 0.083% 
amino acid drop out mix, 0.01% adenine hemisulfate and 2% glucose) or YPAD medium (1% 
yeast extract, 2% peptone, 0.01% adenine hemisulfate and 2% glucose). For glycerol utilization, 
3% (v/v) glycerol was used instead of 2% glucose in the synthetic dropout medium.  The 50 g/L 
filtered norvaline (NVA) solution stock was added into the synthetic dropout medium to select 
for NVA resistant strains.  Before mixing, both the medium and NVA stock were adjusted to pH 
= 5.6.  S. cerevisiae strains were cultured at 30 °C and with 250 rpm agitation in baffled shake-
flasks for aerobic growth, and at 30 °C and 100 rpm in un-baffled shake-flasks for oxygen 
limited fermentation.  E. coli strains were cultured at 37 °C and 250 rpm in Luria broth (LB) 
medium (Fisher Scientific, Pittsburgh, PA) with the supplement of 100 μg/mL ampicillin.  All 
chemicals were purchased through Sigma-Aldrich or Fisher Scientific. 
 
4.4.2. DNA manipulation 
Plasmid cloning was done by Gibson Assembly Cloning Kit from New England Biolabs 
following the manufacturer’s instructions or by the DNA assembler method50.  For DNA 
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manipulations, yeast plasmids were isolated using a Zymoprep II yeast plasmid isolation kit 
(Zymo Research, Irvine, CA) and transferred into E. coli for amplification.  QIAprep Spin 
Plasmid Mini-prep Kits (Qiagen, Valencia, CA) were employed to prepare plasmid DNA from E. 
coli.  All enzymes used for recombinant DNA cloning were from New England Biolabs unless 
otherwise noted.  The products of PCR, digestion and ligation reactions were purified by 
QIAquick PCR Purification and Gel Extraction Kits (Qiagen, Valencia, CA).   
 
4.4.3. Construction of the RAGE2.0 library 
The ccdB gene was cloned from the plasmid pLRX-ccdB
23
 into the PTEF1-TPGK1 cassette 
constructed in the Chapter 3
13
.  The adapter sequences (indicated as bold font) and the PmeI 
sites (indicated as italic font) were incorporated by the primers PR608-PR611 (Fig. 4.1 and 
Table 4.6).  The expression cassettes were then cloned into the pRS416 or pRS426 plasmid, and 
the resultant constructs were digested by the PmeI enzyme to serve as the backbone vectors for 
the RAGE2.0 library.   
Table 4.6 Primers used for the RAGE2.0 library construction 
Name Primer sequences (5’3’) Cassettes (Fig. 4.1) 
PR608 agttttaattacaaa aagcagtggtatcaa gtttaaac caggaagggatggctgagg 
PTEF1p-ccdB-TPGK1-F 
PR609 tcaattcaattcaat cggggtacgatgaga gtttaaac gagctctagagatatcgtcg 
PR610 agttttaattacaaa cggggtacgatgaga gtttaaac caggaagggatggctgagg 
PTEF1p-ccdB-TPGK1-R 
PR611 tcaattcaattcaat aagcagtggtatcaa gtttaaac gagctctagagatatcgtcg 
 
The normalized, full-length cDNA library was prepared as follows.  The total RNAs from the 
CEN.PK2-1c strain were isolated using the RNeasy mini kit (QIAGEN, Valencia, CA).  A 
cDNA library was synthesized using the In-Fusion SMARTer Directional cDNA Library 
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Construction Kit (Clontech Laboratories, Mountain View, CA) with some modifications.  In 
particular, the double-stranded cDNA library was treated using the Trimmer-2 cDNA 
normalization kit (Evrogen, Moscow, Russia) according to the manufacturer’s instructions.  
Small cDNA fragments were then removed by the size fractionation step in the SMARTer kit.  
The treated cDNA library was cloned into the linearized backbone vectors using the Gibson 
assembly cloning kit (New England Biolabs), and the enzymatic mix was electroporated into the 
NEB 10β E. coli strain and amplified on LB+Amp plates.  More than 106 independent E. coli 
colonies were obtained for both the overexpression and knockdown libraries.  The plasmid 
minipreped from the E. coli library was used to transform the CAD or CAD-EGII strains by the 
standard LiAc/ssDNA/PEG protocol
51
 with an optimized condition, where 50 μg plasmid DNA 
was used to transform 40 OD600 unit competent yeast cells by heat shock at 42 °C for 1 hr.  More 
than 10
6
 independent yeast clones were obtained for every library using the optimized protocol.  
The yeast transformants were amplified on SC-U plates for four days before being harvested for 
screen. 
 
4.4.4. Screen of EGII-displaying mutants 
The CAD-EGII strain was constructed by integrating the EGII-displaying cassette into the 
leu2 site of the yeast genome with the help of the pRS405 plasmid.  Harvested from the SC-U 
plates, the RAGE2.0 library created in the CAD-EGII strain was used for subsequent screen and 
analysis.  The CAD-EGII strain contained an empty pRS416 plasmid was used as the control 
strain.  The immunostaining assay and flow cytometry analysis were performed as described 
previously
27
.  The PE fluorescence was analyzed with a LSR II Flow Cytometer (BD 
Biosciences, San Jose, CA).  FACS experiments were performed on a BD FACS Aria III cell 
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sorting system (BD Biosciences, San Jose, CA).  In the first round of sorting, 30,000 cells 
representing the top 1% brightest fluorescence were collected and grown for two days in the SC-
U medium.  Then the second round of sorting collected 93 individual yeast cells with the top 1% 
brightest fluorescence into a 96-well microplate.  After retransformation in the CAD-EGII strain 
with a fresh background, 29 plasmids that still conferred an improved PE fluorescence were sent 
for DNA sequencing analysis.  The retransformed yeast mutants were further analyzed by the 
CMCase assay.  Briefly, 5 OD600 unit yeast cells from overnight culture in the SC-U medium 
were washed twice with ddH2O and resuspend in 1% (w/v) CMC solution (0.1 M sodium acetate, 
pH=5).  After incubation at 30 °C for 16 hr with shaking (250 rpm), the supernatant was used for 
reducing sugar analysis by a modified DNS method
52
.  The released reducing sugar amount from 
the CMC hydrolysis by EGII was used to quantify the enzyme activity.   
 
4.4.5. Screen of glycerol-utilizing mutants 
Harvested from the SC-U plates, the RAGE2.0 library created in the CAD strain was used for 
enrichment in the synthetic SC-U 3% glycerol medium.  The CAD strain contained an empty 
pRS426 plasmid was used as the control strain.  Serial subculturing was performed according to 
Table 4.3, where 1% or 0.1% inoculum was transferred into the fresh SC-U glycerol medium 
when the cell density exceeded OD600=1 in a previous round.  The initial OD600 was 0.01 for 
both the RAGE2.0 library and the control strain.  After enrichment, single colonies were 
obtained by streaking the library onto a SC-U glycerol plate.  20 randomly picked colonies were 
examined for growth on glycerol in liquid medium.  After retransformation in the CAD strain 
with a fresh background, 20 plasmids conferring improved glycerol utilization than the control 
strain were sent for DNA sequencing analysis.  The retransformed yeast mutants were compared 
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with the control strain for glycerol utilization via an aerobic growth assay.  Overnight culture in 
the SC-U 2% glucose medium was used to inoculate 3 ml SC-U 3% glycerol medium in 14 ml 
falcon tubes.  The initial OD600 was set to 0.1, and the cell densities were monitored at 24 hr 
interval under the aerobic condition.   
 
4.4.6. Screen of isobutanol-producing mutants 
Harvested from the SC-U plates, the RAGE2.0 library created in the CAD strain was used for 
enrichment in the synthetic SC-U medium containing increasing concentrations of NVA (Table 
4.5).  The CAD strain contained an empty pRS426 plasmid was used as the control strain.  Serial 
subculturing was performed according to Table 4.5, where 1% inoculum was transferred into 
fresh selective medium when the OD600 exceeded 2.5 in a previous round.  The initial OD600 was 
0.01 for both the RAGE2.0 library and the control strain.  After the enrichment, single colonies 
were obtained by streaking the library onto a SC-U plate containing 6 g/L NVA.  20 randomly 
picked colonies were examined for isobutanol production in 14 mL sealed falcon tubes with 3 
mL SC-U medium without NVA.  After retransformation in the CAD strain with a fresh 
background, 2 plasmids conferring improved isobutanol production than the control strain were 
sent for DNA sequencing analysis.  The retransformed yeast mutants were compared with the 
control strain for isobutanol production.  Overnight culture in the SC-U 2% glucose medium was 
used to inoculate 10 mL SC-U 2% glucose medium in 125 mL un-baffled flasks.  The agitation 
was set to 100 rpm for oxygen limited fermentation.  The initial OD600 was 1, and 1 mL culture 
was taken at 24 hr intervals to measure the cell density, ethanol titer and isobutanol titer.   The 
alcohol concentrations were determined using the GC-MS program described in Chapter 2
53
.    
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Chapter 5 RAGE3.0: Automated Genome Engineering in Yeast 
 
5.1. Introduction 
Laboratory automation can greatly accelerate fundamental and applied research, by 
improving productivity and reliability, increasing throughput, and reducing experimental error 
rates due to human factors
1
.   For example, pharmaceutical industry has heavily relied on 
automation technologies to identify new drug lead compounds by screening small-molecule 
libraries
1
.  For biological system engineering, the promise of automation has been demonstrated 
by several recent examples
2, 3
.  Phage-assisted continuous evolution (PACE) executed 200 
rounds of protein evolution in 8 days, during which targeted activities effectively emerged from 
undetectable levels
2
.  Moreover, multiplex automated genome engineering (MAGE) created over 
4.3 billion combinatorial variants per day, enabling 5-fold increase in lycopene production in 3 
days
3
.  By eliminating human intervention, rapid and continuous generation of vast diversity 
space help to fully harness the power of directed evolution. 
In previous chapters, we developed plasmid-borne RNAi libraries for genetic screen in S. 
cerevisiae.  For directed genome evolution by RAGE, a separate step is required to integrate the 
selected cassettes from the plasmid library
4
, hence manual intervention is unavoidable.  To 
automate genome engineering by RAGE, it is desirable to combine the screen and integration 
steps by directly integrating genome-wide modifying cassettes into the yeast genome for library 
construction.  Nonetheless, while the transformation efficiency of an episomal plasmid can easily 
achieve a complete coverage of the entire genome, the integration efficiency needs to be greatly 
improved to create a comprehensive library.   
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It has been shown that introduction of DSBs can greatly enhance integration efficiency by 
stimulating homologous recombination (HR) rates.  In S. cerevisiae, the Delitto Perfetto system 
was used to improve targeted genome integration by 4000-fold, where a single DSB was created 
by an inducible I-SceI endonuclease and subsequently repaired with integrative recombinant 
oligonucleotides
5
.  Though effective, an I-SceI recognition site must be first introduced at the 
targeted genomic loci through the traditional methods, and this prerequisite limits the general 
application of this method.   Recently, the bacterial type II CRISPR-Cas system has been used in 
S. cerevisiae for efficient genome editing
6
.  The Cas9 nuclease and designer CRISPR guide 
RNAs (gRNAs) created specific genomic DSBs, which increased HR rates by 130-fold with 
double-strand oligonucleotide donors.  More impressively, if the gRNA was maintained on a 
plasmid and the Cas9 protein was constitutively expressed, the wild-type cells carrying targeted 
genomic sequences were negatively selected.  Therefore, only recombinant strains whose 
targeted sequences were modified by the donor DNA can survive, resulting in near 100% 
recombination frequency
6
.  However, the mutations introduced by this method are limited to the 
scale of several nucleotides that are embedded in the donor oligonucleotides.  Whether CRISPR-
mediated DSBs can increase the integration efficiency of large DNA constructs in S. cerevisiae 
is unclear.  
Delta (δ)-integration is an effective method for stable and multi-copy integration in S. 
cerevisiae
7-9.  The δ sequence in the yeast retrotransposon elements Ty1 and Ty2 is the homolog 
of the mammalian retroviral LTR
10. Approximately 250 copies of the δ sites are dispersed 
throughout the S. cerevisiae genome
11.  Hence, the δ sites are the ideal targets for high copy 
number integration, which is desirable for high level expression of a recombinant protein in S. 
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cerevisiae
12-14.  In addition, cocktail δ-integration has been used to introduce different genes 
simultaneously to construct metabolic pathways, including a three-gene cellulolytic pathway
15
 
and a five-gene isobutanol pathway
16
.  Therefore, it is possible to accommodate multiplex 
integration in the δ sites, allowing continuous accumulation of beneficial RAGE cassettes. 
 
Figure 5.1. Scheme of automated genome engineering in S. cerevisiae by RAGE3.0.  CRIPSR-
assisted δ-integration is used to continuously incorporate genome-wide modifying cassettes in the yeast 
genome. 
 
In this chapter, we sought to develop an automated genome engineering method in S. 
cerevisiae by combining RNAi, CRISPR and δ-integration technologies.  An inducible CRISPR-
Cas system was used to introduce specific DSBs in the δ sites.  A GFP-based reporter system 
was then used to optimize the performance of CRISPR-assisted δ-integration.  Finally, genome-
wide modifying cassettes from the RAGE2.0 library were continuously and iteratively integrated 
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into the δ sites (Fig. 5.1), enabling isolation of fast glycerol-utilizing mutants integrated with 
multiple RAGE2.0 cassettes.   
 
5.2. Results 
5.2.1. Design of RAGE3.0 
A δ sequence derived from the LTR2 element of a yeast transposon Ty1-H3 is used to design 
the CRISPR targeting site (δ.a) and the homologous arms (Fig. 5.2).  The δ.a sequence, 5’-
GAAGTTCTCCTCAAGGATTTAGG-3’, contains a 20 bp target site followed by “AGG” as the 
required protospacer adjacent motifs (PAM)
17.  The δ.a sequence is flanked by two homologous 
arms, δ1 and δ2, and insertion of a donor cassette will remove the δ.a sequence to avoid CRISPR 
recognition after integration (Fig. 5.2).  The expression cassette of the RAGE2.0 library is used, 
so that comprehensive genome-wide modifying cassettes can be cloned as the integration donors 
(Fig. 5.3).   
 
Figure 5.2.  Design of a CRISPR target site and homologous arms for δ-integration.   
 
A homology-integrated CRISRP-Cas (HI-CRISPR) system, which was recently developed in 
our group
18, was exploited to introduce DSBs within the δ sites.  In HI-CRISPR, the donor 
Ty-H3-LTR2
334 bp
Homologous Arm Delta 2 246-334 bpHomolgous Arm Delta1 1-218 bp
Delta .a 230-252  bp
Acc I (266)
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cassette was maintained on a plasmid to improve HR rate.  The Cas9 expression cassette was 
integrated into the leu2 locus of the CAD strain to create the CAD-PADH2-Cas9 strain.  The 
alcohol dehydrogenase II promoter (PADH2) was used to drive inducible and high level expression 
of Cas9.   A multifunctional donor plasmid was constructed (Fig. 5.3), consisting of the targeting 
CRISPR RNA (crRNA) and trans-activating crRNA (tracrRNA) cassettes to direct Cas9 to the 
δ.a sequence, a 2-micron replication origin to ensure high plasmid copy number, a KanMX 
selection marker to maintain the plasmid during induction in rich medium by the antibiotic G418, 
a URA3 selection marker for selection and curation of the plasmid, and an integration donor 
cassette.  In addition, the δ.a sequence was also incorporated immediately outside the 
homologous arms of the donor cassette (Fig. 5.3), so that linear integration cassette can be 
released in vivo from the donor plasmid upon digestion by Cas9.  
 
Figure 5.3. Design of the multifunctional integration donor plasmid 
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A complete cycle of RAGE3.0 library construction comprises three steps: transformation, 
induction and plasmid curation (Fig. 5.4).  First, the donor plasmid library harboring the 
genome-wide modifying cassettes (RAGE2.0) is transformed into the CAD-PADH2-Cas9 strain.  
During competent cell preparation and transformant selection, synthetic dropout medium is used 
to minimize Cas9 expression from the PADH2 promoter.  After 3 or 4 days, transformed cells are 
transferred into the YPA rich medium containing 2% galactose and 1 g/L G418, so that the 
glucose-repressed PADH2 promoter can be induced to express the Cas9 nuclease at high levels.  
Following induction, the cells are cultured in the synthetic dropout medium containing 5-
fluoroorotic acid (5-FOA) for plasmid curation.  The cells grown in the 5-FOA medium are then 
ready for the next round of RAGE3.0. 
 
Figure 5.4. Scheme of RAGE3.0 process.  Though manipulation is shown with solid medium in petri 
dishes, it is also possible to perform these steps in liquid medium. 
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5.2.2. Highly efficient δ-integration of a GFP reporter 
To optimize CRIRSPR-assisted δ-integration, a GFP-based reported system was devised.  
The gfp gene was inserted in the PTEF1-TPGK1 cassette of the donor plasmid (Fig. 5.3), and the 
resultant GFP-integration donor plasmid was used to perform one cycle of RAGE3.0 (Fig. 5.4).  
After plasmid curation, only the cells integrated with the GFP donor cassette retain GFP 
fluorescence, hence the percentage of GFP positive population is a fair estimation of the 
integration efficiency.  To ensure high expression level of Cas9, a modified protocol different 
from that in Fig. 5.4 was used.  In particular, competent cells were prepared using the rich 
medium YPAD, and the transformants were directly selected in the YPAD medium containing 1 
g/L G418.  When glucose was depleted, Cas9 expression from PADH2 was automatically induced 
in the same medium.  After plasmid curation in the SC+5-FOA medium, flow cytometry analysis 
indicated that very high integration efficiency was achieved (>90%) in the CAD-PADH2-Cas9 
strain (Fig. 5.5).  In comparison, there was no GFP positive population in the CAD strain 
containing no Cas9 expression cassette, indicating effective curation of the donor plasmid by 
counter-selection with 5-FOA.  If Cas9 expression was driven by a constitutive PTEF1 promoter, 
the GFP positive percentage was remarkably lower than that of the CAD-PADH2-Cas9 strain, 
probably due to the weaker promoter strength of PTEF1 compared to PADH2.  Together, an efficient 
Cas9-dependent δ-integration of a GFP donor cassette was successfully demonstrated. 
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Figure 5.5. Cas9-dependent δ-integration of a GFP donor cassette.  Left Panel: flow cytometry 
histogram.  Right Panel: the percentages of GFP positive population.  Error bars indicate standard 
deviation from biological duplicates.  No GFP control (grey fill) was the CAD strain transformed with an 
empty donor plasmid.  For all other strains, the donor plasmid containing a GFP expression cassette was 
used.  Blue line: the CAD strain.  Green line: the CAD-PTEF1-Cas9 strain.  Red line: the CAD-PADH2-Cas9 
strain. 
 
Although high integration efficiency was observed in the CAD-PADH2-Cas9 strain with the 
modified protocol, the transformation efficiency was extremely low (<10
2
 CFUs/ μg DNA).  
This is probably due to the fact that the PADH2 promoter is not strictly repressed by glucose in 
rich medium
19
.  It is speculated that under this condition, Cas9 continuously creates DSBs at the 
δ.a site on both the donor plasmid and the genome, resulting in cellular toxicity that prevents 
recovery of transformants.  Instead, if synthetic dropout medium containing 2% glucose was 
used to prepare competent cells and to select transformants (Fig. 5.4), the obtained 
transformation efficiency was comparable to the levels routinely achieved by heat shock 
transformation (10
4
 CFUs/ μg DNA).  This is consistent with a previous report that gene 
expression driven by PADH2 is at a minimal level in synthetic glucose medium
19
.  After selection 
in the SC-U medium, cells were transferred into YPA medium containing 1 g/L G418 and 
different carbon sources for induction, including 2% glucose, 2% ethanol and 2% galactose, 
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followed by plasmid curation in the SC+5-FOA medium.  A minimal level of GFP integration 
(<2%) was observed if the SC-U 2% glucose medium was used during the induction step (Fig. 
5.6, grey fill), confirming the relatively stringent repression of PADH2 promoter in the synthetic 
medium
19
.  Among different induction media, the most efficient integration was achieved with 
the YPAG induction (Fig. 5.6, blue line), though the efficiency was a little lower (~70%) 
compared to that in Fig. 5.5.  However, as a high transformation efficiency is required to create 
genome-wide strain libraries, the current protocol represents a good balance between library size 
and integration efficiency.   
 
Figure 5.6.  Comparison of different induction media on CRISPR-assisted δ-integration.   
 
To further investigate whether iterative cycles of transformation, induction and plasmid 
curation can enable accumulation of integration cassettes, an additional round of RAGE3.0 was 
performed with the GFP donor plasmid.  Seen from the flow cytometry results, the percentage of 
GFP population and the collective GFP fluorescence both increased after the second round of 
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RAGE3.0 process (Fig. 5.7), validating the effectiveness of RAGE3.0 to accumulate multiple 
genetic modifications in the yeast genome.   
 
Figure 5.7. Accumulation of GFP integration cassette by RAGE3.0.  The control strain is the CAD-
PADH2-Cas9 strain (grey fill). 
 
5.2.3. RAGE3.0 to improve glycerol utilization 
Encouraged by the results with the GFP reporter, we employed the RAGE2.0 library for 
automated genome engineering via CRISPR-assisted δ integration.  Three rounds of RAGE3.0 
were performed according to Fig. 5.4, and the solid medium was used to minimize uneven 
amplification of the strain library.  For each transformation steps, >10
6
 independent clones were 
obtained by transforming 100 μg donor library DNA.  For each transfer step between plates, 20 
OD unit yeast cells (about 10
8
 clones) were spread onto twenty 15 mm diameter petri dish to 
ensure oversampling of the library.   
148 
 
After three rounds of RAGE3.0, 10
7
 cells were screened on twenty 15 mm diameter SC-L 
plates containing 3% glycerol as the sole carbon source.  Twenty colonies with remarkably 
bigger sizes were selected for subsequent analysis.  The glycerol utilization capacity was 
investigated using a growth assay in SC-L 3% glycerol liquid medium.  All the selected strains 
exhibited substantially faster growth rates compared to the CAD-PADH2-Cas9 strain as the control 
strain.   
 
Figure 5.8. Growth of RAGE3.0 mutant strains on glycerol as the sole carbon source.  The strains 
were grown aerobically in 3 mL SC-L 3% (v/v) glycerol medium.  The initial OD600 is 0.1.  The CAD-
PADH2-Cas9 strain was used as the control strain.   
 
For the top 3 mutants with the highest growth rates (G5, G6 and G10), specific primers were 
used to amplify the integrated cassettes by PCR using genomic DNA as templates.  The PCR 
product was cloned into an E. coli plasmid, and 20 individual E. coli colonies was picked for 
each strain to prepare the plasmids for DNA sequencing.  The sequencing results indicated that 
multiple RAGE2.0 cassettes were integrated in each strain (Table 5.1).  Some common cassettes 
were identified from different strains, including a knockdown cassette for the BUL1 gene in the 
G5 and G10 strains, and a knockdown cassette for the AFG1 gene in the G5 and G6 strains.  
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Notably, the same knockdown cassette for the AFG1 gene was also identified from the RAGE2.0 
library (Fig. 4.3), suggesting the screen with the RAGE3.0 library for improved glycerol 
utilization was effective. 
 
Table 5.1. Integration cassettes of RAGE3.0 mutants with improved glycerol utilization 
Overexpression Knockdown 
Plasmid Inset information Plasmid Inset information 
G5 
G5_2-F CPR3 1-549/549* G5_11-R AFG1 1-449/1530 
G5_5-F IV 130506-130188** G5_12-R XIV 284075-284374 
G5_7-F XIV 629601-629503 G5_15-R BUL1 2140-2931/2931 
G5_9-F UBR1 5453-4982/5853   
G6 
G6_1-F RKI1 1-777/777 G6_14-R MOS1 1-294/294 
G6_4-F MRPL36 1-534/534 G6_15-R XIII 28149-27978 
G6_5-F PFY1 1-381/381 G6_17-R YSF3 1-258/258 
G6_7-F HYP2 1-474/474 G6_18-R AFG1 1-449/1530 
G6_8-F ERG6 829-1152/1152
$
 G6_19-R YLR446W 1-408/1302 
G10 
G10_1-F RPL10 1-666/666 G10_11-R BUL1 2140-2931/2931 
G10_2-F STE4 435-1272/1272
$
 G10_12-R SOD1 1-465/465 
G10_4-F RPP1A 1-321/321 G10_13-R V 130506-130188 
G10_5-F FMC1 1-468/468 G10_18-R XVI 436924-437120 
* For the genes, A-B/X indicates that the inset corresponds to the A-B bp region of the gene’s ORF, 
whose length is X bp. For overexpression cassettes, A indicates the nearest nucleotide to the PTEF1 
promoter, while for knockdown cassettes, A indicates the nearest nucleotide to the TPGK1 terminator. 
** If the fragment is not from an ORF, the location is denoted as a reference to the chromosome. 
$
 Some overexpression cassettes do not contain complete ORFs. 
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5.3. Conclusions and Future Prospects 
In this chapter, we successfully developed a highly efficient δ-integration method to enable 
automated genome engineering in S. cerevisiae.  In a single round of transformation, more than 
10
6
 independent clones can be obtained, and about 70% cells are modified without any selection 
marker.  Coupled with the comprehensive genome-wide modulating cassettes from the RAGE2.0 
library, continuous genome evolution has been achieved.  Compared to another automated 
genome engineering method MAGE in E. coli
3
, RAGE3.0 achieved substantial improvement in 
many aspects, including but are limited to recombination efficiency (MAGE can modify 30% 
cells per single transformation), and the scale of genetic targets (from dozens of predefined 
genomic loci by MAGE to the genome-wide modifications by RAGE3.0).  Together, this is the 
first example of automated genome engineering in a eukaryote.  
There are two search dimensions for genetic modifications conferring an improved trait.  
First, genotyping to find relevant genes of a given phenotype, mostly by screening genome-wide 
strain libraries including overexpression
20, 21
, knockout
22-24
 and knockdown
4, 25
 modifications.  
Second, fine-tuning gene expression of many relevant targets simultaneously to search for the 
best combinations, mostly via combinatorial modulation on promoters
26
, RBSs
3
 and intergenic 
regions
27
 of predefined gene sets.  Theoretically, some positive genetic modifications can only be 
identified when these two search efforts are performed at the same time.  These modifications 
may be moderately beneficial, neutral or even detrimental to a given trait when introduced 
individually, but will confer a remarkably improved phenotype when introduced simultaneously.   
Different strategies have been used to identify these beneficial genetic combinations.  For 
example, double-mutation strain libraries have been constructed by the synthetic genetic array 
(SGA) method to systematically investigate genetic interaction network
28-30
.  Global 
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Transcriptional Machinery Engineering (gTME) introduces mutations into key transcription 
factors to modulate hundreds of genes simultaneously
31, 32
.  RAGE3.0 may also serve to identify 
beneficial combinations of genetic modifications, as multiplex modifying cassettes can be 
incorporated in a single cell (Table 5.1).  This multiplex property can be attributed to two factors.  
First, several donor plasmids can be taken up by a single cell during transformation, and the 2-
micron replication origin allows co-existence of multiple plasmids for subsequent integration.  
Second, the RAGE3.0 cycle can be iteratively performed with minimal human intervention, 
hence integration cassettes from different rounds can be accumulated.   
It should be noted that due to the vast combinatorial space of multiple genome-wide 
modifications, it is not possible to cover all the combinations even only considering digenic pairs 
(~6000 yeast genes give rise to ~10
4
 single overexpression/knockdown modifications and ~10
8
 
double mutations, while the library size in each round is about 10
6
).  All the automated genome 
engineering strategies will inevitably face this limitation due to finite transformation efficiency, 
although it has been proposed that through successive cycles of diversity generation, more 
variants can be cumulatively generated to exceed the actual size of the cell population in a single 
cycle
3
.  The same argument is also valid for RAGE3.0.  As RAGE3.0 involves only simple liquid 
handling steps, it is readily automated by a robotic liquid handling station for continuous genome 
engineering practice.  On the other hand, even the library size at any single round may reflect 
only a subset of all the theoretically possible variants, beneficial genetic combinations may still 
be identified.  For example, 170,000 interactions were identified from 5.4 million digenic pairs in 
S. cerevisiae
30
 (by crossing 1711 queries to 3885 array strains), indicating the prevalence of 
genetic interactions (3%).  Therefore, it may be possible to isolate a few synergistic 
modifications from a 10
6
 library.  In the future, it will be helpful to further analyze how multiple 
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genetic modifications collectively or synergistically confer improved glycerol utilization in the 
mutant strains isolated in the chapter. 
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5.4. Methods and Materials 
5.4.1 Strains, media, and cultivation conditions 
S. cerevisiae strain CEN.PK2-1c (MATa ura3-52 trp1-289 leu2-3,112 his3Δ1 MAL2-8C 
SUC2) was purchased from EUROSCARF (Frankfurt, Germany).  The CAD strain containing a 
reconstituted RNAi pathway was constructed previously
4.  Zymo 5α Z-competent E. coli (Zymo 
Research, Irvine, CA) and NEB 10β Electrocompetent E. coli (New England Biolabs, Ipswich, 
MA) were used for plasmid amplification and library construction, respectively.  S. cerevisiae 
strains were cultivated in either synthetic dropout medium (0.17% Difco yeast nitrogen base 
without amino acids and ammonium sulfate, 0.5% ammonium sulfate and 0.083% amino acid 
drop out mix, 0.01% adenine hemisulfate and 2% glucose) or YPAD medium (1% yeast extract, 
2% peptone, 0.01% adenine hemisulfate and 2% glucose). For glycerol utilization, 3% (v/v) 
glycerol was used instead of 2% glucose in the synthetic dropout medium.  For induction, 2% 
ethanol or 2% galactose was used instead of 2% glucose in the YPA medium.  The induction 
medium was also supplemented with 1 g/L G418 to maintain the donor plasmid.  For plasmid 
curation, 1 g/L 5-fluoroorotic acid (5-FOA) was added into the synthetic dropout medium 
(pH=4).  S. cerevisiae strains were cultured at 30 °C and with 250 rpm agitation in baffled shake-
flasks for aerobic growth, and at 30 °C and 100 rpm in un-baffled shake-flasks for oxygen 
limited fermentation.  E. coli strains were cultured at 37 °C and 250 rpm in Luria broth (LB) 
medium (Fisher Scientific, Pittsburgh, PA) with the supplement of 100 μg/mL ampicillin.  All 
chemicals were purchased through Sigma-Aldrich or Fisher Scientific. 
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5.4.2. DNA manipulation 
Plasmid cloning was done by Gibson Assembly Cloning Kit from New England Biolabs 
following the manufacturer’s instructions or by the DNA assembler method33.  The list of 
primers used in this chapter can be found in Table 5.2.  For DNA manipulations, yeast plasmids 
were isolated using a Zymoprep II yeast plasmid isolation kit (Zymo Research, Irvine, CA) and 
transferred into E. coli for amplification.  QIAprep Spin Plasmid Mini-prep Kits (Qiagen, 
Valencia, CA) were employed to prepare plasmid DNA from E. coli.  All enzymes used for 
recombinant DNA cloning were from New England Biolabs unless otherwise noted.  The 
products of PCR, digestion and ligation reactions were purified by QIAquick PCR Purification 
and Gel Extraction Kits (Qiagen, Valencia, CA).   
The integration of the Cas9 gene was performed with the help of the pRS405 plasmid.  
Briefly, the PTEF1-Cas9-TADH2 or PADH2-Cas9-TADH2 cassettes from a previous study
18
 were 
subcloned into the multiple cloning site of the pRS405 plasmid.  The recombinant pRS405 
plasmids were then linearized in the middle of the LEU2 marker, and transformed into the CAD 
strain.   
The GFP-donor plasmid was constructed as follows.  First, the BsmBI site in the URA3 
maker of the pRS426 plasmid was removed with the primers PR361/PR362 using the Q5 Site-
Directed Mutagenesis Kit from New England BioLabs, resulting in the construction of pRS426-
mut.  Then, a PSNR52-BsmBI-TSUP4 cassette for crRNA expression was PCR amplified with the 
primers PR364/PR365 from the pCRCT plasmid
18
.   The crRNA cassette was then inserted 
between the two BsmBI sites on the pRS426-mut backbone via Gibson assembly to create 
pRS426-mut-PSNR52.  Then the crRNA targeting the δ.a site was constructed through Golden 
Gate assembly method as previously described
18
 with the primers PR346/PR347.  The resultant 
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pRS426-mut-PSNR52-crδ.a plasmid was then linearized by PCR with the primers PR436/PR437, 
and used for insertion of the homologous arms by Gibson assembly to create pRS426-mut-
PSNR52-crδ.a-LTRout.  The homologous arms were synthesized as gBlocks Gene Fragment 
PR432 (Integrated DNA Technologies, Coralville, IO).  Two δ.a sequences flanking the 
homologous arms and a PmeI site separating two arms were incorporated during DNA synthesis.  
The GFP expression cassette was amplified from the plasmid pRS405-TEF1p-GFP-PGK1t in 
Chapter 3 with the primers PR451/PR452, and inserted at the PmeI site of pRS426-mut-PSNR52-
crδ.a-LTRout.  The resultant plasmid pRS426-mut-PSNR52-crδ.a-LTRout-PTEF1-GFP-TPGK1 was 
linearized by PCR with the primers PR438/PR516, and used in Gibson assembly to be spliced 
with the KanMX cassette amplified from the pUG6 plasmid with the primers PR511/PR512, and 
the tracrRNA cassette amplified from the pRPR1p-tracrRNA plasmid
18
 with the primers 
PR513/PR514. The final construct, pRS426-mut-PSNR52-crδ.a-LTRout-PTEF1-GFP-TPGK1-
KanMX-tracrRNA, was used as the GFP donor plasmid.   
The same expression cassette in the RAGE2.0 library, PTEF1-TPGK1, was used in the 
integration donor, hence the construction of the donor plasmid library followed the same 
procedure described in Section 4.4.3.  Briefly, the GFP donor plasmid was processed into 
backbone vectors for RAGE2.0 library construction, by replacing the gfp gene into the ccdB gene 
flanked by two 15 bp adaptor sequences with the primers PR608-PR611, as specified in Section 
4.4.3.   
 
5.4.3. RAGE3.0 cycle: transformation, induction and selection 
The donor plasmid library was used to transform the CAD-PADH2-Cas9 strains by the 
standard LiAc/ssDNA/PEG protocol
34
 with an optimized condition, where 50 μg plasmid DNA 
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was used to transform 40 OD600 unit competent yeast cells by heat shock at 42 °C for 1 hr.  More 
than 10
6
 independent yeast clones were obtained in each round using the optimized protocol.  
The yeast transformants were amplified on twenty 15 mm SC-U plates for 4 days.  Cells were 
harvested from the SC-U plates, and 20 OD600 unit cells were spread on twenty 15 mm diameter 
YPAG plates containing 1 g/L G418.  Cells were collected after 2 days, and 20 OD600 unit cells 
were spread on twenty 15 mm diameter SC-L plates containing 1 g/L 5-FOA (pH=4) and 
allowed for growth for 3 or 4 days.  Then 20 OD600 unit harvested cells were inoculated into 20 
mL SC-L liquid medium containing 1 g/L 5-FOA (pH=4) in a 125 mL baffled flask.  After 
cultivation for 1 day, 10 OD600 unit cells were used to prepare competent cells in the SC-L 
medium for the next round of RAGE3.0.   
The RAGE3.0 procedure can also be performed with liquid medium with some modifications.  
In particular, after transformation, all the cells were transferred into 50 mL SC-U medium to 
grow for 3 days.  Then a re-inoculation step was included to minimize the presence of 
untransformed cells, by inoculating 20 mL fresh SC-U medium with 20 OD600 unit cells.  After 
cultivated for 1 day, 20 OD600 unit cells were transferred into 20 mL YPAG medium containing 
1 g/L G418, and induced for 2 days.  For plasmid curation, 20 OD600 unit induced cells were 
resuspended in 20 mL SC-L medium with 1 g/L 5-FOA (pH=4) to grow until saturation.  The 
cultivation in the SC+5-FOA medium was repeated once, and the cells were ready for the next 
round of RAGE3.0. 
 
5.4.4. Analysis of the GFP reporter system 
To ensure high expression level of Cas9, a procedure modified from the protocol in Section 
5.4.3 was used.  Specifically, competent cells were prepared using the rich medium YPAD, and 5 
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μg GFP-donor plasmid was transformed into the yeast strains.  For the negative control, 5 μg 
empty donor plasmid was used.  The transformants were selected in the YPAD medium 
containing 1 g/L G418, and then automatically induced in the same selection medium when 
glucose was depleted.  To obtain a high transformation efficiency, the same protocol in Section 
5.4.3 was used, where synthetic dropout medium was used for competent cell preparation and 
transformant selection, and induction was performed as a separate step.  Different carbon sources, 
including 2% ethanol, 2% glucose and 2% galactose, were used in the induction YPA medium.  
In all cases, after plasmid curation, GFP fluorescence was analyzed by a LSR II Flow Cytometer 
(BD, Franklin Lakes, NJ).   
 
5.4.5. Screen of glycerol-utilizing mutants 
After three rounds of RAGE3.0, 10
7
 cells were screened on twenty 15 mm diameter SC-L 
plates containing 3% glycerol as the sole carbon source.  Twenty colonies with remarkably 
bigger sizes were selected for subsequent analysis.  The yeast mutants were compared with the 
control strain (CAD-PADH2-Cas9) for glycerol utilization via an aerobic growth assay.  Overnight 
culture in the SC-L 2% glucose medium was used to inoculate 3 ml SC-L 3% glycerol medium 
in 14 ml falcon tubes.  The initial OD600 was set to 0.1, and the cell densities were monitored at 
12 hr interval.  The genomic DNAs of the G5, G6 and G10 strains were isolated by Wizard 
Genomic DNA Purification Kit (Promega, Madison, WI).  Specific primer pairs, PR615/PR616, 
and PR617/PR618, were designed to PCR-amplify the integrated overexpression or knockdown 
cassettes, respectively.  The PCR products were cloned into the empty donor plasmid via Gibson 
assembly, and individual E. coli colonies transformed with the Gibson assembly reaction mix 
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was picked to prepare the plasmids.  DNA sequencing analysis was performed with the primers 
“S TEF1p For” and “S PGK1t Rev” in Chapter 3.   
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Table 5.2. List of primers used in this chapter 
 Primer name Primer sequence (5’3’) 
PR361 p416-ura3-Mut For ATGACAAGGGTGACGCATTGG 
PR362 p416-ura3-Mut Rev CTAAACCCACACCGGGTG 
PR364 pRS-BsmBI-SNR52 For ATCACGAGGCCCTTTTCTTTGAAAAGATAATGTATG 
PR365 SUP4-BsmBI-pRS Rev CAGACAAGCTGTGACAGACATAAAAAACAAAAAAAG 
PR346 crDelta-2 F AAACGAAGTTCTCCTCGAGGATATG 
PR347 crDelta-2 R AAAACATATCCTCGAGGAGAACTTC 
PR432 
(gBlock) 
pRS-H3LTR-end-out 
(pRS-homolog-δ.a-arm δ1-
PmeI-arm δ2-δ.a-pRS-
homolog) 
AATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGGAA
GTTCTCCTCGAGGATATAGGTGTTGGAATAGAAATCAACTATC
ATCTACTAACTAGTATTTACATTACTAGTATATTATCATATACGGT
GTTAGAAGATGACGCAAATGATGAGAAATAGTCATCTAAATTAG
TGGAAGCTGAAACGCAAGGATTGATAATGTAATAGGATCAATGA
ATATAAACATATAAAATGATGATAATAATATTTATAGAATTGTGT
AGAATTGCAGATTCCCTTTTATGGATTCCTAAATCCTTGAGGAGT
TTAAACGAACTTCTAGTATATTCTGTATACCTAATATTATAGCCTT
TATCAACAATGGAATCCCAACAATTATCTCAACATTCACCCATTT
CTCAGAAGTTCTCCTCGAGGATATAGGTCACTGCCCGCTTTCCA
GTCGGGAAACCTGTCGTGCCAGC 
PR436 pRS-H3LTR-up Rev CCTGATGCGGTATTTTCTCC 
PR437 pRS-H3LTR-down For CCAGTCGGGAAACCTGTCG 
PR438 pRS-H3LTR-down Rev CGACAGGTTTCCCGACTGG 
PR451 LTR-out-TEF1p For GATTCCTAAATCCTTGAGGAACACACCATAGCTTCAAAATG 
PR452 LTR-out-PGK1t Rev ACAGAATATACTAGAAGTTCCAGGAAGAATACACTATAC 
PR511 crD2-KanMX For CGGGAAACCTGTCGTGCCAGTAGGTCTAGAGATCTGTTTAGC 
PR512 KanMX-Rpr1 Rev GTTATGTTCAATTGGCAGATCATTAAGGGTTCTCGAGAGC 
PR513 KanMX-Rpr1 For GCTCTCGAGAACCCTTAATGATCTGCCAATTGAACATAAC 
PR514 Rpr1t-pRS Rev ATTCATTAATGCAGCCGCGGTCTTTCTGTATCGCAAATAAG 
PR515 crD2-dKanMX For CGGGAAACCTGTCGTGCCAGACATCCGAACATAAACAACC 
PR516 Rpr1t-pRS For CCGCGGCTGCATTAATG 
PR615 TEF1p-15F For AATCTAAGTTTTAATTACAAAAAGCAGTGG 
PR616 15F-PGK1t Rev TCGATTTCAATTCAATTCAATCGGGGTACG 
PR617 TEF1p-15R For AATCTAAGTTTTAATTACAAACGGGGTACG 
PR618 15R-PGK1t Rev TCGATTTCAATTCAATTCAATAAGCAGTGG 
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